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JC virus (JCV) is a ubiquitous human neurotropic
polyomavirus and is the etiological agent of the human
delllyelinating disease, progre8sive tIlultifocal
leukoencephalopathy (PML). clinically, PML is found when
immunodeficiency is caused by neoplasia, chronic disease, the
illlllunosuppressive chemothe.rar-y used for organ transplantation
and, more recently, AIDS. JCV is closely related to two other
polyomaviruses, BKV and SV40 . Unlike BKV and SV40, JCV has a
narrow tissue-tropism to glial cells. Several lines of
evidence were used to attribute the JCV neurotropism to thd
viral regulatory region, which is organized as two 98 bp
repeats.
Previous studies from our laboratory demon strated glial
cell-"Ipecltic expression of JCV in differentiating P19
embryonal carcinoma cells. The specificity was shown to be
conferred by the NF-l Dlotlfa preaent in the JCV regulatory
region (Nakshatri II Al ., 1990a; Kumar At 41., 1993) . A eDNA
encoding a factor that binds ee the JCV HF-l motif was cloned
from a P19 glial cell eDNA library (KWllar, 1994) .
The objective for this thesb was to characterize this
eDNAto understand its role in the expression and lifecycle of
JCV. First, the eDNA sequence was determined . The analysis of
the sequence of the eDNA revealed a significant homology both
at protein and nucleic acid levels to a recently characterized
fact o r i nter ac ting wi th BcI-2 prot o-oncoq en e p r ota i n called
BAG··l. Howe ver , the cDNA isolated i n cu r laboratory has a
different 3 ' -end (nt 710-97 3). Therefore the cDNA wa s na aed
1z.A9.=2. The 3 ' - end of t he eDNA a ppeared to be altornativClly
s pUced, becauae t he point of divergence of the eDNA s e que nc e
froa that of bAs::.l VllS a co nsensus splice IIl te .
The ~ e DNA encoded a maj or 30 kDa prote i n , a s
de terllline d by~ translation. The~txQ-trans l ated
BAG-2 protein was bou nd s pecifically t o the JCV NF-l II/III
ol i gon uc l eot i de and to the JCV enh an c e r , .s de t ertlli ned by
mobility shift llnd So ut hwes ter n b lot assays . Fur t he r, t he
t r llns fected~ -::DHA speci!ic a Uy tranaa ct ivated JCV early
(JCVf ) and l at e (JCVL) p ro Doters in no n-qUal HeLa cel l. and
the t r a nsactivatlon required t he i ntegrity o f the J CV NF-l
moti fs . The recombinant BAG-2 produced i n bacteria stiaulated
JCVf t r an s c r i p t i on ..I..n.....Y.1. b y 3-fo ld , further sU9gesting t hat
BAG-2 controls transcription. InterClstingly . overexpression o f
BAG-2 i n P19 911al cells i nh i bited t he activated, but not the
basal, level o f t r an s c r i p t i on of both J CV. and J CVL in a d ose
dependent llIanne r. Howeve r, Buch a n i nh ib i tory effect wa e not
observed in U87 HG human gUoblastolll& cells . These r e s ults a re
re':Ilinlsc ent of tho s quelching observed f or eUka ryotic
trsnsc ript ion f actors. The~ an d 2 IIRNAe were 8xp res8ed in
mouse embryonal carcino lllil a nd human ce rvical cells but not i n
U87 HG cells . However , the BAC· 2 s pecific c-termlnus was
e xpres s ed on ly i n Pig c e lls .
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Del etion an alysis of BAG- 2 revea l ed t hat t h e C-ter1llinus
(a . a 19S-229 ) v a a e aae nt ia l fo r t r a naac t i va t i o n . whil e the
cent ral a-h e lic a l r eq i on waa import ant for DNA-binding' .
ThoUg'h, the BAG-2 C-t.~inua waa ob aerved i n Pl9 VD. glial and
. uscle celh" . only in PI9 g lial cella waa BAG-2 t rans l oc a t ed
i nto t he nuc l eua . This was f urther co nfirmed by Southwestern
blot ana lysis with nuclear ex tracta t roll these cells.
Th/l BAG- I i a impo rtant for modulating c e ll death . s inc e
SAG-2 s howed a s ignificant homology t o BAG-I, I t e s t e d t hCl
elfact of BAG- 2 o n pS3 promoter to delineate its possible. rol e
in apoptosi s . The BAG- 2 neg atively r egUl ated t he mouse p 5J
prollloter , as re vealed by CAT usays . Thu a . the BAG- 2 migh t
prote c t v i r ua- i n f e c t ed cella from pS J - induced ap op tosis by
decreas ing the express ion l evels of p5J. A model wa s proposed
t o explain t he latency of JCY out_Ide the central nervous
sy ate. (CNS) and. :ICY 911 al cell-apacific e xpression in CNS. In
the model. BAG-2 ia a nove l tranacript ion factor that
JDOdul a t es the expression of J CY differentially i n glial and
non-qlial ceUa. In the former it activates the expression of
JCV as a t r a ns c r i pt i on f actor i n the nucleus, explalnln9 the
neurotropism of scv, In the l a tter i t i nh i bits t he apoptosis
induc e d by p5J thu a . a llowing t he v i rus t o pers i st for
pro longed time.
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1.1 General Introduotion
'rhe overall objective of bioloqical research is to
understand the basic proce sses of life . This knowledge can
then be ap p lied in l earning new strategies for t"~rrecting
anomalies in the physioloqical mi l ieu and t o control the
invasion by microbes, in an effort to preserve ho meostasis .
"Life" can be derined as a complex mosaic of organ, tissue,
cellular and subcellular orqanizatiol' endowed with the
propensity of qenetic c ontinuity through self-replication.
Therefore, the study of viruses lios close to the heart of
biology, because the study of vi ruses not only encompasses
the study o f life processes but also ent wi nes p athological
processes .
studying vi ruses to under s t an d the complex process or
cell regulation is not an unfami liar co ncept . Si mi an vi rus 40
(SV40) is an excellent mod el for s t u d yi ng DNA r e p licat i on and
t r anscr ipt i o n . Also, the huma n ne u r ot rop i c JC v i ru s (JCV)
represents a 900d model to understand brain-specific qene
expression. JC'/ is a member of the polyomaviruses of the
fully , papovaviridae (Shah , 19 90). JCV i s the etioloqical
aqent tor the sUbacute fatal demyelinatinq disease called
progressive multi foca l leukoencephalopathy (PML) . The f i r s t
description of PKL wa s a8 a "unique and non-class i fiable
process" , ....ith discrete areas of demy elinat ion and bi z a r re
e n 1 a rqe d astrocytes i n two patients (Hallervorden. 19 3 0 ).
Later, PML was described. as a disti nct clinica l entity in
chronic lymphocytic leukaemia lind Hodqkln
's IY1llphoma. patie n ts
on the ba sis o f unique pa t holog i cal f e a tu res , like e xtensive
demyeli.nation , abnormal oli qodendrogl ial nuclei and qiant
astrocytes (Astrom n 41. , 1958) .
A v i ral etiology fo r PML w as 8u~pected ....hen i nclusion
bodies det ect ed i n the nucl ei of i nfected
oligodendr ocytes (ca vanaugh & A1,., 1959). Mor p h ol og i cal
evidence to f urth er sup p or t t his obs erv ation W A S first
obtained ....hen part icles resembling pol yomavi r us wer e found i n
the nuclei of ol1godend r o cyt e s with i nclusion b odies by
e l ect r o n mic r oscopy (ZU Rhein an d Chou, 19 65 ; ZU Rhe in, 1967) .
Subs e que ntlY, a pol y o ma v i r us was is olated frolll a PML patient
a n d named JCV af t er t he initials ot the patient (Padgett I..t
Al,- , 1971 ) . At the same time, anot h e r vi rus with s imilar
characteristics as J CV was i solated fro1ll t he urine of a renal
transplant p atient, and n amed BK virus (BIN ) a.fter the
initials of the patient (Gardne r §t ll. , 1971). U t h o uqh both
we re associated with i mmunosuppres si on and fou nd in urine, BKV
wa s never- f" l;,n::1 i n the bra i n of PML patie nts . Furthermore, BKV
was detect ed more frequent1y t han JCl/ in th e urine (Arthur n
A.l.- , 198.5 ,1988 1 Berger & Al ., 19 87). Although an SV40-1ike
ag e n t Was also i solated from the PML pa t ient , thQ r01. ot this
aqent in PML patho1oqy was unclear (Wei ner .t..t 4.l., 197 2) .
However. overwhelming evidence now indicates that J CV i s the
actual etiological agent of PML (Stoner and Ryschkewitsch,
1991 : !izuru n Al . , 1993) .
J C viru s is a ubiquito us hu man s ymbi ote and
se r o epi d e lllio l oqy studies suggest that the virus is world wi de
in distribution, with an overall prevalen ce in adu l t s of 69'
(Wa l ker and Padgett, 1983) . The spread o f J C'I is postulated to
be by oral or respiratory means (Shah, 1990). So on after
entering the body , JCV re mains latent in the ki d ne y (Arthur.it.
1.1 . , 1988). This conc l u s ion was ba sed on ob se rvations t hat J CV
DNA "dS detected in the kidneys of normal individuals by ONA
hybridization me t hods ( Ches ters fir. Al ., 19 83 : Gr innel l J.t SIl.,
1983) , sU9 ges t i ng that t he k i dn ey is a n impo r t a nt s i t e of
vi r a l persistence . Persis tence r ep rese nts a latent no n-
productive infecti on . Reac tivation of JCV is believed to occur
under the cond i t i ona of immunosup pre ssion obs,,- rv e d in bo ne
mar r ow a n d renal t ransplant r ecipients , in pregnant women, in
elderly individuals , in cancer and in AIDS (Coleman §..t .ill . ,
1983 ; Hoqan J.t. Al . , 1983 1 Gardner II Al ., 1984 1 Arthur n Jll .,
1988 ; Xi t alltur a §.t Al., 1990) . Further s upport for the above
hypothesis comes from the observat ion that a protein that is
inducible by c ytokines regulated J CV e xpre s sion (Raj and
Khalil i, 1994).
Interestingly, J CV DNA was identified i n spleen B cells,
bone marrow and brain parenchyma (HOUff .!1t: AJ.., 1988) . This
suggests t hat r eactivated JCV may en ter the c entral nervous
Bystelll (CNS ) vi a infected B cells and th iB ent ry u y be the
initial event in PML (revi ewed In Cre enl • • , 19 9 0, Major R
Al., 19 92). A ha e matoq e nouf, lIIode of sp read is also supported
by the na t ure of th e mul ti rocal de. yd inatInq l es i o n s and
their location near the grey-white ma tter junctions , where tho
arteriole s end (Frls que and Whi te , 1992). Also, thea
unintegrated fo rm of J CV DNA was detected In livsr , spleen,
l ymph node, and lung to further c onfirm t he hasmatogenous
spread (Gr i nnell m. AI.. 1983).
Most cases of PML are believed to be the consequence of
r eactivated Infection during i lllllunos uppression. Hence, the
appearance of JCV in t he AI DS popul atIon is rdat ivaly
frequent. AI DSacc ounts f or near ly 5 5- 85\ o f the recent cases
of PML (Krupp J.t Al ., 1 98 5; Be rq er .n Al. , 1987 ) . supporting
the notion th at J CV is ass o ciated with i lUlun o sup pr ess1o n .
Furth ermo r e, dire ct I nteract i on of a human Immunodefi cienc y
vIrus (HI V) .t.1:A.m- requlatory pr o tein Tat wi th the J CV
roqulatory reqion wa s demon s trated and thIs i nt era ction
requlated the t ranscription of J CV (Ta da .c:.t. al ., 19 90). Recent
evidenc e indIcate s tha t 4-5\ of patients with AIDS devo!lop PML
(Berger Jlt. J..l., 19 87; Levy ~ A1,., 1988: Quinlivan .tlt Al.,
1992) . Thus, this formerly rare disease, once regarded as
clinical curiosity, ha s lately become remarkably common. PHL
is the ca u s e ot' death of 2-4\ ot AIDS patient. in North
America (Markovitz tt. A.l ., 199 31 .
An assoc 1ation of PML was also observed in lymphatic
leukaemia and HOdgkin I s l ympho ma (AstroID. It .sU., 1958).
I mportantly, PML, the once rare diseas e, is noW' more common
because of widespread use of i1lllllunosupprsssive chemotherapy in
organ transp1!lnt recipients (Gardner It Al.., 198 4 ; Arthur .!It.
A,l. , 1988) . R8cently, JCV was a180 implicated in the etiology
of multiple sclerosil (MS) (stoner, 1991) .
Studies on the neurooncoganicity of J CV are s c a nty .
However, the existing r eports demonstrated that the
intracerebral inoculation of hamsters Io'!th J CV resulted in
medulloblastomas, astrocyt omas , g1 iobl astol'llas, peripheral
neuroblastomas , me ning i omas and r e t i nobl a s t omas (Walker II
Al., 1973; zu Rhein, 1983) . A similar i noc u latio n of owl and
squirrel monke y.J resulted in astrocytomas and neuroblastomas
(London It ill . , 1978, 1983) . Thus, JCV, unlike SKV and SV40,
is the only pol y o mavi r u s that induces tumors i n non-human
primates . JCV was shown to induce gliomas in PML patients
( Sima n AJ.., 1983) .
Transgenic mice harboring the J CV early region were
developed to study virally-induced tu mors and PHL. Some
animals developed adrenal neuroblastomas wh ich subsequently
metastasized to the brain and digestive system (Small ~ ill.,
1986b) and some anbals s uf fe r e d from dysmyelination of the
eNS but not of the pBripheral nervous system (PNS) (Small §.t.
Al., 1986a; Haas J.t. Al ., 1994). Further studies have
dellonstrated that JCV larCjlB tUJllor (T) antigen was expressed
mainly i n oliCjlodendrocytes of these transgenic mice (Trapp .It.
Al., 1988). The same study also observed the down-regulation
of myelin-specific genes, like myelin basic protein (MBP),
proteolipid protein (PLPl and myelin associated glycoprotoain
(MAG). Since T-antigen expression was observed in the cells
that produce myelin, it was thought that T-antiqen altered the
expression of Ilyelin-specific genes and the maturation or
oligodendrocytes (Trapp Jlt Al., 1988) . However , the mechanism
of dysmyelination remains unclear.
As a group, polyomaviruses served as Illodels for
addressing various biological conundrums, ranging frOlll cancer
to the regulation of gene expression. continued study of the
lllolecular bioloqy of JCV may eventually open new vistas in
JCV1s PML pathoqenicity and neurooncogenicity . Specifically,
this knowledge may help in finding a cure or prevention
strategy for PML. Generally, the information may shed light on
the brain disorders that devastatlll the lives of so lIIillion
Americans, with an economic impact of $400 billion (Scientific
American, 1994).
1.2 JCV
1.2.1 a.DOIII.
The genome of JCV is a covalently closed circular,
double-stranded DNA molecule consisting of 5,130 bp (Fig . 1.1;
Frisque S!t .A..l.., 1984). The viral genome codes for two
regulatory proteins, T and small tumor (t) antigens; three
viral structural proteins YPl, YP2, VP3; and a 7.9 kDa protein
called the agnoprotein since its function is not known.
Sequence analysis revealed that the JCV genome was organized
as three functional regIon!:' . The early region is proximal to
the oriqin of replication, the late regIon Is distal to the
origin of replication and the non-coding or regulatory region
is located between the early and late regions. The regUlatory
region contains the promoter-enhancer signals that
important for transcription and the core elements for DNA
replication.
The early region codes for two proteins, T- and t-
antigens. A sinqle cpen reading frame (ORF) codes for both T-
and t- antigens but an alternative splicing event generates
two mRNA species. Therefore, these two proteins have same N-
terminal end but different c -terminal enda. The JCV T-antlgen
has not been studied in detail. Nevertheless, the existing
data suggest that it is essential for DNA replicat ion (Lynch
and Frisque, 1991), v i r al - i nduce d cellular transformation
(Frlsque II A,l., 1980: Bollag llll., 1989; Haggerty §.t. ill.,
1989) and ~-regulatlon of JCV late promoter. The latter
determines the transition of transcription from the early to
the late stage (Lashagari n Al., 1989; Nakshatrl n Al,.,
1990a; Tada n ill., 1990). Despite 92\ hOlllology between JCV
and SV40 t-antiqens, JCV t-antigen is not effective in
enhancing transforJllation, especially under conditions in which
the concentration of T-antigen is limiting (Haggerty n li.,
19(19) .
Fig. 1.1. Circular map of the JC!V gene•••
The late and early regions are shown in clockwise and
anticlockwise directions, respectively . The numbers indicate
the nucleotide positions . The locations of core origin of
r eplIcation and regulatory reqion are indicated at the bottom.
The reqions A and B i ndicate the two 98 bp tandem repeats of
the requlatory region . The large open arrows inside the circle
indicate the open reading frames of larq8 and ama1l tumor
antigons, respsctively . Ths wavy line indicates the intron
sequence in the large T-antigen coding sequence. The open
ar-rows outside the circle i ndicate the open reading frames of
viral s t ru ctur a l proteins and of agnoprotein . The figure is
not drawn t o scale.
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The late region codes f or the Ilgnoprotein and three viral
structural proteins, namely VPl, VP2 and VPJ. The slIlallest ORF
is at the 5 I end of the late coding region and encodes the
agnoprotein, whIch may be involved in the v i r al capsid
assembly (Hou-Janq n Al . , 1987 ) and has DNA binding c a p a c i t y
(Jay .I..t. ll• • 19B1) . The larqest ORr is at the ] ' end and codes
for VPl. the major v i r i on structural protein. Sequences
between the 5 ' and 3 I ORrs of agnoprotein and VPl e nc ode VP2
and VP3 (see r ig . 1.1; Frisque n ill . , 1984) . J CV exhIbits a n
extens i ve 70\ s e quenc e homology with SV40 an d 75\ wIth hu man
BK virus (BKV) and t be homology is weakest in the no n ccd Inq
region (Osborn n .ill. , 1974 1 Howley n y ., 1976). Unlike BKV
and SV40, the J CV Mad-l strain is strictly neurotropic and
replicates efficiently only in cultures which are rich in
sponqioblasts or astrocytes (Pa dgett II Al ., 197 7 ; Major and
veeenee , 1989).
Most of the JCV isolates were derived from brain tissues ,
k i dne ys and urine of PMLpatients and a few were from urine of
transplant recipients or normal i nd l v fdue La , The first
isolation of JCV was r eported from Madison, Wisconsin after
cultivation of JCV i n primary human fetal qlial cells (PHFG)
(Padgett n Al,. I 1971) . It was referred to as the Mad-1 strain
and was designated as the " pr ot ot ype " , since no rearrangements
were observed in the viral genome during continuous passage in
culture . Mad-l has two 98 bp tand•• repeat. of regUlatory
region with a uniquely duplicated TATA bo x (Martin n 41.. I
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1985). Subsequent isolates were designated Mad-2 , Mad-4
etc.
The genomes of JCV from urine of non-PML patients
revealed a 23 bp insertion In the regulatory region which is
absent in the Mad-l strain (Martin Jlt J.l., 19S3) . A 66 bp
insertion was also found in these genom8s between nucleotide
position (nt) 80 and 98 of the t and em repeats (Yoga n Al . •
1990) . The refore, the JCV genome with sequence rearrangements
containing 23 bp and 66 bp insertions was suggested to be the
llarchetype" genome. Based on these reSUlts, i t was suggested
that the hypervariability of t he JCV genome may be a process
of adaption of JCV for replication in the brain (Loeber and
OOrries , 1988).
1 .2 .2 Requ latory reqion
Though JCV exists in kidneys, replication and expression
on ly efficient in the brain . This rf'lstricted tissue-
specificity was attributed to the promoter-enhancer region ,
because t he greatest degree of divergence of DNA orqanization
was i n the regulatory region of JCV, compared to other
papovaviruses such as BKV and SV40 (K'mney n Al ., 1984 ). JCV
promoter-enhancer signals were identified, based on sequence
comparisons with the BKV a nd SV40 regUlatory regions (Frisque
~ Al., 1984) . Sequences between nucleotides 5,014 to 276
represent t h e non-coding region of JCV . The regulatory region
of JCV is bidirectional in function and contains the origin of
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replication and ill-acting signals for early and late
transcription .
The regulatory reqion of JCV has uniquely duplicated TATA
boxes. These two TATA boxes were believed to control early and
late transcription of the virus. Some contraversy exists
reqardinq the location of the 5' terminus of early mRNAs.
Initially, 81 nuclease mappinq was used to show that viral
mRNA start sites for early gene expression were at nt 122-125
and concluded that the TATA elelllsnt present in the repeat B,
distal to origin of replication functioned aa a component of
the early promoter (Kenney n.al., 1986) . Later, transcription
initiated at nt 5,112 and 5,082 from the TATA box WAS
attributed by primer extension analysis to the repeat A,
proximal to the replication origin but not in repeat B
(Khali11 .!i!.t A.l., 1987) . A more recent report resolved the
discrepancy by showing that the early and late genes were
initiated at nt 5,115-5,125 and 200-203, respectively (Daniel
and Frisque, 1993). Taken together at face value, these
resul ts suggest that both TATA boxes are utll hQd for the
early and late gene transcription of JCV.
In general, viral enhancers are modular collections of a
myriad of ill-acting elements that are bound by a variety of
cellular transcription fac~ors to enhance and/or repress
transcription. Considerable attention was focussed on theslIiiI
elements , because they affect gene expression in a tisSUQ- lind
species-specific fashion.
lJ
1.2.3 UAILI.-aotlll.g' faCltore bill.diJl.9 promoter-enhancer
••queue••
Cell culture studies clarified that the glial 0811-
specific expression of JCV was due to a number of
intracellular factors that bind to the promoter-enhancar
sequences of JCV (Frisque .I..t .ill ., 19 79) . s ubs e qu e nt studies
delineated the ill-acting DNA signals and their cognate tnulA-
a c t i ng- protein factors.
To identity the cellular proteins that i nteract with JCV
enhancer sequence s , UV crosslinkinq and qel mobility sh ift
a s s ay s were empl oy e d with HeLa a nd human fetal brain nuclear
extrar.:ts a nd complementary oligonucleotides that span the 98
bp tandem r epeats ot JCV . oligonucleotides spann i ng the nt
134 -160 of 98 bp repeat interacted with proteins of'S and 85
kDa trom fetal brain and HeLa cells , respectively .
Ol i go nuc l e ot i de s havinq homoloqy to the 5 I and 3 I t erminal
regions of the JCV 98 bp repeat s equence interacted with 82
and 78-30 k Da proteins (believed to be a TATA-li}ce factor)
tram both extracts . A 230 kDa protein which was present in
both extracts interacted with s ev e r a l regulatory sequen ces
within the 98 bp repeat (Khalili §..t u ., 198 8) .
Further I three protected r egions were observed using
DNaae I footprint ing ass ay a wIth lQouse brain nuclear extracts I
two were within and one wa s outside the repeats. The two
protected sequenclilli within the repeats were shown to be
homologous to nuclear tactor-l (NF- l ) binding sites (nt 35-58
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and 133-156) and the se quences outside the repeat cnt 208-229)
were shown to be a paeudo NF- l motif (Tamura .It .a.l •• 1988) .
Later studies employing mobility shift assays identified
binding activities in nuclear extracts frolQ A172 human glioma ,
PHrG and HeLa eel ta. No bindinq was detected with extract.
from HEK cells . Furthermore, DNase I footprint ing studies were
done with the same e xtracts protected the NF-l sequences
similar to those, identified in the above described studies .
Protection of these NF-l sequences was compe ted by
oligonucleotides homologous to the adenovirus replication
origin, which contains NF-l binding s i t e s (Amemlya ~ Ai • •
19851). Also, a SacI mot i f wa s reported to ov erlap each NF-l
site present in the repeats . Howeve r, the nature of the
proteins that bind to this moti f was not clarified (Tamura .e.t
Al . , 1990b) . Later, it was shown that this reqion interacted
with the c yclic AMP response element (CRE) blndinq protein
(CREB) (Kumar, 1994).
Studies from our laboratory identified three protected
reqions in the JCV regulatory region by DNase I footprintlnq
assays with nuclear extracts f r om P19 glial c911111 . The two
protected regions present i n t he repeats were named region II
and III. The protected region outside the repeat wall named
region I . All these regions contained sequences homologous to
NF-1 binding sites (Nakshatri n Al ., 1990a) . Subs eque ntly ,
the proteins interacting with these NF-1 motifs were
characterized in mobility shift assays (Kumar n Al . I 1993) .
(Mote: The NF-1 motifs in regions II and III are 6 bp inverted
palindromic repeats containing the same sequence. The refore,
the JCV NF-1 motif is referred NF-1 II/III mot if , throughout
the text) .
A. 45 kDa protein from calf brain that interacted with the
JCV B domain (equivalent to NF-1 II/III) was purified by DNA-
affinity chrolllatoqraphy from calf brain and was s hown to
specifically stimulate transcription of JCVr (Ahmed n Al. ,
1990a) . Subsequently, a eDNA was cloned from a hUlla n brain
eDNA library using domain B 218a probe that codes for a 45 kDa
glial factor-l (GF-l), stimulated the transcription of JCVL
a nd to a limited extent JCV[ (Kerr and Khalili, 1991) .
ree-i , a POU-do main transcript ion factor family member,
was shown to stimulate JCV transcription and DNA replication.
Therefore, Tst-l was suggested to be one of the f actors
determining the qlial cell-speclticity of JCV (Wegner n Al.,
1993) . A CRE adjacent to the NF-l region II/III was speculated
(Amemiya n .il.l., 1992). Work in our laboratory shOWQd that a
43 kDa protein interacted with this putative CRE and regulated
JCVr gene expreAslon (Kumar, 1994) .
By DNase I tootprinting with purified proteins, binding
of Jun , a proto-oncogene product to the AP-l site near the NF-
l region 'Was shown and the binding suggested a direct
interaction between Jun and 8F-l proteins bound to theil.-
respective DNA sites (.'->i19mi ya At .il.l., 1991) .
An AGGGAAGGGA pentanucleotide repeat domain, also called
rs
the lytic control element (LeE) (Tada and KhaUU, 1992) is
present betwoAn the NF-l region II/III and TATA box of each
repeat and was shown to have a role in transcription (Tada At.
11.•• 1991) and replication (Lynch and Fr!sque, 1990 , Chang' I.t
Al., 1994). The LeE also binds to a 50-52 kDa 81n91e strand
LeE binding protein (Lef-I) derived fron glial cell extracts
(Tada and KhaliU, 1992) . Al so, a 56-60 kDa double-stranded
DNA- binding protein from glial and ncn-eqk LaI cell extracts
down-regulated JCVL gene express ion (Tada n Al ., 1991: Sharma
and Kumar, 1991) .
In the presence of the adjacent NF-l and TATAmotifs this
pentanucleotide repeat was shown to interact with a protein of
70-80 kDa. This suggested that the interactIon facilitated the
transcriptional regUlation of JCV1 promoter (Kumar .Il.t. ill.,
1994). Interestingly, a cDNA was isolated from a HeLa cell
cDNA library, using a 8 region probe comprising the NF-1 and
AGGGAAGGGA motifs (nt 134-160) . This eDNA encoded a YB-l
protein that bound to the pyrimidine-rich opposIte strand
(early strand) of the pentanucleotlde repeat In 81ngle- and
double- stranded conformations (Kerr.e..t. ar. . 1994). The same
stUdy demonstrated that Pura and LCP-l were the same proteins.
Subsequent work from the same group showed that Pura (a
single-stranded DNA binding protein) interacted with the
pentanucleotide repeat of the late strand and activated the
transcription of JCV1 (Chen .tit. Al .• 1995 a and b).
The HIV type 1 (HIV-l) UADJi-regulatory proteIn tat was
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shown to be II potent activator ot JCV late gene expression
(Chowdhury Jlt A,l.. 1990; Tada J..t Al. .. 1990). The tat-
responsive region was mapped to nt between 5,112-5,130. Tat
responsiveness is mediated by two regions within the JCV~ on
eithtllr .ide of the transcription initiation start site
(Chowdhury At Al . , 1993) . Tat was shown to interact directly
with the JCV RNAtranscript containing the downstream region,
analogous to its interaction with HIV TAR (Chowdhury J..t .ill.,
1992) •
In another study, two T-antigen binding sites were
identified which playa role in JCV DNA replication (Chang n
41., 1994) . The T-antigen binding site I was identified at the
early side of the origin of replication While the T-antigen
binding site II was in the origin of replication containing
four T-antigen binding "&1tell.
Another stUdy speculated that a transcription factor
abundant in B celb binde the Oct-l lIotif and the NF-1C.B
binding sites in the JCY enhancer (Major !It .ill ., 1990).
SUbsequent work characterized the NF-KB site present outside
the repEu,ts and showed that it regulates the transcription of
the JCVl (Ranganothan and Khalili, 1993) .
Domain D on the late side of the JCV regulatory region
interacts with 43-50 kDa range proteins from both glial and
ReLa cells. This domain activates the early, but not the late
promoter of JCV in brain cells (AhlIled rt Al., 1990b).
Taken together, these data suggest that the cell type-
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specific expression ot JCV Is regulated by both positive and
negative regulatory mechanisms . Though JCV 18 present in II
vast majority of the population as a latent i nfection of the
kidney , only under h ununocompromlsing conditions doss a
productive infection occur . However, it is not clear how
immunosuppressive conditions would reactivate JC virus .
Recently, .. stUdy identified a noval 81 kDa protein which was
inducible by interleukin-l,tl. THF-a , y-interforon and TGF-I1.
The 81 kDa protein was bound to a GGA/C-rich sequence in the
viral origin of replication and was shown to act a8 a
transcriptional repressor of JCV~ . This novel inducible
protein was named GBPi for ~C-rlch region Rindlng Rroteln
inducible . When a change in the cytokine profile occurs ,
usually under iuunocompromlsing conditions , reactivation ot
JClI infection follo....s (Raj and Khalili, 1994; Atwood n Al. ,
1995) . Fig. 1 .2 summarizas the JCV .l&ll-acting signals ilnd the
putative transcription factors.
1.2.4 a••trioted qrowth in qUal oell oulture.
JClI is strictly II h\Ullan neurotropic virus . JCV
originally isolated troll cultures of PRFG. Enhanced
propagation of JCV was observed in these cells at 39° C rather
37° C (Grinnel .e..t. Al. , 1982) . The PHFG cell popUlation 1&
heterogeneous, and most studies have shown that a culture
containing a high proportion of spongioblasts, the precursors
of oligodendrocytes, was necessary for optimum gro....th of JCV
I'ig. 1 .2 . J(!I1 r.qul.tory ngoion indioating m-el...nt. and
their .tnn.I.~aating faator••
The numbers indicate the nucleotide positions. The ~­
acting- elements are indicated by the lo....er case letters . The
legend belo.... the figure shows the molecular weights and the
cha r ac ter isti c s of the tuM-acting factors that interact with
the ili-acting elements. A detailed description of these
.t.n.n.s.- acting facton is given in the text . The diagram is not
drawn to scale .
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(Pad!]'ett At Al., 1977). Virions were detected in the nuclei of
the sponqloblasts and rarely in the nuclei of the astrocytes ,
the second most abundant glial cell population (Padgett n
Al.., 1971). Contrary to these resUlts, another stUdy showed
that JCV can be propaqated in astrocyte-enriched cultures
(Major and Vacante , 1989) .
The PHFG cells provided the best s ys t e m for propagation
of JCV, because continuous passage of JCV in these cells
produced no changes in the qenome, transcriptional activity
and length of the lytic cy cle of the virus. However, the
procurement and cultivation of these cells are difficult. In
addition , the JCV cytopathic effect (c .p .e) is subtle. An
alternate permissive cell s ystem for JCV propagation was
sought for . To this end, primary human embryonic epithelial
cells originating froUl the kidney, lung, liver and intestine,
and fibroblasts , were assessed (Padgett and walker , 1976 1
HiyamuI"a fi.Al., 1980 ; Beckman fi Al., 1982). Although JCV was
adapted to propagat ion in human embryonic kidney (HEK) cells ,
the DNA found in the virus was defective. Also, the other cell
systems were not found to be useful.
Unlike nueen cells , animal cells were absolutely non-
permissive for JCV. So, it was thought that the restricted
host range of JCV was at the stages of virus adsorption,
penetration or uncoating . To test this hypothesis JCV DNA was
transfected into HEX, lung and PHFG cells. Viral DNA was
recovered only frolll the PHFG cells , not the other cell types
"(Frisque .tt. Al.., 1979) . Thus, it appeared that the r e s t ricted
cell-specificity ot JCV wa s due to I ntracellular factors
control linq viral expression and r fil p l1c llt i on (Frlaque .I..t .al .•
1979: Ki ller n 11• • 1983) .
1.2 .5 Lat.ent;Sa iDfea tioD
The c ell t ype i n whi ch J CV remaIn s latent after primary
i nfection is e l us iv e . Initially, it wa s though t J CV co uld be
latent in brain cel l s . Brain samples from t he immunos upp ressed
a nd non-immunosuppre s s ed , but not PML IndlvidualD. failed t o
s ho w any signs of viral genomes o r vI ra l pr ot e i ns , eithe r by
PeR or immunohistochemistry (Hogan .e.t Al • • 19 80; Arthur e.t
Ai. , 1989; relent! .e..t .Ill ., 1990: Henson .Il.t Al ., 1991). This
suggest s that J CV remains latent outside the CNS and beeDllleli
reactivated i n the event of blllllunosupp: ~'88 ion and gains 4CC8ea
to the CNS. Thi. reactivation could have two .equalae . ana i s
the lytic infection of o l i ljlode nd r oc yt . s and the other is
viruria , in wh i ch intactloua v i rua may be shed in urine
( reviewed in Fri8 qu e and White , 19 9 2 ) .
The idea t hat kidney i . the main . ite of J CV l a tency was
ba s ed on viruria observed d uring p regnancy (Coleman I..t Al . ,
1980), o l d age (Kita mur a n ill., 19 9 0), ca nce r (Hogan I..t Al . ,
1983), AI DS (Ma r ko....itz r..t Al. , 19 80) , a nd other unc lasaU ied
condit ions (Arthur and Sha h , 19 8 91 . The J CV genolll8 ....a.
r e;>orte d i n l ot of nonal kidney. (Ch••t e rs !l.t Al., 19 83 ) . By
dot blot hybridization , J CV DNA was alao fo und in th.. l ung'S,
2'
Hvers, lymph nod•• a nd spleens of PML patients (Grinnell .itt.
Al • • 19 8 3 ) .
Interestingly. JCV DNA was also found i n B cells in the
bone aarrow, splee n a nd brain parenchyma (HOUff liAl• • 1988).
The presence of capaid antiqon. and 200 c opies/cell o f viral
DIfA i n 8 cells , suggests that viral replicat i on had oc curred .
Hor e recently, periphe r al blood leucocytes o f norma l
ind ividua ls vClre all1 0 . ho....n to ha r bor JCV, t hU3 provIding
s tronq eviden ce lor the persistenc e o f J r:v i n these cel ls
(DorrIes n Al. , 1994) . Take n t ogether, the s e r e sults s uggest
that JCV r ema i n s latent in B ce l ls of bone mar row, and ",it h
t he loss of t he integrated immune respons., s uc h as during
cellular immunodeficIency, the B cells JDay expand . Such
ac t i vated B cella t hat aid i n the active phase of v I r a l
replicatIon lind transcriptIon, may e nt e r the CN'S by the
va scular system and in t ec t the b r a in (Au l t an d Stoner, 1994) .
The other sites at the J CV latency are u nkn own at this time.
Ho....eve e , it is ponible that other o rqa n s besides B cells and
kidney acy harbor JCV.
Ho....ever , t he exact .echani•• ot JCV l a t e ncy is no t knovn .
s ev e r a l lIlech an i s ms ha ve been p roposed to e xpla i n the latency
e xhib ited b y mos t of the DNA tWllor v i ruses (Ahmed and Stevens ,
1990 ) . I ....ould like t o limit my d iscuss ion t o t he r ole at Bcl -
2 protein in v iral l ate ncy , in partiCU l ar , because this
discu s sion is more pertinent t o t he resu lts obtained in t h is
stUdy.
"
801 -2 stands t o r »-s;.e ll lYmph oaa /leuka811l!a-1. g e ne . Bcl-2
first discovered throuQ'h it. involvelllent i n B cell
-al1qnancies, whe re th e ~.2. qene i • • eved froa it. no raa l
chrollosoaa l l ocation i nto jurtapoalt1on with powerful
pro1loters of the Immunoqlobulin hEla vy c haIn (I9H ) gene . Thue ,
deregulation by the translocat ed bs:.l.=.2 q ene lead to the
ove rp roduction of ~ 1IlRNAs and their e nc oded proteina
(Tsuj f..1II0to n .41• • 1985; reviewed in Cro ce , 19 87 : Nowell and
Croce , 1987). BcI -2 was first shown t o prolong cel l su rvival
in i1llllla t ure p re-B-c&11s , where stable t r a ns fer of ~
permitted pro l onged cel l surviva l even in the absence of
lymphoklnes (Vaux Jl.t. Al • • 15I8B). Sin ce l ymphokin88 p r ol onq the
cell survival by preventlnq apoptosh or programmed cell death
(PCD) (Tu shl n sJci A.t. Al • • 1982 = Williallls J..t .1.1. ., 1990). thue
results sugg est that eer-a I s capable of blocking PCD, and
s ubsequently th i s ab ility tODally delllOnstrated
(Hockenbuy n 11 . , 1990) . The pr otein en c oded by the Qs:l:1
gene c ont a i n s no .eque nce moti fs that mig ht s ugge st a
b iochemi ca l function for acr -z , The lIlos t notewor thy feature 18
a stre t ch ot highly conserved 19 hydrophobic amino acids at
t he c-eerednu e , wh i ch serve to anchor BcI- 2 to lIIembr a nu
(Caza l s - Hatem I..t. Al.. , 1992 , Sa t o.lt. A.l. , 199 4) . However , the
mechan islll ot action by wh i ch the BcI -2 prot e in prote ct. celt.
trom a pop totic ce ll dea th 18 no t very clilar. Por o xalllple , i n
c ells protected b y Bcl-2 f rO ID apo pt oa i a , none of the
cha ra c teristic IlOrpholoqlcd chang'e. , Buch a s , cd l shrinkage,
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chromatin conde nsation a nd nuclear fragme ntat i on,
observed. This indicates that act-a blocks a final c Oln1llon
pathway leading to apoptosis . Th e participants in this pathway
are no t known. However, one such lIediator co u l d be the tumor
suppressor p 53 based on the observation that Bcl - 2 protein
interferes with the p53- indlJced apoptosis without i lllpa i ring
the p53-induced Gl/S a r r e s t (Wang J..t li. , 199 3 1 Ryan .it Al . ,
19 94 ; Selvakumaran n J.l. •• 1994) . p53 was s hown t o i n d uce
a poptosis under a va r i e t y of conditions (reviewed in Sach s and
Lotem, 1993 1 Hof f man a nd Lie bermann, 1994 ; L iebermann.it Al . ,
1995) a nd i n p53-def i cient tumor cell lines upon expression of
wild-type p53 ( Yanish-Rouaeh .ll..t i\l . , 1991 : Shaw .ll..t AJ.. , 1992) .
I t i s not c l e a r hoW' p S3 induces apoptos is . Howeve r , p53 was
shown to neg a t i Vely regUlate the~ gene through III ill-
acting" negative response element in its 5 1-untranalated reqion
(Miyashita n ill. , 1994b). Aleo, p53 was shown to incr ease the
level ot 1ln mRNA (Miyashita .!lk Al. , 199411I ; s et va x aearan n
.Al., 1994). Bax is a Bcl-2-reiated 98ne product t hat was shown
to accelerate s en by torming heterodimers wi th BcI-2, thus
inactivating BcI-2 (Oltavi it Al., 1993) . Re c ently, p53 was
s hown to i ncrease 1ulx mRNA l evels by transacti vating t he W
promoter (Miyashita a nd Re ed, 199 5).
Howeve r, pS3 i s not the wh o le s t o ry of a p opt o s is, since
p53 mediates a p optosis for only a particular sst of signals
(Lows .At. Al. , 1993). ser-a wa", also shown to inhibit pSJ-
i ndepe nde nt apoptosis (Se n t man .i..t 41., 1991; Miyas hita and
as
Reed, 1992 and 1993) . By exploiting the yeast two-hybrid
system. (Fields and SonCJ. 1989) to identify interactIng
proteins that mediate Bcl-2 ls fu.nctions, it was shown recently
that Bcl-2 inhIbits apoptosis through a novel protein called
12.cl-2 Associated athanogene 1 (BAG-I) (Takayama n Al ., 1995).
Interestingly, BAG-l also does not contaIn any protein
motifs that would i ndicat. II biochemical function .
Furthel'1llore, i t showed no homology to Bcl -2 or 8c1-2-related
proteins and any relationships between BAG-l and p53 are not
known at this time . However, gene transfer experiments IIhowed
that BAG-l can prsvent PeD (Takayama n A.1. • • 1995) .
Latent and/o r persistent infections are II part at the
lifestyles of ma n y virus e s, as the ability to ma i n tain a long-
term relationship with the hosts is vital for their survival.
A variety of viral lIIechanisms ha ve evctvea to prolong the life
span of host cells one such mechanism is by exploiting the
anti-apoptotic properties of acr-a , An example i8 Epstein-Barr
virus (EBV) , a DNA tumor v i rus which is ubiquitous and is
associated with tumors of B celh and epithelial cella
(Magrath, 1990 ; Shibata and Weiss, 19921. In B lymphocytes,
the infection is non-productive or latent, whereas in
epithelial cells, the infection is productive (Miller, 1990).
The ilUlediate early protein of EBV, BHRF-l, shows similarity
to acr-z , Bcl-x and Bax (Bc1-2 homo1ogs) . Like t!..c.l.=2. , BHRF-l
acts as a "cell survival gene" (Cleary At Al., 1986).
Furth8rtllOra , cells that are negative for EBV, but IlO'lCpress
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BHRF-l, showed strong resistance to apoptosis induced by
growth factor deprivation (Henderson ~ li., 1993) .
Furthermore, the EBV latent EBNA-4 gene was shown to increase
the e xpression of BCl-2 (Silins llnd s cul l e y, 1995). The
importance of these f inding's 18 that the virus es can harbor
Bcl-2 homologs whIch are capabl e of inhibiting PeD. When taken
together wi th the ob servatIons that Bcl-2 ca n bloc k or delay
apoptotic death of v i rus- infected cel l s and co nvert a lytic
viral i n f ec tio n into a non-lyt ic persistent infec t ion (Alnemri
At.al., 1992 ; Levine .itt Al ., 1993). these result8 suggest that
virally-encoded Bcl-2 homologs contrIbute to viral l at ency or
allow for persIstent infectIons in t he absence of cell l ysis,
Analoqous t o EBV, the African swine fever virus is a DNA
virus which remains persistent for Il long time in peripheral
blood monocyte/lIIacrophages of i n f ec t ed pigs (Vinuela, 1987) .
The IMW5-HL protein of Afri can s wi ne fever v irus also shows
significant s i mi l ari t y to acr-a , su ggesting a role for the
viral protein i n the su p press i on of apoptosis in viru8~
infected cells (Neilan rt li. , 1993). Anothe r vir a l pro t e i n,
the p35 baculovirus g ene product , has the abil.ity to bl ock the
host apoptosls response (Clell Jilt Al. , 1991) .
More recently , the adenovirus ElB 19K protein was also
shown to exhibit a modest homoloqy with Bcl -2 and can
functionally act Il8 D. hOlDOlOtj o f Bc1-2 (Chiou n A.l., 1994 ) .
ElB 19K waa ahown to inhibit t he apoptosia t hat i s induced by
the ElA by inhibiting the Balt (for .D.cl~2 h omol og ous
2.
,Antagoniat/.killClr) wMch promotes the apoptosia (Farrow A..t.
Al./ 1995 1 KIefer §.t Al • • 1995; Chittenden At. ill. . , 1995) .
1.S .w:aryotic 'rZOlUl.lori.ptioll
1: have e xpl ained (section 1. 2.3) se veral ce l lula r YInI.-
ac tin g fac t o rs thl'lt bi nd t o the ili-actinq signals in the JCV
en hancer . Before explaining the role of th e s e factors in qUal
call-specific expr ession of JCV , I would like t o des cr ibe BODle
general fe a t ure s of eUka ryot i c transcription .
1.3.1 l'rolll.oterl and Enhanoer.
Most of t he pr otein c o d in g genes in eUk a ryotes are
t ranscribed by RNA polymerue II (RNAP II) . Eac h gene orten
contains two sets of elements; t he basal promotBr ellamenta or
minimal core pr omo t er elements and the modulator promoter
elements or enhan c er sequence. , The bnal promoter ele ments
usually detenine t he specificity of MAP II and tha d i rect
basal le vel of transcription . On the other hand , mod u la t or
promoter elements enhance or reduce the basal le vels ot"
transcription . The ba sal promoter elements g enerally consist
of a TAT A motif , locat ed approximat ely 30 nucleotides upstream
o f the transcription s t art site, a nd the ini t iat or (I nr)
e l ement vhich sp ecifies t he start site (revie....ea i n Con away
and Con away, 1993 ; Zawel and Reinberq, 199 5 ).
Enhancers are usually recoqnized by proteina vhich ar e
modular in nature. containing a DNA-binding' domain and an
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activation domain . Enhancers are of two t ypes : inducible and
temporal, or tissue-specific. Ind ucible enhancers respond to
environmental cues, such as heat s hock, heavy metals, v i r al
infection, growth f ac t o r s a nd hormones for the
••tallothionein, v-interferon a nd ~ g enee (reviewed in
Maniatis n Al. , 198 7) . T!&sue-speciflc enhancers have a vital
role in de velopmental and in tissue-specIfic 98ne expression.
For #xampl. , the Ig8 gene enhancer expresses only in lymphoid
cell. (Maniatis .It 41.• • 1987 ; Mitchell and Tjian, 1989). Thus ,
the efficiency and tissue- specificity of gene expression is
determined by t he i nterplay between enhancer binding' factors
and .t.nn.ll-activat ors ( r evi ewed i n Tjian and Man iatis, 199 4) .
1.3 .2 RNA polymerase II
The RNA polymoraslI2 II (RNAP II) initia tes trans cription
ot lIlossengor RNA (lDRNA) at prolllotors located 5 I ot the cod i ng
sequence of each gene . HWllan RNAP I I is a complex mo l e cul e
ma de up of 10 s ubunits with apparent molecular weights ranging
from 10-240 kDa. The largest subunit has a u n i qu e c a r boxy
ten!nal domain (CTD) with mUltiple s e r i ne , threonine ,
tyrosine and prol ine residues , suggesting tbat it is
phosphorylated at serine, tyrosine and threonine r esidues .
Furthermore, phosphorylated and unphosphorylated forms of RNAP
II can be resolved on polyacrylamide gels (Woyc hike an d Young,
1990) . The r ole of the CTD in transcription initiation is
still elusive. However, t he genet ic manipUlation data suggest
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that removal of the repeat. in CTO 11 lethal to~,
I.t..A.n lind murine cells (Allison n. 11 •• 1988: Bartolomei !it
Al.. 1988 ; Edwards ~ .Il.. 1991). The role of the CTO in
enhancer-driven transcription was recantly demonstrated.
Removal of most of the CTD abolished transactivation at Illost
enhancers (Gerber R Al . , 1995) indicating that CTD is
eslitential in lIledlatlnq I enhancer'-type transcriptional
activation. Recently. it suggested that the
unphosphorylated form of the CTD is present in the
pre initiation complex while the phosphorylated fOl"lll is present
in the elongation complex. Thus , the conversion of CTD from an
unphosphorylated to a phosphorylated form may allo\ll the
transition from transcriptional initiation to elongation
(Laybourn and Dahmus, 19901. Other proposed functions are RNAP
II localization, DNA binding, removal of chromatin proteins
from DNA and regulation of RNAP II activity (reviewed in
Corden, 1990; Dahmus , 1994) .
1.3.3. aeDeral transcription hCltors
The process of transcription initiation requires a
concerted interaction betwQan RNAP II and at leallt dght
protein factors. These factors are termed general
transcription factors (GTFII) . A total of eight GTFa were
identified in human colI. and they are called TFIIA, B, E, F,
H, I, J and D. Toqether with RNAP II, GTFs are necessary for
the basal level Clf transcription. The first step in the
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a•••ably of the initiation complex lli1 the binding of TrUD to
DNA. TFIID is the only component of basal initiation factors
that contaIns DHA~bindln9 capacity to the TATA box sequence.
TrII0 is a llluitimeric protein complex containing- the TATA box
blndlnq protein (TaP) and TOP-associated factors (TAFs) (Pugh
and Tjian. 1990) . Human TFIID consists of TBP and at least 8
TAFs with lIIolecular weight.,. rang-ing from 30- 2 5 0 kDa (Tanese
n Al., 1991) . TOP requires no other factors for TATA element
recognition and t he TBP-TATA element co mplex subsequently
incorporates the factors f or basal transcription, but can not
respond to transcriptional actIvators without TA~s (Pugh a nd
Tj!an, 19911 Hoe y !l..t. Al . , 1993). In the assembly of the
multimeric initiation complex the bindinq of TFIID to the TATA
box appears to be the first step . The TFIID-DNA c omplex
provides a recoqnition site for the association of other basal
factors and RNAP II (Buratowski At Al ., 19B9) .
TFIIA promotes stable binding ot' TFIID to the core
promoter . TFIIA wall also sh o wn to allilociatQ with TBP or the
TF1ID complex , even in the absence of DNA (Cortes Jlt .al . ,
1992) . Several negative re gUlators of transcription were shown
to displace TFI1D from t he promoter and others were shown to
block TFIID's interaction with other GTFs (Auble and Hahn,
1993) . TFIIA was shown to counteract these negative factors by
its direct interaction with TBP (Reinberq n Al., 1987) .
TFIIB recog:nhes either the TFIID-DNA complex or the
TFIID-DNA-TFIIA complex to form DB or DAB complexes,
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r espectively (Bur atovski .e..t. Al.. , 19 89 ) . Rec ently, TrIIB v••
s hown t o be crit i c al for i nt e ract i o n bet w8e n the init iatio n
c oaplex and upstreall ac t ivat o r s (Li n .tl.t1.1., 1991 ). It i. alao
r equ ired f o r th e recru itment of RNAP II. TFIIB alao s e rve•••
II bridge betveen TFIID and RNAP II . Tf IIB can interact with
MAP II i n s ol ution th e r efor e , it I s aho po . dble th a t t h•••
two compone nb c ould be pre•••ociabd upon enterinq t h e
i nitiation c oaplex (Conaway and Conaw ay, 19 93) .
TrIlF assocfates with RNAP II: even i n the absence of
other factor. and also it is an lIlpor tant baesl fact or.
bec ause it i. abs o lutely e ss ential f or transcription
ini t i ation (Reinb e r q an d Roede r , 198 7 1. RNAP II recrultm~nt la
c arried ou t by t he small s u b unit of TrIll, p ossibly v i a
i nt e r actio n with T r U B (Flores .a..t. 1.1• • 199 1 , Ha .Il..t. Jl. , 199J).
Besid e s act l nq as an i n i tiatio n factor, Trur a lso a ffects
e10nqati on o f M AP U (Price n Ai. , 1989 ) .
Th~'I, TrUD , A, B, r and RNAI' I I to r. a .iniaa1 c Ollpl ex
o r preinitiation cO&ple x (P I C) . For a c omplete i nitiatio n
COJlplex, TF IIE and H a r e necessary. However, under some
cir c u mst ances the .ini mal complex can i n i tiate transcript ion
(Pa rvin and Sha rp, 1993 ) . TFIIE i s nece s sary f or further
i ncorporation of TrUH ( Flores J.t. ill ., 1992) .
TFIIH is the last basal factor to enter into the complex.
It is a mul t isubu n i t comp l ex with many biochemica l activit1ee.
The i mportant a c tivities a r e DnA hellcase, DNA-depe ndent
ATPase and CTD ph osphorylatio n (se rbava n 11., 1993) .
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Finally, t r a n s crip t i on initiation requires t he hydrolysis
of ATP or dATP (Sa",adogo and Roeder , 1984; Goodrich and Tjian,
1994), and this proce ss 18 termed t he activation of the
in itiation complex. TFIIH may be th e fac t or mediating
activation, sinc e it possesses ATPase ~ctivity .
:In TATA-less pr omoters, TFII-I binds to t he zn r e l emsnts
a nd proillotes TBP binding (Smal e, 1994) .
1.3 .4 ••queIlCle·.peoitic t.ran.criptioD faotora
Besides CTr s , add i t i onal tran scription fa c t ors b ind to
speci:fic DNA sequences in the ups t r eam r egUlatory region.
These are called transcri ptional activators or r epr e ssors ,
depending whether til ey stimulate or repress transcription. A
c l as s ical transcription factor has a s pecific DNA-binding
d omain, a hinge or mult imerha t i on domain for the f ormat ion of
homodimers or heter odim ers and an ac tivation domai n. DNA-
binding domains a r e clas s H'ied aS I the he l !x-tu r n - helix (HTH)
do.ain, t he home odomain, zinc f i nger seq:mcmts , tho s te roi d
receptor binding domai n, the leucine zippe r domain, th e helix-
loop-helix do mains and the IS-sheet domain (re v iewed in Pabo
and Sauer, 199 2).
Several other activation domains are classi f ied as
acidic, glutuine rich and proline rich a ctivation domains
(Mitchell and Tj i an , 1989). A~ter interaction of Bequence-
specific transcription factors with enha n CClrll , t hey contact
the basal transcription machinery to directly or i ndi r e ctly
3.
stimul ate the rat . o f t ra nscri ption (r e viewed i n pt••hne and
Gann , 19 90) . Not all acti v ation do_ i na o f" II giv e n c l •••
int e ract wi th the same tarqet. He nce , there _:I be ••ve r aI
d isti nct t ype. of a c t ivator s act i nq on the a._ act iv atio n
do main . Ynt ere sti nqly . the im porta nt ••ino acid reaidu•• f or
ac t ivatio n ar e not neces s a r ily t he abunda nt 91utalllnell ,
acidic. or prolines . The hyd r ophob i c redd uea in t e rspers ed
amo ng t hese abundan t residues are import ant for activ ation
(Gi l l .It. Al •• 19 94) .
1.3.5 MachaDism of transoriptionl activatioD. by
transoriptloll. facton
Gene expr essi on in eUkaryote . requi re s sequence-s peci f i c
transcription factors that b ind t o ••t . of dJi-actinq e lea8nt.
s pec ific to each 9Qne (Mi t c hell and T j ian , 1989 : ptaah ne ,
1988 ) . tt..A.nI -actlnq factors may be ub iqu i t ous , tissue -specific
or staqe-spec i f i c a n d they can int erac t eyne r qLstic a lly with
ea c h othe r, thue faninq a un i que nucl eopr ot ein complex
(Sawadoqo and Sent ena c , 199 0 ) . Several s t eps in the assembly
of the i nitiation complex are potential ta r qe te for .t..1:A.n.:l-
ac t ivato r s. These t..r.A.M-act ivator s lIay f acil itate TBP bin d i::"l9
to TATA b o X, wh i ch i n turn accelera tes t he recoqni t i o n ot the
promoter by the GTFs . Alternatively, they may stabil iz e the
bindinq of TBP to weak TATA boxe . . Several ••chan i s_. have
been postUlllte d for transcriptional activation . The qreater
de ta.ils o f the lIechanls ms are dis cus.ed 1n the fo llowinq
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sections.
1 .3 .5 .1 luter.oUollo with Q'1"Pa
TFIID b ind I ng t o the TATA box is the fi r s t s t ep in the
assembly o f t h e PI C. TFIID was t hought to be the IlOs t likel y
tarqet for ac tiva tors . Ye as t Ga 14 (Horikos hi n li. , 1988b).
mamlaUan activating transcription factor (ATF) (Horikoshi .!l.t
Al ., 1988a ) an d up stream stimulatory f actor CUSF) (Sawa dogo
a nd Roede r , aSS) verfll shown to t arget TFIID and thI s
interaction was s hown to activate transcription . other
activators , like herpe s simplex virus VP16 (stringer n Al • •
19 90) , papi lloma v I rus E2 protein (Dostani II Al. , 1991) lin d
!:p s tein- Ba r r vl rull Zta protei n (L iebe rma n and Berk, 199 1 ) .
e nh an ce t ranscription by i nteractIng a nd 8 t a b il lz i nq the TFIIO
co mplex a t t he promoter . The ps eu dor ab i e s v irus I J:lIlle d l llte
ea r l y prote i n (I E) s timulates t r a ns cri pt i on by ac c e l era tinq
the recruitme nt of TFIID to t he TATA box (Abmayr .i..t Al ••
1988) . The t umor suppressor p5J vas shovn to interact vith TBP
or partially purified TFI I D and ac tivated t ranscript ion by t h e
fona. ation of a mo re atable Tr IID- DNA co mpl ex (Che n At Al • •
1993 : Traunt n Al • • 1993 ) . The other activator, PU. l , vaa
sbown to interact with TBP d ire c t l y (Schuetze .e.t Al • • 1992 ).
In addition to TrIID, other GTFs we n also likely t o be the
t a rge t s for activators . The VP16 activation domain vas s hown
to stimulate t r an s cription b y r e cruit1nq TFIIB to the PIC (Lin
and Gr een , 19 9 1). CREB was al so s h own to I nte rac t d irectly
,.
wi th TFIIB an d TrIID. ThUll , CREB aay proDot. b• ••l
transcription initiaUon through interact ion wIth TFIID and by
r e rauiting TFIIB t o the p ro1llOter (XInq At Al • • 19 95) . Ce llular
t r a ns c r i p t i o n f acto r LSF was a l l10 ahown to accelerate t b.
association of TrUB with TrUD bound to t h e r ."TA box
(Sundseth and Han sen, 1992 ) .
1 . 3 .5.2 Interaotion with 'rAJ'lI/ C1oao t i va tor .
The i ntor acti on between tnwI-a c t i v at or s and CTF. )Day
cont r I bu te to , but Is not sufficient for the p r ocess of
act ivat ion because stUdies with pur i f i ed TBP e xh i b ited baa.l,
bu t not activated , l eve ls of t rllngcrlptlon, eve n In t he
presence of sequ enc e - s pe c l tic t r an s cri pt l e n !actora .
I nt ere s t i ng l y , the ad dition of partial ly purified TFIID
r ec on s t i t ut ed the activated l avel. o f tranacription . Thh
suggests that TAra are i llportant to r act i vated t r a ns c r l pt J on
(Pug h and Tjian , 1990 ) . A subset a t TAr. are also ca.lhd
coact ivators , since t hey int e r ac t with activators and tOni a
bridge be tween T BP a nd activators. SUbs equent I d ent U i ca t i on
ot TAFil l Cla d t o the coa ctivator hypothCls!& (Dyn lacht t:..t Al .,
1991; reviewed in Tanese an d TjIan, 19 93 ). Some TAr. a re
t ightly a nd s toichometr ical 1y asso c i ated wi t h TBP an d s ome are
tranBlentl y ass oc iated wi th TBP (Dr apkin !It. Al.., 1993 ) . Fo r
e xalDple, an ac tiv i ty t ermed upa t r aa. s t i llu latory ac tiv ity
(USA) i a require d tor act ivation by SP l, USF an d a coact iv a tor
r e quired f or .t..r.A.nfl-actlvatlon by a e ru.a response f actor (SRF)
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c a n be separate d froa TFI ID i n chroaatoqraphic columna
(Me i stameat It Al• • 1 9 91 : Zhu a nd Prywes , 1992 ).
Sub.equently, TArs we re iaolated froar. TFI I D and addit ion
of the•• TAr . to the recombi na nt TBP et i . ulated the r ate o f
t r an ac rlption i n the prell_nee o f tran acription acti vator s
(Dynhcht n 11. , 1991) . Thus, a c tiva t ors • • y interact wi th
ana or lIore o f the• • TAF. directly t o r equ l ata the activity of
TBP.
As of thh date, 8 TAra have been isolated whI ch are
i.portent for activator-medIated tra nscription f or MAP II .
only a f ew h ave been cloned, t he hua en TAFII250 and~
TAFlIllO, 80 , 40 a nd 15 0 ( Dynlacht n Al. , 19 93: Goo drIch .Il.t.
Al.. 1993 ; Hisatake J.t Al. . 1993: Hoey n Al ., 1993 ; Ruppert
.It Al . , 1993 ; Verrijur.e..t Al . , 19 9 4) . RUIlIan TAFII250 was shown
t o be involved. in ce ll cy c le proq r e . a ion (Wanq a nd Tjian,
1994).~ TAFlI l 1 0 i nt e ra c ts with TAF1l1 5 0 and TAF II 300
and, thus, 1s r . c ru i t ed to TB P which i. boundi to t he TATA bOK
(Xokubo n &1. , 19 9 3) . It als o i n t er a c t a with TFIIA (Yokollori
n Al. , 19 93 ) .~ TAFu 2 50 and 110 s e rve aa
co ac t ivator s fo r SP I by bridg i nq SPI wi th TBP to stimulat e the
rate of trans c r iption (Weinzierl .I.t. 41.. , 19 93) . Th e acidic
activator, VP16 , was s hown to i nteract with dTAFu-40 to
activate transcription (Goodrich n Al., 199 3). CREB was a l s o
shown to interact with dTAFII40 throu gh the r egions , sim ila r
t o that of S PI (Gill.e..t..ill., 19 94) . The acidic transcriptional
act i v a tion do.a i n o f p 53 was shpYn to int e r act with hTAFu 40
"
and 6 0 for trans criptional activation (Thut t.t .I.l • • 1995 ) . The
dTAFu150 va . _ho wn t o I nt e r a c t with the DNA • • quence.
ov erlapping the transcription start site . ThUll, t 098 ther with
TBP, i t is r espons i ble for TFIID i nteraction with the cere
pro.oter (Verrijzer .c.t Al., 199 4). Th i . BU9gea t . that
d ifferent classes of activators i nteract wIth distinct TAF• •
I n additIon to the interaction of TAr. with activa tora , t hey
may serve a8 ill brIdge be t w• • n TrnD and other b• • • l
t r ansc r ipt ion factora (Choy and Gr ee n, 199 3) . More recently ,
TArs wer e shown t o play ill critical r ole i n p rolllote r
selectiv i ty and t rans cr i ptiona l regulation t hrough direc t
contacts with c ore pr omot er element- (Verr1j zer At.Al • • 1995).
Thus , different ac t iva t ors interact with dIfferent TAF~ ot the
lIlultlsubunlt TFIID co mplex, co ntrlbutinq t o the spec1rlclty of
qene regulation (Ruppert n Al.. , 199 3) .
The rol e of co actlvatorll i n t h .llue-sp'lC::iflc 9Qne
express i on i n eUka ryot eB is a l s o wel l d ocumented . Fo r example ,
the l y.pho id cell- specific cOllcti vlltor was shown to be
important for I 9H ge nll transcription (Luo .at Al ., 199 2).
Another case i. hepatocyte nuc l .... r f llctor -1 (HNF-I) , wh i ch
a ctiva t es l i ver specific-liene expreliBion a ll a d i ..r, Th h
diller i za ticn wall .hown t o be Illediated by a liver . pe c i f i c-
c oa ctivator (Men de l .e.t. Al., 1991 ).
I n ge ne ral, activato rs , TAF. a nd GTPe may participa t e at
d ifferent steps and i n s pec i f i c order. d urinq t he dynallic
p r oces s of initiation o f transcription . The existence o f
.everal TAF. , their tie.ue and develop_ntal distribut ion a nd
their putative t is.ue-specificity a180 tapl y that d ifferent
cIa•••• of activator. i nt e r a ct directly with d i.tinct TAFs .
1.3.5 .3 lllteraotioll "itb adaptor. and aCCle••ory proteiD.
Bes ides TAFs/coa ctivators, .t.x:ln.I-activators i nteract with
other proteins , s uch as adaptors a nd accessory proteins . An
adaptor c an bind to a DNA-bindi ng' protein and med i a te
transcriptional activation through i ts ac tiva t i ng r egion .
Accessory proteins help in DNA-binding , co mplex assembly or
activation (stanway, 1991).
One example of an adaptor i a the he rpes virua VP16
protein. VP16 bind. to the DNA alonq with Oct-l and t wo othe r
cellular proteins , Cl a nd C2 (Mc Kni g'ht .ilt. A1.., 19 8 7, Krietb
At Al., 1989). Baddea activating t ran.cription through i t s
activation domain via a coact i vator , VP16 a lso a llows oot- l to
act i vate transc ription by ada pt ing Oot -l to the gen era l
t ranscription machinery . Unlike the c l a s s ica l ada pt or, as
define d above, VP16 a lso makes d i r ect DNA contact (Kristie n
Al., 1990) . Two f unctional studies with the VPlfi activa t ion
region have l ed to a nov el hypothes is called ·sque l ch ing " , for
inhibition of transcription due to the overexpression o f an
activating region that competes with a functional activator
tor the bindinq .ite. of tarqets (reviewed in ptaahne, 1988 :
Gi ll and pta.hne , 1988) . 'I'ha VP16 activation domain was tused
to the Galt DNA-binding do..in . The chimeric Ga!4-VP16
.0
construct was shown to inhibit the activated, but not the
basal, level of transcription from the dAJ ciT upstream
activating sequence (UAS) -promoter (Berger .I.t Al ., 1990) . The
eeee study also demonstrated that inhibition of activated
transcription do•• not depend on DNA-binding . This aU99 ••t.d
that VP16 binds to a targeted factor In the transcriptional
apparatus . The specificity of this effect tor activated
transcription suggest. that such a target i. nee••sary for
activated, but not basal, transcription. One hypotheeia ill
that such a tarqet is an adaptor that connects !'.Dula.-
activators to the basal apparatus, by titrating out the
adaptor . Thus, Ga14-VP16 prevents the activating effect of the
clA:dT activator . Similar results were obtained in another
study using Ga14-VP16 and the dA:dT VAS-promoter. This study
(Kel~eher n Al., 1990) ruled out the possibility of ... GTF
acting as an adaptor, as speCUlated by the above stUdy (Berger
~ Al., 1990) .
Similarly, adenovirus EIA wa. shown to require an adaptor
tor transactivation, basad on squelching experiments (Martin
.e.t. li., 1990) . overexpression ot the EIA activating ragion
inhibited EIA activation iILY.iYO: and in.....Y.it..t. (Martin ~ Al.,
1990) . subsequently, cellular transcription factors, like
CTF/NF-l and SRF, were shown to require II. coactivator/
adaptor/cofactor tor activation . In all the cases,
overexpression of the activating regions lead to the
squelching or inhibition of the activated level of
.,
tran scription (Mart i ne z n Al . • 1991, pryw •• and Zhu , 1992) .
Such aqu e l c hl n q experlae nte provide a uch of the knowledge
of ad apt or s . Though the s e ada ptors are no rma l l y present i n t he
cell , they do not squelch t r ans c r i pt i on . It i . possible that,
co nton at i ona l chang•• or c ooperativity may be required for
such an ac t i vat i on.
In 9.n8ra l , t r an.crlptio04 1 adap t or ., .CCCilla . c ry prot. i na
and coact i va tor a p rovide a n explanat i on for h ow wide va rieti es
ot transact i vat inq reql ona c an I nteract wi t h .. li.ited set o t
b••• l factors. The.e factor. alao r epre aent add i t i ona l step s
i n the proc e.s o f t ranscript Ional acti va t ion that a r e
poten t ially subjec t to requ latlon in t he cell .
1 . 3.' 'fran.oripHon.! r egu l a tio n ot tis.ue·spa c I f l c q eDB
.-pre••ioD
Thoug h cell-specific gene expres s i on is requlated a t
dif fe rent leve la , trans criptional r e gUlatio n plays a crucial
r ole . The upstrealll ill-act i ng e lem ent. a nd t he ir cognate
t r ans criptional factor. involved i n tissue - specific gene
e xpre.s i on a r e veIl dOCWII.e nted i n .ev.ral c a •••• For e xample ,
gene expre••i on was e hown to be co ntro lled aainly at the
t ranscriptiona l level in the muscle, p i tui tary , e rythroid ,
i_une lIyste. lind b r ain . Among the. e d iffere nt organs , the
bra i n is a c omple x one c ontaininq a h.te r oq e neous popUlation
o f c e lls . Hence , i t is difficul t to s tUdy brain-s pe cifi c g ene
e xpression. The protot yp e human JCV e xp t 'e s s es a nd r eplica t e s
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only in the brain . Thus, JCV ••rv •• a... good. .odel for the
study of brain-specific CJ8n. axpre••lon (Major n Al •• 1992).
JCV enhancer sequences share 110.'" si.Uarltle8 with the
regulatory regions of myelin basic protein (MBP). qUal
fibrillary acidic protein (GFAP) and proteolipid protdn
(PLP). JCV and all these brain-specific qones have NF-l and
AP-l binding sitos in their regulatory regions. Also, the
importance of NF-l binding sites Willil well documented for all
of these genes (Aoyoma .e..t. ill. , 1990: BeEmard !!.t .Al., 1991:
Nave and Lemke, 1991).
1.4 GUal aell-spaoiflc .xpr••doll of JC'I
The promoter-enhancer sequences of JCV were identified .
based on sequence comparison with other polyomavlruseB. A
unique feature of JCV Is that the TATA box is duplicated,
unlike tbat of SV40 (Frisque J.t. al ., 1984). It was thouqht
that the 2 JCV TATA boxes would control early and late
transcription of the virus .
The first report to de monstrate that the 98 bp tandem
repeats act as promoter-enhancer signals was from Kenney J.t.Al
(1984). They fused JCV promoter-enhancer signals to the CAT
reporter gene in two orientation_ and assayed activity in
PHFG, uete , HEK and. CV-l cells . The higheet CAT activity was
observed. in PHFG. In contrast, SV40 requlated CAT activity was
found In all cells. These result. sugge.t that, unlike other
palyoJllaviruses , the JCV promoter-enhancer is strictly qUal
"
c ell-specif ic.
Chi cer i c v irus studies al llo de mons trated. the i a po rtance
at' the J CV r lt<ju latory regi on in q Ual c e l l - s pe c Ific
expr•••i on . When the JCV requlato ry r eqion wa . replaced with
that of SV40 o r BKV. the hybrid constructs ",sre not v i able In
PHFG cells . Wherea s , the hybrid SV40 and BKvirus• • co ntaining
the JCV requlatory r egion could control the synthe.is of SV40
or BKT-ant i q8na in 91 1al c ella . Thi . 8uqqest. that SV40 or BK
T-antigens c a n Interact with the J CV r egUl atory regIon , but
that the reverse I s not true . Furthermore , this implies that
J CV T-antigen plays a significan t role in glia l cell-specI fic
e xp r e s s Ion of JCV (Chu ke .e.t al., 1986) .
I n Section 1 . 2 . 4 , seve r a l .t.1:A.wl-acting f actors
Interactinq wi th the JCV r equlatory r e g i on were i nt roduced .
Though Beve ral hcton hav e be en i de ntified b y so-called in
ill.r2 · prollOter- tlashing· exper iments, virtually n o studies
i ndicate Wh i c h interaction 18 enenthl .1.D.....YJ.yg. Adde d t o
this, a recent r eport demon s t r a t ed t ha t t he JCV mi n iaa l core
promot e r element conta ining only the TATA b ox and an 8 tip
polyeT ) reg ion , wi thout the aid o f upstr e am ill- e l ements, was
able to s upport glial cell-specific transcription (Kr ebs J.t
Al•• 199 5) . Thu s , the role of t he se tran s cription factors i n
glial cell-specific e xpres sion i s questionable.
Neverthele llUl , I would like to d iscuss the i mportance of
the interaction o f so me o f these trans cription factors in t he
qlial cell-spec ific ex p r e s sion of JCV. In this laboratory, we
..
used PI9 embryonal carcinoma (Ee) cells as a model system to
study the glIal cell-specific expression of JCV. EC cells are
ill good model system to stUdy development. They are the
malignant stem cells of ill teratocarcinoma and are pluripotent
in nature, similar to cells of the inner cell mass of
preimplantation mouse elllbryoll (Hartin, 1980). When EC cells
were lIubject8d to different chemical treatmQntll they yielded
different cell types with characteristic features of the oel18
of thrt;,e of the germ layers (Martin, 1980) . ThIs suggested
that the mechanism of dIfferentIation of EC cells Is sbl.ilar
to that of normal embryonic cells (McBurney n Al., 1988).
'Furthermore the EC system allows experimentll r8quiring
different cell phenotypes of an identical qenotypG.
Addition of retlnoic acid (RA) to EC cells in lIl.onolayers
or aqqreqated cells q8ve rise to different kinds of
differentiated cells. Furthermore, the concentration of RA had
an effect on this process. For example, when 10"' M RA was
added to monolayers of EC cells , the result was II
heterogeneous population which were fIlndoderm-like, llle8oderlll-
like and a few were neuron-like cells (Jones-Villeneuve .at
.Al. , 1983). When lidded at 3XIO·r M to aqqreqated cells, RA
treatment yielded a heterogeneous popUlation of neuronal cells
consisting of neurons, astroqlia, .icroql1a and fibroblast-
like cells (MCBurney, 1993). EC cells can be differentiated
into skeletal and cardiac muscle cells by treatinq the
undifferentiated cells (UD) with dimethyl sulfoxide (DMSO)
.5
(McBurney, 1993).
A prev ious study from our laboratory demonstrated that
JC'l was expressed in PIg glial cells , but not in P19 muscle or
UD cells (Nakshatri .I.t A.l • • 1990a) . Thus, these cells paved
the way for further studios of the glial c e ll- speci f ic
ex pression of J CV. Although the UD a c cells can be
differentiated into d iffe r en t cell t yp e s from an i dentical
g enotype, t he PIg RA-differentlated cells giv e a hete r ogenous
population ot neuronal cells . ThIs is the d i sadvantage of the
EC system . Nevertheless, I also employed these cells in my
study, since prev ious a t udle s ob illi.rved efficient express ion of
J CV i n PIg glia l cells (Naks hatri.t..t Al • • 1990a : Kumar n Al .•
1993). (Jlota l Recently, I have demonstrated that 70 \: of t he
PIg RA-d ifferentiated cells are glial c e lls whi ch are positive
for GFAP, a marker specific for glial cells . Therefore, I ha ve
referred to RA- dif f e rent l a t e d c e lls as Pig glial cells .
S i mila r l y , DMSO-differe ntiated cells are r eferred to as Pig
muscle cells , t hroughout t he t e xt) .
Previously, DNase I footprinting wi t h nuclear e xt r a c ts
froll VD, Pi g glial and Pl 9 mu scle cells wer e used to detect
the proteins i nt e rac t i ng wi t h the J CV regulatory region . only
the Pl9 g11al cell nuclear extracts protected three regions.
Two protected regions were observed within the 98 bp repeats
and one was towards the late s ide and outside the repeats . All
these reg i ons co ntained sequences homologous t o NF-I binding
motifs. The regions ....ithin the repeats ....e re named reg ions II
••
and III and the region outside the repeat was named region I
(Nakshatri n .ill., 1990a).
Other studL•• u8ing~ bindlnq a.say. d••on.tret.d
binding to the HF-l sites in the JCV regulatory region
(Khalil! n Al., 1988). The same study showed that JCV nt 62 -
160 was bound by prot'dn(s) from huaan ratal glial cells in a
tissue-specific manner. The exact sequence was identified as
an NF-l Dot!f by DNase I footprintinq with mouse brain nuclear
extracts (Tamura .c..t. Al ., 1988). The same study alao
demonstrated tho;; importance of the NF-l motif as a saa-actinq
element for glial cell-specific expression using .1n...-:dtx2
transcription techniques. Amemiya n ill (1989) have shown that
three regions, nt 33-58, site AI nt 131-156, ait. 8: and nt
209-230, site c, can be protected in the JCY regulatory region
in DNase I footprlnting experiments with extracts from glial
cells. The protected regions were shown to be hOlllOloqoU8 to
NF-l motifs and the bin1ing that they showed by gel shift
assay could be compClted with an oligonucleotide homologous to
the NF-1 site of the adenovirus DNA origin of replication .
They concluded that an NF-1 or an NF-1-like factor was
interacting with the JCV regulatory region . However, there
were no prior reports to clearly demonstrate the importance of
these NF-1 motifs (Kumar n Al., 1993) .
NF-1 was first identified as a factor froll "eLa cells
required for adenoviral DNA replication (Nagata .I..t. Al., 1982)
and was shown to interact with adenovirue DNA origin of
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replication (Nagata n Al., 1983 1 Rawlins n ill. , 1984) .
Subsequent wor k has d emonstrated the i mpo r t an ce of NF- l in
transcription of the a denov i rus maj or late promoter
(Gronostaj ski n Al.. 1988). The sam e i s true for man y
cellular 9anes, l ike t ho se encodi ng human aI-globin (Jones n
Al •• 1987) , mou se albumin (Lic hstener n Al., 1987 ) . mous e
02 (I) collagen (Ros8i .lilt Al . . 1988) , ch lckon lysozY1lle
(BorqJloyer JLt. .ill .. 1984). human IgK (Henn19hausen ~ .Al.,
198 5).~ (Slebenl1st At Al . , 19 84), ad i pocy t e gene (Grave s
n Al ., 1991) I ovalbumin (Bradshaw II Al., 1988) and several
ot h e r pr oteins ex pressed i n the CNS (Amell'llya II Al •• 199 2) . I n
partiCUlar, the i mportance o f NF- l i n v iral gene express ion
also emerged from the finding t hat this pr otein binds a nd
a c t i v a t es a large f r ac t i on of the viral regulatory elements .
For example, " F- l a c tiva t es the cy t ome ga l ov i rus (CMV) promoter
(He nn l qhauseh a nd :n e c kens t e i n , 198 6) , hu man pa pilloma virus
type 16 (HPV16) and 18 (HPV18l enhancers (Nakshatri n Al. ,
1990b1 Chong at;. A.l., 1990 ), human BKY polyoma virus promoter
(Nowock It 41 ., 1985) , the long terminal repeat (LTR) of
feline leukaemia virus (Plumb .I.t Al • • 1991) and the hepatitis
B virus enhancer (Sen-Levy n A1• • 1989) . Interestingly , the
MMTV-LTR was used to sho,,", a unique co operation between "F-l
and the glucocorticoid receptor (Archer n .ill., 19 92) .
The mi nimum number of nuc l e otide s required fo r "F-l
b inding is 15-16 , with a two- fold ads of s ymmetr/, s epa r ated
by II 6 nucleotide spa cer (TGGA/CNNNNNNGCCAA) (de Vries §.t Al . ,
..
1985; l.eegwater.tit..A1.., 1985). Though the first 3 nucl~otld.8.
in the first lIIotif and the spacer regIon are aUfflcient for
"F-l binding. the presence of Ale at the 4th position in th«s
5' half site increases the af!inity to NF-1. The NF-l
sequences found in the JCV regulatory reqion contained the
optimal fourth nucleotide and spacer (Amellliya .!It .Ill • • 1989;
Nakshatrl n ill.. 1990a). Another stUdy showed that CCAAT
transcription factor (CTr) can interact with part of the NF-l
consensus sequence. subsequently, it was demonstrated that CTr
and NF-l are related but are dIstinct froll. each other (Chodosh
n Al •• 1988 ; Raymondjean n .ill. , 1988) . Further, isolatIon of
cDNAs for NF-l proteins from different tissues confirmed this
finding and showed that these cDNAs had homology at the region
necessary for DNA bindinq (Paonessa Jlt Al ., 1988 : Santoro .Il.t
ill., 1988; Rupp §.t .Al., 1990). Some of these cDNAe were shown
to arise from alternative splicing (Mennod .e..t. ill. , 1989) .
vth e r s were coded by different genes (Gil n Al . . 1988;
Paonessa n ill . • 1988). Since NF-1 mediates transcription a nd
replication, it is also possible that both pecceseee c ou l d be
functionally coupled by the binding or CTF/NF-1 factors to
cceacn DNA sequences (de Pamphilis, 1988) .
NF-1 is a large family of proteins . SOllie NF-1 proteins
are tissue-specific in regulating the .)Cpr.saion of genes . For
example, an epithelial specific NF-1 protein interacts with an
NF-1 motif in the HPV 16 enhancer and regUlates the
epithelial-specific expression of the virus (Apt n Al.,
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1993). similarly , HPV 11 contains multiple NFwl motifs and
expresse s e ff i ciently i n Pl9 gl i al ce l ls (Kas inadh u ni , 1994).
Since JCV also expresses efficiently in these ce lls, it i s not
clear whether the sa me factor(s) i s invol ved i n the
express ion. Interestingly, BKV abo cont aina NF-l motifs in
its regUlatory r egion but expresses efric iently i n both PIg
glial a rrd no n -glia l HeLa. c ells , unlike J CV (Nakshatri §.t .ill ••
1991) . Thi s s ugge sts that different NF-ls in these two cell
t ypes r egulate the differential expression of t hese t wo
related viruses . The glial cell-specific NF-l i s e s s ential for
the restricted glial cell-sp ecific ity of J CV. Furthermore,
nuclear e xtracts f r oJllbrain cells completely protected the NF-
l motifs In the JCV regUlatory region, wlleren the HeLa c ell
extracts protect partially (Amemiya ~ Al" , 19 89). This
suggests that the NF-l in HeLa cells ma y be different from the
NF-1 ot brain cel l s . I ntere stingly. the protected r eg ions can
be comp eted wi t h ol i gonucleotides homologous t o NF-l motifs
but no t t o CT F mot i f s . Thi s further indicated that not all the
NF-l family o f proteins inter a c t wi t h the JCV NF-l motifs
(Amemiya n. Al" 19 89).
To conclusively test t he importance of these NF-1 s i tes,
tme se motifs were d estroyed by s i te-di re cted mut ag e nesis and
assayed functionally (Kuma r tS- ill. I 1993) . Mutation of one of
the NF-l moti fs in 98 bp r ep eats resulted in 3.5- to 4-fold
reduction and mutat ion of both mot ifs re sulted i n a 7-fold
reduction in t he activity of the JCVE• Mutation of the NF-l
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motif in region I had no effect. Thus, the resUlts showIng
that NF-l motifs present in the repeats. but not the one
outside the repeats are important for JCV expression is a
novel study. The sallie study a l s o confirmed this fInding by in
illI:2. transcription assays (Kumar §.t. Al, •• 1993). Studies trom
our lab and from thoSQ ot otherll liJuggested that protein(lI)
binding to the NF-ll11otifs are important for JCV transcription
(Ahmed .e.t. ill., 1990a: Amemlya n Al. ., 1989, 19921 Kumar ~
Al• • 1993). NF-l motifs were also shown to be essential for
JCV DNA replication. Mutations In NF-l motifs complQtely
abolished DNA replication (Sock n. .iU. , 1991) .
Like JCVE• the JCVL was also glial cem-epecrrte, only a
low level of JCVL activity could be detected in glial cells,
but, in the presence of JCV T-antigen, a 9- to 12- fold
activation in glial cells and a 4-8 fold activation in
non91i81 cells was observed. This suggested that T-antigen
acts as a transactivator (Lashgari .tl.t.Al., 1989) . However , the
mechanism of transactivation was not clear. Work from our lab
has shown that the integrity of the NF-1 motifs in the 98 bp
repeats is important. Furthermore, T·antigen was shown to
facilitate an increased binding of NFMl to its JCV NF-l site
(Kumar, 1994).
Since the JCV NF-l motifs played an essential role in
g11al cell-specific expression ot JCV, further studies wore
done in this laboratory to clone the protein(s) that interacts
with the NF-l motifs. To this end, a eDNA was detected and
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c l one d f ro _ a PI9 q Ual c e ll expr u 8ion lib rary, us b tq an NF- 1
r eqlon II/X XI pr o be u*lng Southw••tern blot usays . Th e eDNA
",as p r elh l.lnarily c haracter ized and wa s auq gested t o stimulate
the expres s ion ot J CVr a nd JCY'L to an equa l extent In t he Neta
ce ll s y s t e. ( Kuaar , l!l94 ). At t h e same ti.e , wor k f 1"O:l a nother
l abo r a tory i s ol a t e d a clone fro ll a h u man b r ai n e DNA l ibrary ,
udnq a probe tha t partially o v er l aps the r egion II/I I I Nr- 1
lIoti f (Kerr and Kh a lil!, 1991). This eDNA was shown to code
for a 45 kDa protein t h a t stimulated t he e xpressi on of J CVl •
but not JCVE • The i r eDNA di d not re v eal an y homology to Hr-1
or HF-l-related g e nes .
Attempts were also mad e t o pur ify the pro tein,. )
in ter a cting 'With N Y- ! motUs. A 45 k oa protein was pu ritied
t ro. calf brai n udng a p a rtia lly overlapping sequence
correspondi ng to the NF-l region I I /III. Thl s pr ot ein vas
shovn to t r a ns activate J CV1 in~ t ranscri ption assays
(Muted n A.l. , 1990al, Alth ough a cDNA and a pro tein vere bot h
tao latoo i n Khali li'. lab, usinq the sa H NF-l r e gi on II/ II I
probe, the r e sul ts vere contra dictory . Tho ug h the expre s sion
of the cDNA b o l ated i n our lab t r ans activated both Jr:;v
pro moters in HeLa. ce l l s, it vae n ot clear whether t his
activation required the i nt eg r ity of the r egion II/Ill: NF- l
sites.
Different fa c tors were involved i n the activ a tion o t JCVr
and JCVl , Th e cDNA Vall s holom t o t rans activ eee b o th JCVr and
J CVl in non - g llal c ells. further con:rirai n g th a t the prot ein
sa
encoded by the eDNA is important . but may not be solely
responsible for the glial cell-specific expression of JCV.
However, neither the ap8cificity of binding ot the protein
encoded by the eDNA nor its structure-function st u dies were
determined . The f ac t tha t the protein encoded by a e DNA
stimulated the transcription of both JCV promoters r a llie s an
interesting pos sibility of t he e xi stence of al t e r nativ e l y
spliced products of t he putative factor. The basis f or this
a ssumption i s an earl i er demonstratio n t hat different members
of the NF-l fa mily of proteins ari s e from alternat ive splic i ng
(Sant oro ~ Al. • • 1988 1 Marmod At ill ., 1989) . From the previo us
studies i n ou r l ab , it wa s not clear Whether our e DNA c o des
fo r NF-l or not. Hence. t o address t he above-mentioned
questions and to cha ra cte r iz e the eDNA . I initiated my work
with the following hypothesis and specific aims .
1 .5 Hypotll..ia and speoirio dma
1.5 .1 Hypothesis
JCV i s a n eurotropic v ir us ..1IL.rl.Y..2 and~ and the
regulation of gene e xpre ss i on i s c entral to this neurotrop ism.
Our lab had previously fou nd two NF-l s i t os in t he JCV
regulatory reg i on that ar e es sentIal f o r JCV e xpression. The
cDNA c l o ne l s o l atGd by South....esternblot ana l ysia in filter
binding assays was used to demonstrate the i mportance of a
protein sncoded by t he eDNA in the glia l ce l l - spec i f ic
expression of JCV. However , t he characterization of t he eDNA
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vaa n ot carri ed. out 1n detail. The s truct u r al features ot t h e
prot e i n encoded by eDNA can addre ss, t o a c e rtain exten t , the
above • • nt i oned ques tions . Ther efor• • y s p ecifi c aillS are :
1 ,5.2 .peo!.fh .i.••
Tbe pu rpo.a of the pr••"nt study vaa :
1. To .equence the eDNA collpletely .
2. To cha r a cteri z e the protein encoded by tJlis eDNA us inq in
~ and .1..n...Y..1m aIIi1ay s .
J. To delineate any possible DNA bind!nq and transactivation
domains of the factor .
4. To study the other p ossible fun c t i ons o f t h e eDNA in Jr:v
expro1!!sdon.
These s t udi e s ve e e pur s ued to provide i ns i ght into the
det a iled molecular lIle c hani s m t or t he gl ia l cell-s pe ci f ic
8lCp r eellion o f JCV •
..
XATIRIAL8 pm XB'l'BOD8
Restriction enayaee , T4 DNA ligase, DNa s e I/DNA
polymerase I purchased from Bethesda Research
Laboratories (GIBCO-BRL). Calf intestInal alka1 ine phosphatase
was t r om Boehringer Mannha!lIl. Reverse transcriptase (RT) was
from Life Sciences. ThroDltlin was purchased from Novagen.
Radlochemlcals , like [14C] chloramphenicol (IeN BIomedicals) ,
(J5S]dATP, e~S]methionine and
[3H)leucine were purchased frolll bersham .
Alpha modified Eagle's mediUIi (aHEM) was from leN
Bio:medlcals. Phosphate buffered saline (PBS) was from Flow
LaboratorIes . Dulbecco's modified Eagle medium (DMEM), fetal
calf serum and trypsin-EOTA were purchased from GIBea-BRL. All
trans~retinoic acid (RA), aootyl ccenayme A (eeA), o:-amanitin,
bovine serum albumin fraction V (BSA), Nonidet P-40 (NP-40),
dithiothreitol (DTI'), sodiulll dodecyl sulfate (5D5) and
protease inhibltorll like antipain . pep.tat!n, aprotinin ,
phenylmethylsulfonylfluoride (PHSF) were trom Siqma .
synthetic oligonucleotides were from General Synthesis
and Diagnostics (GSD). Toronto . Poly(dr-dC) . poly (d:I ~dC ) was
purchased from Pharmacia. Thill Xbal tranllliation termination
linker ligated at the 3 1 · end of the Dlutant cONAs was
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co..ercially obtained tro. NewEngland Blolabs. Nitrocellulose
tilters were purchase'll t r om Schleicher and Sc h u ell . The total
RNA halation liIy.tea, Tlli'~ translation .yate., priaer
extension sys t e m and RNasin (ribonuclease inhibitor) wer e from
Prolll eqa. Sequenase Version 2. 0 kit was f r o m Uni t e d s t a tes
Biochemical (USB ) tor DNA sequencing. Bi o·Rad protein assay
kit was used to determine the protein concentration in whole
c e ll extracts . GST-fus ion prot e in purificat ion sys tem, pGEX-
4T-l ve c tor and E.coli BL21 ce l l s we r e from Pharmac i a. The
1II0noclonal antibod ies t o BAG- l and ser - a were from Sant a Cruz
~iotechnoloqy a nd Pharmlngen, r e sp ective ly. The anti-rabbit
IgG rITe conj u g a t e wa s from Sigm a . Di me thyl sulfoxide (DMSO)
was from Baker. Triton X-100 vas froll New England Nuclear.
The PI g embryonal carcinoaa and KeLa cella were
llIaintained i n this laboratory. U8? HGhWZlan glioblastomacells
were purchase d frolll A1rIerican Type CUlture Co l l ectio n (ATCC) .
EUkaryotic expression ve c tor pRc /CMV was p ur chased from
Invitrogen. Th i n layer chromatography (TLC) plates and X-ray
l i l m were purChased from Koda k.
2.2 ••thod.
2.2 .1 ODNA ••queno. analysb
The W::.2. eD NA in pBluQscriptIII<S+ (pBSIIXS+) was used for
double-strand DNA sequencing. DNA sequencing was performed
using sequeneae Version 2 .0 kit, using conditions that a r e
recouBnded by the supplier. Intemal sense and antisense
5.
strand primers were used to obtain the complete eDNA sequence
and for verification. Where bands on a sequencing gel .....r.
ambiguous or compressed, reaction mixtures containing dITP .
instead of dGTP were included. The aequence Inalyda was done
throuqh KCBl BlAST E-mail se rve r lblast(lncb!.nlm.nih .qov) with
the sequences in GenBank (relealle 89) I GenBanlr. update and non-
redundant protein data bases. Further structural analysill of
the eDNA was done ....i th the appropriate programs in Pedro
Biological Research tools available on world wide veb (the URL
ishttp: / /www.pUblic. iastate. edu /'pedro/research_tools .html. )
and thtl programs available in the PIC Gene program.
2.2.2 Del.tiOD &Daly.is of :b.u=i. cDllA
The eDNA was truncated at definite points with
restriction enzymes. The truncated cDNAs were verified for
sizes in polyacrylallide qela and recloned into eith_r pRC/CMV
For cloni09 into pRc/CKV, translation
termination linker havinq a termination codon in a11 ot the
three ORFs Wll8 1iqated at the 3' -end to the Ilutanta. The
truncated cDNAs were numbsred for the sizes of deletions from
the ar-ena . Plasmids 06244, 4371, 4477, 4511, 4602, 6715 had
deletions of 78, 205, 311 , 345, 430 and 549 nt, respectively.
Fig. 2.1 sho....s the sizes of de18tions, their encodBd protein
sizes and rBStrfction enzyme aitos uaed to qenerate tholl.
rig... 2.1. De1.UoA lUIaly.i. of Jug:l oDJO,.
The cDNA vall truncatGd at definite pointe with the
res t ric t i on enZYJles, as indicated in the figure . The numbers
right indicate the number of basee deleted and the
corresponding size of the protein coded by that truncated
cDNA . The lines represent the untrans1ated sequences and the
boxes repr esent the ORr of the eDNA. The figure is not drawn
t o scale .
~ .;
o ~
- < « 0Qi~il~M~ ~ £
WT ~ : : : : : : I 687bp 30 kDa
1 127 264 377 468 502 608 735 813 979
A 244 ~ I 609bp 27 kDa
127 7~
A 371 ~ I 482bp 22 kDa
1 127 608
A477 ~ I 376bp 18kDa
1 127 502
"' 511 ~ I 342bp 17 kDa
127 468
A 602~ 251bp 14 kDa
1 127 377
A 715 ,------q 138bp 9 kDa
1 127 264
~
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trult.otlon
The ECcell_ were cultured in aKEN supplemented with lOt
heat-inactivated calf serum. These cells were differentiated
according' to the method described by Rudnicki and McBurney
(~9871. Briefly, confluent JDonolayers of cells were
trypainized and lIullpendl1ld in mMEM containing 300 nM all-tranll
retinoic acid (RA) or U DMSO and plated and incubatsd for 48
hr•. Bacterial culture plate. were u.ed to prevent attachment
to the surface and incubated for 48 hrs. Another 48 hr
incubation was continued after the addition of fresh media
containing RA or DMSO. Then, the cells were washed with PBS,
trypsinized and plated onto tissue culture plates containing
medlUlll without RA or DMSO .
Eight to ten hra aftar plating, cells were transfected
with the indicated amounts of test plasmids. In all cases the
amounts of DNA was adjusted to 20 119 with pUC19 or pCMV. The
DNA was transfected accordinq to the calcium phosphate
precipitation protocol of Graha. and van dar Eb (1973). The
indicated aJIlounts of DNA wall aixed with 500 /.IL of 0.25 M caCl!
and 500 pL of 2X bis buffered saline (BBS) and incubated at
room te.perature IRT) for 13 .in. The DNA lIixture was added to
cells in drop. and the plates were incubated for 18-20 brs at
37° C and in 3\ CO2' Then, the cells were washed two times with
PBS and incubated at 37° C with 5' CO2 with fresh mediulIl for
48 hrs before harvesting'.
KeLa and U87 MG cells were cultured in OMEH supplemented
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with 10' hea t -inactiva t ed calr ••ru..- , 50 U of penicillin and
SO 1'9 o f s t reptomycin per aL o f aedlwl. Co nfluent aono layar .
vere s ubcUlture d a t . 1:5 rat i o. Call. var . trana t acted b y the
calc !UJI ph o sphate pr.cipit.lt i o n • • thocl • hra aft_r pl atinl;l ••
described above , \11th t he ex c eptio n of g l.yce rol ahock , at ..
hr. post tra n. t ectio n .
2 .2.4 ChlorampheDlcol ao.tyl trusfer... CCAT) alllay
Cells wer e ha rvested 48 hr a pas t t ransfection,
describad (G on an I..t .a.l.., 1982) . Celie wera washed with PBS,
sc rap e d with rubber polIcemen and. co llected into Eppendor:t
t ubes. FollowIng' pelle t1:l:atl o n by c ent r i t u9ation . the cl1 1
pellet ",as resuspended in 0 . 2 5 MTri.~HCl pH 7 .8 . Cel l s were
disrup ted b y thr ee cy c l •• of freez lnq and thawing' i n liquid
ni trogen and i n a. 37' C ",a t er bath t or 5 lIlin . The ce ll d ebri .
va. pelleted by . i c r oc ent r i fug'a t i on and the resul tant
supernat ant VlIB aspirated and stored at -200 c .
T en ilL of t h e su pernatant was incubated in a reactio n
. 1xt u r e co n t ai ni n g 14 J'L of 1 M Tris-HCl pH 7. 8, 4 pL ot 4 mH
ace t y l CoA, 1 pL water and 0. 1 pCi o t (I4C ]ch l or alllphenic ol a t
37° C for 1 h r . Fo llowin g- incubation, th e [ l' C]chloramphenlcol
acetylated p r oducts vere extracted in 500 J'L et hy l acetate IlInd
dried in VL.CUUlIl . The dried sample. were resuspended in 15 ilL
at ethyl a cetate . spo t t ed on TLC pla t e. and aUbjected to
asce n d in g' TLC i n a j ar c ont ainine) chl orofo ra :methanol (95:5)
to separate the acetylated and non- acet yl ated fOrIDB o f
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(14C]ChlOramphenlcol. Dried. TLC plates were sUbjected to
autora.diographY. Percentaq.. acetylation WAS detenined by
liquid scinti11l11tion counting- . The pRS v-,B-Gal plasmid was used
as an internal control tor transfectlon efficiency. The {J-
qalactosidase a118ay wu p.rtorw.ed, .s described (Xu.ar, 1994) .
The recombinant plasmidlil were constructed according to
the standard procedures described in Sambrook It. Al ., (1989) .
Wild type JCV£ and JCVL CAT constructs , containing- the J CV
requlatory region , with the difference being that they were in
reverse orientation vere made by Nakshatri .i.t.u., (1990a).
The n: 1DCAT containing mutations in NFMl motifs in regions II
and IJ::I and DM10 CAT containing lIutations in NF-l motifs in
regions I, 1:1 and III were deacribed earlier (XUJllar n. AI . ,
1993). The plasmid pRIIECAT containinq only a sinqle 98 bp
repeat in an early orientation was constructed previously
(Kumar n Al. ., 1993). The plasmid pUC19~C containinq the JCV
requlatory reqion in pUC19 at XbaI site was made by Kumar ~
Al., (1993) .The pCKV-BAG-2 plasmid was constructed by
insertinq the eDNA, isolated Using the JCV HF-1 region II/III
probe :troll P19 glial cell eDNA library, at the HindIII and
Nott sites of pRc/CKV from Invitrogen (KUlllar, 1994). The
p lasmid, pBSIIKS+-BAG-2, was constructed by insertinq the cDNA
at the Sal I and NotI sites of the pBSIIKS· plaslllid. The
plasm.id, BK,. CAT, contained the requlatory region of human BX
6'
virus in an early orientation (Pater a nd Pater, 1988) . The
human~ eDNA in pBSIIKS· wa s kindly prOVided as a gift
f r o m Dr. S .J . KOrB.eyer. The adenovirus ma j o r lat. pro_oter
(AdM LP) in pUCl3 vas ki ndly pr ovided by Dr. Katlo KUmar . The
pO .7CAT, containing the mu r i ne p53 promoter upstream of CAT
gene i n pUC18 CAT, was a generous 91ft trom Dr. D. Reisman
(Reisman and Rotter, 1993) .
2. Z .' IfUClleaZ' extraot prep.ratioD
The met h od was described previ ously (Henn iqhau88n and
LuboR, 1987). Briefl y , the confluent monolayer cells were
washed three times with PBS . Cells ....ere harve sted by s craping
with rubber policemen in to 50 mL tubes . Cells wer e pelleted by
centrifuginq at 1,800 rpm for 10 mi n at 40 C. The cell pellClt
was washed two times with 10 vol ume s of PBS . The cell pellot
wa s suspended in 5 volumes buffer A ....ith 0.3 M suorose ( 10 raM
REPES-NaOR pH 7 . 9, 10 mM KCl, 1.5 11M MgCla, 0.1 11IM EGTA, 0.5
mM D'I'T , 0 .5 mM PKSF and 2 ~g/JJ.L each o~ protease i n h ibi t o r s ,
like antipa1n, pepstatin , leupeptin and aprotln i nl. Cell II were
homoqenized in a OOu n ce glass hOlllogenizer vith a B type pestle
by applying 10 - 12 strokes . Later, NP-40"as addsd to a final
concentra.tion of 0. 3 - 0 . 4\ and hOlDogenization was con t i nued tor
another 1-2 strokes . Cell nuclei pelletized by
c e n t rifu g a t i o n at 2 ,700 rpm for 15 Dlin at 4° C. Nuclei were
washed two times ....ith buffer A containing 0 .3 M sucrose .
Next, the nuc l e i were r esuspended i n 2 .5 voll;llIes of
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butter B (4 00 DIM NaCI , 10 1QM HEPES-HIlOR pH 7.9 , 1.5 mM Kgelz'
0. 1 DIM EGTA, 0. 5 mM DTT, 0 . 5 mH PMSF and 5\ glycerol ) . Th e
nuc l e i were homogenized in Dounce g lass homogen izer by
a pp lying ex a ctly 10 strokes . The homogenized nuclei we re
stirre d ver y gently at 4° C for 30 mi n. Then, lysates were
d ia l ysed a g a inst 50 volume s o f bu f f er C ( '20 tnM HEPES-N a OH p H
7 .9 , 7S InK Na CI, 0 .1 mM EDTA, 0 .5 mM OTT , 2 0\ glycerol a nd 0. 5
mM PMSFj for 4 hra at 4° C. The n , the dialys ed Iysate s were
centrIfuged at 20,000 rpm for 1 hr at 4° C. The resultant
s upe rn atant was a liqu ot ed , quick frozen and stored a t _700 C.
The prote i n concentration was determined using a k i t from 810-
Rad according to the manuf a c t u r e r 's instructions.
2.2.7 Whol. call extract preparatioD
The protocol was ad apted from Tasset rt .Al (1990) with
mino r mod i f i c a t i ons . The confluent mon ol a ye rs o f cells were
washed with PBS a nd scraped wi t h r ubber policemen into 50 mL
centrifuge tubes . Cells were pelleted by centrifuging at 1, SOO
rpm f or 10 mi n at 4° C. The cell po;:ll et was wa s hed three t ime s
with 10 volumes ot: ch illed PBS. Then the cell pellet was
suspended in 2.5 volumes of whole cell ex tract (WCE) buffer
c ont ain i ng 10 mM Tris-HCl pH 7.6, II1lH EOTApH S.O , 400 IIlM KCI,
1. 5 mM MgCI2, 20\ glycerol , 1 mM PMSF a nd 2 ~g/mL of each of
protease inhibitors, like antipain , pepstatin , leupeptin and
!lprotinin . The cells were d isrupted by repeated cy cles of
freezing in liquid nitrogen and thawing on i c e . Cell debris
.,
was pelleted by centrifugation fo r 1 hr at 39 ,000 rp'JI an d .0
c . The resultant supernatant wa H aliquoted, quick frozen and
stored at - 7 00 C. The p r ot e i n concentration was determined
usin9 a kit from Bic-Rad .
2.2 .8 ~ t ran81aUoD of v i 14-typ . and a utlUlt ~
cD HA.
The wild-type and mutant bag=2. c ONAs in pBSIIKS' wer e
us e d for coupl ed in.....Y.J...tl t ranscription and translation using
a TNT in..-'£.i.tl:2 translation k i t from ProDleqa . The e DNA was
lineari2ed by cleaving with Nott at its )' end. The mutant
cONAs were made by digesting the wild-type~ eDNA with t he
restriction enzymes indicated i n Fig . 2 .1 . One ~g eDNA
regulated frolll the TJ prom oter waB incubated i n a reaction
mixture containing 25 ~L rabbIt reticUlocyte l ys ate, 2 #L TNT
buffer, 1 J.iL T3 p ol ymer a s e , 1 mK amino acid mix ture , 10 mCi/mL
[lSS]methionine , 0 .5 mci /mL [lH] l euc i ne , 40 U RHaein a nd 15 pL
water . The incubation was carried ou t at J OD C for 1. 5 hre ,
Then , the resulting p rotein was stored at _20 0 C for
subsequent use . The wild-type a nd mutant~ cDNAs were a lso
nonr a d i oa c tiv e ly translated wi th the co mplete amino acid
mixture for DNA-binding assays.
2.2 .9 Produotion of BAQ-2 ira ba oteria
The~ cDNA from pBSIIJCS· was libe r a t ed wi th se i r and
NotI and c loned into the SalI and NotI sites of the pGEX-4T-l
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vector . To e nsur e that the insert was c lone d i nto the co r rect
o r ient a t i on, t he 5' 0 10 n 1n9 s i t e was s equenced using the S'-p -
GEX s e que nc i ng primer. The recombinant pla smid wa s transformed
into E.coli BL21 c e lls .
Subsequ e nt protocols f or the inducti on and purification
of fusion proteins were followed, ali r ecommon ded by the
manufacturer (Pharmacla). FinallY, the concentrat ion of
recombinant BAG-2 was estimated us ing a k i t from a t e - ne d,
2.2.10 Gel .ability llbift &8IIay
The sequences of oligonucleotides used were described
pre viously (KUmar, 1994) . The probes were prepared by nick
translating the oligonucleotide s in the presence of [o 32P]dCTP.
The method for gel retardation was described by Chodosh g Ai
(1988) with modifica tions. The ..1.n..Y1t.l:Q-translated protein was
used in the gel mobility shift as says . The bindinq reactions
were done in 35 #L in a buffer containing 10 'UM Tr is-Hel pH
7 .8, 1 DlH EDTA, 5 mM OTT, 150 mM KCl , 12' glycerol, 10 IJg
pol y (dI.dC) .poly (dI.de), 15 ,000 cpm nick translated probe a nd
4 IJL i.D..Jd.t..t2-trandated protein . The rQa ctions were incubated
at RT for 30 mi n. The reaction products were resolved on 4\
non-denaturinq polyacrylamide gels a t 100 V i n 22 111M Tris-
Bor a te , 0 .5 mM EDTA, wi t h buffer recirculation at 4° C. Gels
were then dried and ;lubj ect e d to autoradioqraphy .
2.2.11 Southwestern blot analyais
••
The method was described previously (Vinson .It Al . , 1988)
and is used here with ..Qveral mOdlt1cations . Briefly , NEa from
UD, PI9 glial ilnd PI9 muscle cells, HeLa cells and US7 KG
cells were resolved on 12\ 80 S-PAGE gels and transferred to
nitrocellulose membranes in II semi-dry transfer ap par at us
(Bic-Rad ) . The filters were then blocked In binding buffer
containing SI: non-fat Carnation dry milk powd er in 25 mM
HEPES-NaOH pH 7 .9, 5 mM MgC1 2, 0 .5 mM OTT and 2S mM NaCI
overnight at 40 c . Following blocking l : t.he r...i.. l k powder, the
filters were probed with 10' cpm/mL of nick-translated JCV NF-
1 II/III oligonucleotide in binding buffer with gentle
agitation at RT for 2 hra . The membranes were washed thrae
tiJDes with binding buffer 15 min each at RT. Membranes ....ere
air dried and sUbjected to autoradiography .
2 .2.12 Par-Western blot analysis
This method is widely used to detect protein-protein
interactions . The method wa s as described (Inostroza n Al, .,
1992) with major modifications. Briefly, 50 "L in.......Y.1..t-
translated aer-a protein was resolved on 12' SDS-PAGE gels and
transferred to nitrocellulose membranes by semi-dry transfer .
Later, the membrane was blocked in buffer A c o nt a i n i ng 20 tlIM
HEPES-NaOH pH 7.9, 50 DIM NaCl, 1 mM BDTA and 10 lllM 6-
mercaptoethanol, with 5\ non-fat Carnation dry milk pOWder at
RT for 2 hI'S with gentle agitation . Membranes were then
incubated with radiolabelled in....YJ...t.r,-translatad BAG-2 protein
.,
In butter B c o n t a i n i ng' 20 111M Tria-Hel pH 7 .5, 100 mM NaCI, 2
aM EDTA, O.n NP-40, 2 aM D'rl' , 0 .05' BSA and. 5' qlycerol f o r
4 hr. at RT. Membran •• were then wash ed three times 15 lIdn
each wi th TENNS buffer (2 .5 mM Tris-Hel pH7.4, 2.5 mK EOTA,
2 50 mK HaCl, I\; NP-40 and. 2.5' sucrose) . Membranes we r e t h en
dried a nd SUb j ect ed to autoradiography.
2 .2.13 RNA preparatioD and analysis
Total RNA was i solated using a kit from Proll'leqa ,
fo110winq the ma nu f a c t u r e r ' s Instructi ons. The RNA in aqu eo us
solutIon was stored at _700 C for further use.
2.2.13.1 Morth.rla blot analyais
The method folloWQd was ac c o r d i nq to Salllbrook m; .ill
(1989) . A total of 2 S ~q RNA In 4.5 JlL water was mi xed wIth 1
JlL lOX formaldehyde q e1 running bu ffer (0 . 2 M MOPS pH 7 . 0, 80
mM sodium a ce tat e and 10 mK EOTA, pH 8.0), 3 . 5 ~L formaldehyd e
and 10 pL o f f o rmami de . Follo..... i ng i nc ubation at 65° C for 15
min , the RNA was resolved by electrophoresis on 1\ ag a r ose
gels containing 2 .2 H formaldehyde . Later, the RNA was
transferred to nitroc ellulose membran es by the capillary
transfer method using l OX ssc ( 1X SSC is 0.15 H Na Cl and 0 .015
M SodiWJl citrate). The membrane was then p r eh ybridi zed i n
hybridization buffer co ntaini ng n BSA, 1 mM EDTA, 0 .4 3 M
NaH2Po,.H20 and 7\ SOS for 4 hr. at 65° C. The probes were made
by nick translating the full length e DNA or the 3 I-end of the
cDNA, a nd y-actin i nt e r na l control in the presence of
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[a32p ] d C'l'P . Probes were then denatu red and ad ded at 105 cpm/ JIIL
o f hybridization buf fer. The hybridization was con tinued
overnight a t 65° C.
Membranes were v lls hed firat with 2X sse lind 0.1' 50s a t
RT fo r 15 min , followed by t wo was hes vlt h a . IX sse, o . n s os
at 65 D C f or 5 min each . Membranes were t hen sUbjected to
au t orad iogr a phy .
2 .2 .13 .2 Pri••r ezten.ion &D&lyala
Primer extension an alysis was don e us ing a ki t from
Promega, acc ording to the manufacturer ' s instructions . A tota l
of 10 jjg of t otal RNA was used . E.eol1 t RNA was u sed as II
negatIve c on trol. The ex tende d produc t IJ ware res olved on a 61:
polyacrylamide-8 M ure a den aturinq gel i n Tria-bo r ate -EDTA
buffer . The dried gels were SUbj ected t o autoradl09raphy .
2 .2 .14,~ transcription &•••y
The in......x.1.tx2 transcription technique ....a. described by
Kumar §.t. ill (1993), ....ith c e r t a i n modifications . Briefly , the
plasmid JCV[CAT was digested with PvuII to yield a 160 nt ru n-
off transcript. One 1J9 DNA telllplate waa incubated with eithe r
75 1J9 WCE or WCE supple mented with 1 /Jg ba cterially produced
BAG-2 protein in a 50 IJL volume conta i ning 12 mM HEPES-HaOH pH
7.9, 12' glycerol, 60 mM KCI, 2 mM MgCl2 a nd I 111M each ATP,
CTP, GTP a nd 0. 5 mM rl2PJUTP. The reaction mixture waa
incubated at 30° C for 1-1 .5 hrs. The reaction ....a s s t opp ed by
adding 1.1 v c ruaee stop bUffer cont a ining 80 mM EDTA, 1\ SOS.
.9
100 mM NaCl, 20 ~q tRNA and 10 1J9 proteinase K. The samples
were incubated in stop but t er tor 30 mIn at 300 C. The s a mples
were t hen ex t ract ed with phe noI-chloroform -!soamylalcohoi and
e t ha nol - prec ipitat e d . The run-off transcripts ....ere analyzed on
5 \ denaturing poly acrylamide-8M urea gels with 0XI?4 markers .
The EcaRI-digested AdMLP in pUClJ wa s u s ed a s an i nt ernal
co ntrol t o yie ld a 40 0 nucleotide r un- of f trans cript . The
bands were quantitated by the Image Quant program (MoleCular
Dynamics) •
2.2.15 lIUIlUDotluor••eenc• • • • •y.
Indlrrsct immunofluorescence was assayed according to the
method of Ha r l ow and Lane (1988) . Briefly, the cells wer e
g rown overnIght on c ove r s lips and fixed with chilled
a c e t one : met han o l mixt u re {l :ll f o r 15 min a t RT. After
fixation , the cells were r eh ydrated with PBS f or 10 mi n a t RT.
The c e lls were treated with 10\ go at s eru m i n PBS at RT for 3 0
min to block non-specific reactions . The cells were then
p robed with BAG-I monoc l onal antibodies in PBS at 0 .1-2 ~g/mL
at RT for 1 hr. The cells were washed three time s with PBS.
The cells wer e then stained wi th a nti - r abbit IgG lITe
c onj uga te for 45 min at RT. After a final wash with PBS, cell
staining was ev a l u a t e d with a Leitz Dlaplan ~icroscope .
ERRATA
A sequence error had appea red i n this t hesis at pageN 72. An
I I A " at p os i t i on" 710 II should appear . Any inconvenience to this
end i s highly regretted . The au thor is thanlrful t o Dr. scha ng for
analyzing t he cDNA by us ing the Wisconsin genetics computer group
sequencing package .
7.
CIlAPfta ,
DaULT.
Prev l oull .tudi.. froa our a nd other laboratori••
d • • onetr a t ed t ha t t he 9118 1 c e ll-.pacific Axp r e s s ion o f J CV
can be a ttributed to the so..1.&-ac t i nq elements controlled by
tiss ue-s pec i f i c t r anscript i on factors . Us i ng~ b i nding
a s says , it \laB BU9Qested that NF- 1 motIfs may p l ay a role i n
the qlial cell-specltic e xpres sion o f JCV (Khalil! J..t. .Al. ,
1988 ; ADIe mlyll. .It .Ill . . 19 89 ; Nakah atrl .a..t Al . , 19 9 0a) .
Subsequent l y. t he f unctiona l role of t h e se NF-1 motif. vae
t ested by site-di r ected mut age nasill. The result. showed that
these . ot its are important f or qUal cell-epecific e xp r e s sion
of J CV (KWla r .I.t. A1. . , 19 9 3 ) . A e DNA va . c loned in our lab ,
u e i ng the JCV NF-l II/III probe froa a Pig glial c e ll eDNA
library . Prelbinary work i nd i cated that this eDNA
transactivated both JCVr and JCVL• Ho....ever, this eDNA was not
t ully ch aracterized. This study addressed the c haracterization
ot t h is eDNA.
3 .1 Sequenoe an.lyds at W:.1 oDNA
As a tirst step i n ch a r ae teriz i nq tho eDNA, the seque nce
ot the eDNA waa de termi ned. To this encl , t he eDNA was i ns e r t ed
into p BSI lKS· fo r sequencing. Bot h s trande of the eDNA we re
s equenced tw i ce. The tull-le ngth eDNA.aqu e nce and the deduced
1'19. 3. 1 . NuClleot.lde .eque l1C1e lUllS ded\loe d ..i ao 80id .efi\leaoe
of mouse JlA9=.l eDNA.
The protein sequence is designated beqinning with
position 1 fo r the t r a nslat i on start codon ATG and s t opping at
t.he position 229 TGA t e rmi na t i on codon . The Hut ATG is i n
bo ld face italics. The stop codon ia singly underlined . The
putative polyadenylation signal is bold face italicized lind
doubly underl ined . The splice site consensus flanking sequence
f or a putat ive alternative axon is in bold face and doubly
und erl ined . The three po ssible initiation Det hio n i ne s are
shown in bold . For the f irst ATG, the i amed.i ately upstream'
nucleotides t hat .atch the 12 nucleotide conseneull sequence
a r e shown in bold . The numbers on the lett indicate
nuc l e ot i d e e and the number. on the riqht indicate the poeltion
of eefnc aclde. bino acide a re indicated by t he dnql e letter
code.
I CCCACGCGTCCGGTGACCCGTAGCAAGMCGTGACCGGGACCCAClClTAGAGGAGGTGACC
6 \ NIO I\TCClAGGAGGCGllCCCAAACCClIU:;GAAfI\ACTClTGClCAGA/lClAGGTGI\CCCAG!\CC
S V I ... T H S N E R Y I> L L '" T P Q Q G
N.JCGT<l.o\TCGTCJ\CCCACMiCI\ATG.'IGAGGTA'l'GACCT'TCTTGTTAJXCCA.CA1JI:AAGGT
E; E E v E LK K L K 0 L E; V S A E Kill
GlVlGNIOI\GGTTGAGT'l'NlA!JAJ\GCTIlMAGA1TTGGAGClTATCTClCAClAGMGAT AGCT
E L Q II E 1\ L C K L O R K ... K ilT I E I>
GAATTGCNo.GCGGJlGGCTCTeTClCMI\CT'l'GI>,TAGGAAAGTAMAGCMCAATTaAGCAII
~T~T~~,.,.g~T~~~~~~~~
R L K R Kil L'" K K V (I v r L II G V T Q
AGG(,."\"MAAAOOANJMT'M'WTGANV\I\GGT'TCAGGTGTTcnAGC!::!!5!IGTGN:.ACNJ
Ii S liT SilK R I> S G C S L O T Ii P W L
TGClAGCAATIICII TCTGCCMGJIaACAGAGCGGCTGCAGTCTIlCAAACT TGGCCCTGGCTG
m
so
'"
II E V I> Ii R V 11 V t, A End
M TGMllTllCllllT(ll\Al]AGTClOCT(lTII CTGllCCT(lAAlll\llCl\llCTT1'IICNlCCCTGCCCT
CTC'!'GGMCAllJIJIGTCGCCTGTTTCTCCIITGIlI.:;:C;CO\G GGGC1IACTIIllCCMJITGTCIIA
=CC(JTCGGTTCTC~TCCTGTCTTTGCAACCTGAAAAMII
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protein sequence are shown i n FIg . 3 .1 . The e DNA has
i nt ac t S' and 3' e nd s . S i nc e the 5 ' e nd c on t a i ns the ATG start
c od on and 3' end contains the TGA stop codon, the eDNA
s e qu e nc e represents an mRNA with a 126 nuc l eo t i d e 5 ' - possible
untranslated regIon and a 156 nucleotide 3 ' - untra ns l a t e d
region . The fIrst ATG at nt 127 Is followed by a long ORF of
687 nuc l e ot i des, which extends to nt 813 . The f Irst ATG Is
followe d by t wo mor e ATGs at nt s 145 and 163 . The meth ionine
at nt 127 is likely t o be the start site , s i nce 7 o f 12
nucleotides immediately adjacent to the ATG ma tch the
consensus 5 1 - n on c o d i n g sequence , ( GCC) GCCA/GCCAT GG, f or
i nit i a t i on of t ra ns lation in ve r tebra t es (Ro zak , 198 7) .
The stop codon i s at nt 814 . A put a t ive polyad enylation
s i q na l, AATGAAA is at nt 925 . The poly(A) signal is usually
s e e n 15-25 nucleotides upstream of the poly(A) t a il in
eUkaryotes and i s i mportant for cleavage and for the formation
of the poly(A) tail (Proudfoot, 1991 ) .
3.2 8tructural feature. of the deduCled _inCl aoid .equenCle
Complete s equencing of the eDNA revealed one large ORY
coding for a protein of 229 Bmino acids, with an apparent
molecular weight of 30. 6 kDa .
The computerized analys is of cDNA through the NCBl b l ast
s e rve r with the s e que nc es reported i n GenBank (re lease 89)
shoWQd a high degree of h omology to a prote in c a l led BAG-I,
for Dcl-2 As s oc i a t ed athanogene-l (Takayama n Al'1 1995)
Vig. 3 .2 . Protein .equeDoe homology between 810-1 aDd BAG-2.
The de du ced ami no acid sequenc e i s a ligned with BAG-l
ami no acid sequence to sh ow maximum ho mology. Id entical amino
ac id sequ e nc es are linked wi th v e r tical bars . The numbers
indicate the position o t amino acids .
MAXTEEMVQTEEMETPRLSVIVTHSNERYD
11 11 11111 111 1111 1111 1111111111
MAXTEEMVQTEEMETPRLSVl vrnSNERYD
LLVTi>QQONSEPVVQOLAQLVEEA TGVPLP 6 0
1111 111111111111 11111111111 11 1
LLVTPQQO NSEPVVQDLAQLVEEATGV PLP 60
FOKLIFKOKSLIlEMETPLSALGMQNGCRVM
111 1111 111 11 11 111 11 11 1111 1111 1
FQKLIFKOKSLKE/olETPLSALOHQNOCRVM
LJOEKSHPREEVELKKLKDLRVSAEKIANII
11 11 111 11111 111 1111 1111 11111 11
LIOEKSMPEREVELKKLKDLSVSABKIANH
t.Q£UoIKELSOIQOllFLAK£LQABALCKLDR
111 11111 11 11 111 11111 111 1111111
LOEUoIKELSO IQQlJFLAKELQAEALCKLDR,
KVKATIEQFMKILE£IOTINLPEQFKDSRL
1111 11111 111 111 11 11 111111 11 11 1
r.VKATJEQFMKILEEIDTNVLPEQFlUlSRL
KRKNLVKKVQVFLAECDTVEQYICQETERL
11 11 11 11 11 1111
K/l:KNLvr;~QVFLAOVTQWSNTSAKR QS(]C
QSTNLALAE
SLQTWP tl LNSVQWRVAVLI\.
7.
(Fig. 3 .2) . Hence , I neaed the eDNA~. The accession
number for the BAG-l is U17162 . The W=l. eDNA ....118 isolated
from a mou se elllbryon i c eDNA library, with the intention of
finding protein(s) that could interact with and mediate the
a nt i - a pop t o t i c effects of 801-2 by the yeast two-hybrid
system. Bcl-z 1s a proto-oncogene, and 18 essential for
protecting the cells from ap ')ptosis, as discussed in the
Introduction. The cloned BAG-l was shown to interact with Bcl-
2. Furthermore , in gene tl'anafer studies, it protected colIs
froID. apoptosis (Takayama n Al.., 1995; .
The homology at the nucleotide lev""l starting from 1st
ATG at nt 127 to nt 709,~ is identical to~ (data not
shown). Similarly, at the protein level from a .a 1 to a.a 194 ,
BAG-2 is identical to BAG-I: from 195 a. a to the end a
different amino acid sequence was observed in BAG-2 (Fig.
3.2). The nt at the point these two sequences diverge is a
splice site with AG at thp. 51 and GT at the 3' end CFig-. 3 .1 ;
Jackson, 1991). Thus, BAG-2 appears to be different from BAG· ·1
at its C-terminus (from a .a 195 to a.a 229) . The BAG-2 111 an
acidic protein with a pI of 4 .81, while the pI of BAG-l is
4.94 . One i.~terestinq feature of BAG-2 is the presence of
multiple glutamic acid (El reaidues (35 of 229) .
A limited amount of homology was observed with the
spveral ubiquitin-like proteins and other functionally
uncharacterized human eDNA clones. Further, structural
analysis of BAG-2 for the hydropathy index (Kyte and
Piq . 3.3. structural detail. at Jlw=..z. eDNA and BAa-z pretein
(the tlqure i. Det drawn to .oal.).
A. St ruct u ral details and partial r estrictien lDap of th~
~g=.z e DNA . The box ed area represents the open reading frame .
Solid lines r e present t he flanking 51 and 3' unt r a ns l a ted
r egions. A partial list of enzymes that cleave .bas=.2. ORF one
t i me are indicated . Shaded area represents the putative
alte r natively spliced a v- ena, The figure i s not drawn to
sca le .
B. Structural f ea t u r e s of mouse BAG- 2 protein.
Numbe r A at the bottom represent positions of amino acids in
BAG- 2. The a-hellcal, BAG-1 and ubiquitin (dotted box)
ho mol og y regions are indicated. The c-termlnus region that
differs from that of BAG-! was shown as a blackened hex . The
puta t.Lve nuc lear localization s i gna l (NLS) is shown between
ami no acids 146-155 , as indicated by a stippled bo x .
AB
~ ~ ~ ~ ~ ~
c, co 0.. U. co co
5' I I I I ! 4 3'
-I I 979 bpPaly A
ATG 709 TGA
127 813
I BAG-' homology II s~riced region I
a helical conformation
.J
rP
79
Doolittle , 1982) suggested that this protein i s &lIlphlpathic.
The region between a .a IJS to 210 of the BAG-2 appears to have
an a-helical c onf ormat i on , according to the COIL prOQ'ram of
PIC qene (Fig . 3 .3). The nuclear localization signal (a .a 146-
155) that is: partially idcmtical to that o f c- myc (Dang and
Lee, 1988) is indicated by a stippled bo x in Fig. 3.3 . B.
3.3 BAO-2 protein subcellular distribution
SI nce 801 -2 is a mitochondrial protein , and BAG-l
Interacts with Bcl -2 to medIate its anti - apoptotic effects
(Takayama .et Al . , 1995) . it is p l')lilslble that BAG-l is a
cytop181oOmic protein . since BAG-2 is 85t identIcal to BAG-l ,
it is also possible that BAG-2 is a cytoplasmic preeedn,
However. previous prelImInary study suggested that BAG-2 is II
transcription factor (Kumar, 1994). To act as a transcription
factor, BAG-2 should therefore be a nuclear protein. Detailed
analysis of the BAG-2 IImino acid sequence revealed a putative
nuclear localization sig-nal (Fig-. 3 .4, 1) that is partially
identical t o the human c-myc NLS (Da ng and Lee . 19M) . The NLS
between amino acids 146-155 was shown to have an arqinine lind
two lysines , that are i mportant for translocation in c-myc
(Dang and Lee , 19881 .
To identify the intracellular location of BAG-2,
i "'.Dlunofluorescence analysis was done in P19 glial cells, which
Fig. 3 • .c. SequeDc. aDd fUDOtioD of BAa-2 Dual.ar loaali••tioD
signal.
1. Location of NIS sequence. The NLS that is partially
identical to the HIS observed in human c-ayc , between ami no
acid s 146-155 is shown i n bold face italicg. The doubly
und erlined argi nine and lysines were shown to be critical in
nuclear tran slocation in human c-eyc , The n umbe r s indicate the
posit i on of amino ac i ds .
2. I mmunofluorescen e an alysis of BAG-2 subcellular
l oc ation. Pan els show i mmunofluorescene i n UD (panel A) and
P19 glial (panel B) cells . Plea se note t he cytoplasmic UD, and
t he cytoplasmic and intranuclear PIg glial i1llJllunof'luorescence .
The fluorescence is also enhanced in glial cells relative to
UD cells.
2MAKTEEMVQTEEMETPRLSVIVTHSNERYD 3 0
LLVTPQQGNS EPVVQDLAQLVEEATGVPLP 60
FQKL I FKGKS LKEMET PLSALGMQNGCRVM 90
LIGEKSNPEEEVELKKLKDLEVSAEKIANH 120
LQELNKELSGIQQGFLAKELQAEALCJ<LD& 150
~TIEQFMKILEEIDTMVLPEQFKDSRL 180
KRKNLVKKVQVFLAGVTQWSNTSAKRQSGC 210
SLQTWPWLNEVQWRVAVL 229
'0\
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were functional tor JCV expression. UO cells were used ar; a
negative control since these cells were not functional for JCV
expression (NaJcshatri.l..t. li. • 1990a). The analysis used a BAG-
1 polycl.onal antibody which would be expected to cross-react
with BAG-2. In UO cells , the BAG-;2 protein was found
exclusively in the cytoplasm (Fig. 3 .4, 2A) . In PIg glial
cells, BAG-2 protein WAS found In the cytoplasm where protein
synthesis is known to occur. but was found mainly in the
nucleus (Fig . 3 .4, 2B). All PIg glial cells did not show the
nuclear immunofluorescence . Since dIfferentiation with
retioaic acid yields a mixture of brain cells, at present it
is not clear in which type of cells BAG-2 protein is nuclear .
Rowever, of the cells with nuclear immunofluorescence, 75\ are
glial cells when stained with antibody to the GFAP marker
protein. The amount of fluorescence was intense in PIg glial
cells than in UD cells , \thich is consistent with the
expression of BAG-2 in these cells only (see Section 3 .5.4) .
The !1lllQunofluorescence experiments were repeated three times
and the same results were consistently observed. Taken
together, these results indicate that BAG-2 protein was
translocated into the nucreue only in PIg glial cells.
Interestingly, BAG-2 was observed in the cytoplasm of muscle
cells and in the cytoplasm as well as in the nuclei of HeLa
cells (data not s h own ) . U2:rJU. Since this immunofluorescence
analysis used II BAG-I antibody, it is possible that both BAG-l
and BAG-2 or BAG-2 alone might have been detected in un and
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Pl9 qlial cells . Therefore, the SUbsequent experiments were
designed to delineate the subtle differences between BAG-l and
BAG-2.
3." Ti••ue-spacific expr.ssion ot BAO-2
3 .... 1 ll'ortbllrn l)lot analysia of total RNA frolll Plt, BeLa and
VI7 KG 0.11s
JCV expresses and replicates efficiently in brain cells
(Kenney At Al., 1984) and the NF-l sites in the JCV regUlatory
region were shown to be critical for glial cell-specitlc
expression (Kumar.l..t. Al ., 1993). The l2A9.=..2. eDNA, cloned using
a NF-l II/III probe from a Pig glial cell eDNA library, was
shown to be expressed at higher levels in PI9 q11al cells,
than in Uti cells (Kumar , 1994). To know whether~ and
possibly~ are ubiquitously expressed or restrIcted to
certain cell types , total RNA f rom mouse cells , for instance
P19 UO, glial and muscle cells, and human cells, like KeLa
cells and U87 MG cells was probed on Northern blots with
either full length~ eDNA or its 3 f-end as probes (Fig.
3 .5) •
The 1. 4 kb and 1. 6 kb R.wI=.2. mRNAs were detected in UO,
P19 glial, Pl9 muscle and KeLa cells, respectively.
surprisingly, no~ mRNA vee detected in U87 MG cells (Fig.
3.5, upper panel). Though U87 MG cells are derived from a
human glioblastoma and support JCV expression, it Is surprising
to nots that BAG-2 is not expressed in these cells. A possible
Pig. 3.5. Hort.ben blot. a.n.lyd. of~ Rlm f roa 4!fhrent.
Cle11 type• •
Tota l RNA (2 0 J.lg) isolated f r om the i nd i cated cell lines
wa s sepa r a t ed on a It a gar o s e an d 0 .66 M f o t1llalde hyde gel an d
hybridized with up-l ab elled l2.A9..:.2. ,~ 3 ' -end (nt 7 35-973)
and y- actin probe s. Mole cula r weight Barkers a r e i nd icated on
t.he right and a re g iven in kb .
Th e probe s are i nd i c a t e d an d t heir s h e s are as follows :
~, 973 bp: .b.a.!I=2 3 1-e nd ( i ndica t ed a s c - t e n i nus in the
f igure), 214 bp 3 1 f ragm8nt f roD~: Act i n , 2 .2 kb BamH I
fragment o f y - act i n .
BAG-2
C-TERMINUS
ACTIN
o(/)
Cl <t ~
::::l 0:: Cl
-2.37
-2.37
-1.35
-2.37
-1.35
8.
explanation for this Is since these c e l l s contain several
chr omos oma l deletions (Po nteen and MacIntyre, 1968) , it is
possIble that the !J8ne whi ch code s for BAG-2 h a s been lost.
ThIs po ssibility c ou l d b e tested in Sou t her n blot analysI s
with ba9=2. a s a probe. InterestIngly, the s ize o f t he .bA9.=.2.
mRNA in Be La cells W IlS appro ximately 200 nt l onge r than .b.A9.=..2.
mRNA from uo, Pig q l i a l a nd PIg mus cle cells ( Fig . 3.5, uppe r
panel). Th e ~ mRNA size d i fference s were c onsist e nt l y
observed between uer.a and PIg c e l ls in 4 independent
experiments . Furtharmore, results with the a r - ene [nt; 73 5- 97 3)
of~ a s II. probe r e vealed the expression of this r egIo n
only in PIg cells , but not. i n BeLa c e lls (Fig. 3 .5, middle
pane l ) . Therefore, it appea r s that this port ion is spliced
only in PI9 c e lls . From these results it is c l e a r that BAG- I
is present in UD, P19 glitl , P19 lIIus cle and HaUl cells ,
whereas the BAG- 2 c-terminus (a . a 195-2 29) i s r estri cted to
only PI9 cells . The unique and longer mouse protein wa s
r eminiscent of another tran s c ription f ac tor wh ich plays II
c ent ra l role i n the r egUlat i on of g ene ex press i on at the
transcript i onal levs!. This transcription fa ctor is TBP (Zawel
and Reinberg, 1993 ).
3.4.2 5'·en4 analysis of um. froa UD!qu. oell typ••
The Northern blot analys!8 revealed a 1 .4 kb mRNA for
BAG-2, but the size of the cDNA was only 973 bp . Therefore,
one possibility is that the presence of e xtra 5 ' sequences.
Fig. 3 . s , Primer extension analysis ot RNA troll Pit glial anl1
UD eeaae,
Tot a l RNA (50 Ilg) from UD (lane 4), Pl9 glial (lane 5)
cell s was hybridized to an oligonucleotide probe derived trum
the~ cDNA at nt 57-85. The hybrids were treated with
avian myeloblastosis reverse transcriptase under conditions
recommended by the suppl ier and the products were resolved by
electrophoresis through a 6\ polyacrylamide/7 M urea gel. The
arro.... illustrates the position ot the major 56 nucleotide hiJsI:.
.z. e xtension product . Lanes land 2 represent primer extension
anal ys is using no RNAa nd l.coli tRNA, respectively . Lane 3 is
a k an amycin RNA positive control , supplied by the
manUfacturer. The arrowhead i ndicates the 88 nucleotide
extended product obtained using the primer supplied along wIth
the kanamycin RNA . The molecular weIght markers in bases are
i ndIcated on the left .
100-
86-
66
48-
4'-
40
2 3 4 5
8 9
Th.e other possibilities are eithe r t he presence of ex t r a 3'
sequence s or the presen ce of othe r alternatively sp liced~
Z-related mRNAEl . To f urther map t he 5' terminus precisely ,
pri "lsr e xtension analysis waa done with total RNA from UD an d
PIg gl i al cells . A syn thetic 24-me r prob e was des igned
corresponding to e equenc ee at nt 57- 85 of has.::1 eDNA.
Elongation of this p r i me r res ulted in '" 56 nu cleot i de f ragme nt
with RNA f ro m both UD a nd PI 9 glial cells as the lI'a j or s pe c i es
and II number of lesser a nd smaller species . Th is ind i c a ted
t hat the 5' end of the 1!A9=.2. mRNA was qsnulne (Fig. 3 . 6, l an es
4 a nd 5 , arrow) . Bey ond 56 nuc leot i des, no further e xtension
was obse rved . As II negat i ve control, I emp l o ye d E.coll t RNA
(Fig. 3.6 , lane 2) a nd a posit i v e c ontrol was ka na mycin mRNA
supplied by the manufacturer (Fig. 3.6, lane 3 , arrowhe ad on
the right). Primer extension ana l ys i s with total RNA from HeLa
cells s ho wed a 400 nt e xt e ns ion product (data not s hown).
3.5.~-b:lDdiDCJ studi•• of BAQ-2
3.5 .1 ~-tr&D.latioDof~ oDNA
To stUdy the DNA-bi nding properties of BAG-2, the~
eDNA .in....-..Y.i.t- t r a ns cribe d and translated . The
radlolabelled ~-translated protein wa s resolved on an
5DS-P AGE den :tturlng gel and SUbj e c ted to a u t o radi og ra ph y to
dete rmine 'che sizes a nd the number of spec ies . Surprising ly,
~ translation sho wed two bands, a major band of 30 k Da
and l!I minor band o f approx imately 28.5 kDa (Fig. 3. 7 , lane 1 ,
I'iq . 3 .1 . SDS-PAGB aualy.i. of ~-.YDt.b.d••d BAG-2
protein.
The US-l ab elled proteins were s y nt hesized us ing a k it
from promega wi t h co nd itions recom:mended . Lanes we re : 1, b..as.=l.
eDNA (1 j.lg) . The arrow indic ates the ma j or 30 kDa protein and
the a r r owhe ad shows the mi nor 28.5 kDa protein ; 2, no DNA a nd
3 , luciferas e control DNA (1 j.l9 ) . Luciferas e is a 61 k Da
protein. Marke r s on the r ight a r e indicated in kDa .
--
1 2 3
-97.4
-68
-43
-18.4
-14.3
arrow and arrowhead , respectively). s ince t here are 3 ATGa at
the 5 ' end. o f the eDNA, a l t e r na t i ve us e of the s e ATGs mig h t be
oc c ur r i ng . s i nce a major band wail obs erved at 30 kDa tor BAG-
2, it is likely t hat t he i n i t i a t ion of translation oc curred
from the first ATG. This interpretation is fur ther suppo r ted
by the recent finding that translati on is r e stricted to t he
first ATG when the second ATG follows the first one c l osely
(Kozak , 199 5) . Most likely, the 28 .5 kDa protein arises from
the 3rd ATG, based on t he expected molecular weight .~
translation in t he ab sence of cDNA did not reveal an y protein
(Fig. 3 . 7, lane 2) . The positive luciferase control DNA ,
yielded the exp e cted 61 kDa protein (f'ig . 3 .7, lane 3 ) . Th e 42
kDa protein mig ht have ar isen from the ba ckground l abelling of
the ret iculocyte l ysate by l5s-methionine in the in..Ji.t..tQ
translation reaction (Jac kson a nd Hunt , 1983) .
3.5.2 NObility .hitt assaya of IlAQ-2 protein probed with JCV
JII'-l II/III oliqoDuClleotid.
To study the DNA-bi nding properties of the BAG-2, t he
unlabelled ~-translated protein was USQd in mobility
shift ass ays . The wild-type and mutant NF-I region II/III
oligonucleotides used as probe and compe t i t or s, were described
previously (Kumar n 41., 1993) . o nly the ~-translated
protein ",,"as able to significantly r etard the mobility of the
JCV NF-1 II/III oligonucleotide . 'this binding could be
competed with a 200 -fold exce s s of unlahellQd wild-type
rill. 3.8 . speoifio~ !lin4ia.q of nG-2 ~o JIF-1 II/III
oliqonuol.ot14. b 9.1 .obility .hift ••••y••
Ass ays we r e done u s ing a ni ck - t ra ns l a t ed dOUble-stranded
NF- l II/I II o l i gonuc l e otide as a probe and 4 ilL each of in
Y.i.t..J.:Q-translated BAG-2, reticulocyte lysate and~­
trans lated l uci f er as e p rotein.
Lan e s : F , f r e e olig o nucl e o t ide probe i n the absence of
pr otein: 8 , b i nd in g assay with no comp e tit or; S, specific
competit i o n by homologous (wild-type) com petitor i n 20 0- fold
e xces s ; NS , no n - spec i f ic c OJ,lpetit i on by lIlutated NF-l II/III
ol i gonucl e otid e in 200 -tol d e xcess . Bro a d arrow and arrowhead
i nd i c ate low- mobility DNA-protein complex and fr ae probe,
respec tiv ely.
The sequences of wild type NF-l II/III oligonucleotide
us ed 11.8 • probe and the IIpecific (5) competitor were:
NF-l II/III 5 I -CTCGACTGGCTGCCACCCAA-) I
3 I - ACCGACGGTCGGTrCTCGAC-5' •
The mutan t NF-l olig onuc l e o tide 11.8 a non-specific (NS)
compet i t o r was :
mut a nt NF- l II/III 5 I -GGAGTACTCCCAGACCAG-J I
3 t - CATGACGGTCTGGTCCCT-5 ' .
F
+BAG-2
B 5 NS
-BAG-2 Luciferase
BSNSBSNS
"
•
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oligonucleotide . Howeve r , the same amount of a mutated NF-!
II/III oligonucleotide had no effect, i nd i c ating that the
complex obs e rv ed was spec ific to the JCV NF-l II/III
oligonucleot ide (F ig. ]. 8 , +BAG-2 l anes) . No s peci f i c bi n d i ng
was observed with rabbit retiCUlocyte l ysate alone (Fi g . 3.8,
-BAG- 2 lanes) • A non-specific protein, lUc!ferase, al so s h o wed
n o binding to the J CV NF- l II/III ol i g o nuc l e o t i de ( F i g . 3.8 ,
luciferase lanes ) . All the se re sults we r e reproduc ible for at
lellst three t bes . Tha background binding observed mi ght have
a r isen from the NF-l or NF-l-Iike proteins pr es e nt i n t he
retiCUlocy te l ysate (Mermod .It. Al.. , 1989) .
3.5.3 ilobility .hitt ....y. of 00-2 protein probed wIth JC'I
To test the bInding of BAG-2 in the context o f the intact
JCV anhancer and to re-ev a ruere t he binding ob s erved in F i g.
3 . 8 , li n end-labelled J CV enhancer wa s used as a pro be in
mobility shift ass ays. Aga i n , ~-translated BAG-2 sh owed
a spec it"ic binding to t he J CV enhancer , and a 200- f o ld excess
at" the wild-type NF-l II/III oligonu cleotide substanti a lly
decreased t he binding . However, a similar ex c ess of the mutant
NF-l II/III oligonucleotide had no effe ct (Fig. J. 9 , BAG-2
lanes). The presance ot another band may i ndicate the bi n d i ng
of NF-l or NF-l-related proteins present in the retiCUlocyte
lysate (Mermod It Al. , 1989) to th.e JCV enhancer. Taken
together, these DNA-bi nding as sa y re sults s u g ges t that BAG-2
Fig . 3.9.~ bin4ing ot n .Q-2 to JCV enhanoer.
Mob i lity s hi f t ass ay s used the pUC19-JC plasmid
co nta i ning the J CVenhan cer at XbaI site . The JCV enhancer was
liberated by cleaving with SalI and NotI restriction enzymes
an d end-l a belled at SalI site with [a JlP]dCTP. Thb was us ed
with 4 $oiL of ~-translatedBAG-2 protein . Lane s: F, i s
a free probe wi t h no protein : B, binding assay with protein ;
S, specif i c competit ion with 200- f o l d excess wild-type NF-l
II/III competitor; NS, Non-specific ".ompetition with 200 -fold
excess mutant NF- l II/III oligonucleotide .
The a r row and a r r owhe a d i ndicate t he specific comp lex and free
probe, respectivel y .
BAG-2
F B 5 NS
0..7
"interacts specifically with the NF~l motifs in the NF-l II/III
oligonucleotide and in the JCV enhancer .
3.5.4 south.lt.tern blot. analyai.
3.5 .... 1 8outh...teZ'D,1I1ot &Daly.h of' n. :fra P1' 911.1, PU
au.ole, BilLa pel 0.7 .a aelh
To characterize the relative amount of BAG-2 proteIn in
the nucleus more quantitatively, Southwestern blots with NEs
from PI9 glial, PlSI muscle, HeLa and U81 KG cells were
analyzed. Proteins of 30 kDA and 28.5 kDa ....ere detected in NED
from P19 glial, PI9 muscle and HeLa cells, but not In U87 KG
cells, suggestive of BAG-2 and its leofon (Fig. 3.10).
However, these results are in agreement with my Northern blot
analysis (Fig.3.S). in whIch the mRNA for BAG-2 was not
detected in U87 KG cells . only a weak band at 30 kDa WIlS
observed in PIg muscle celllll . Interestingly, only a very faint
band at 30 kDa was detected in UD cells (data not shown).
Another band in southwestern blot assays is an 88 kDa protein
present in both glial and non-qlial cells (Fig. 3 .10) . This
WllS domonstrated previously and. WllS believed to be II TATA-like
factor (Khalil! ~ ll .. 1988) . All these bands were
reproducibly observ.:.d f~r 3 tilDes.
BAG-2
Southwestern blot analysis of BAG-2 protein that wall .in
r 19. 3.10. southvut.rn blot analyah of nuolear ••tracta
pr obed vi tb JCV N!'-1 XX/Ill oligonuCleotid.e .
The n uc lea r extracts trom P19 gl l al , P1 9 muscle , U87 KG
and HeLa c ells ....e re r e solved on a 12' 50S - PAGE gel and
transfer r e d to nitrocellulose membr a ne an d probed with nick-
trans lated double-stranded HF-l Il:/l:II oligonuclootide . The
sma l l arr o whead i ndicat•• a u bi quit ous 88 kDa p r otein. The
arroW's in d i cate the 30 a nd 28.5 kDa fo nas ot BAG-2 protein.
Molecular weight mark er. ar e i nd i cated on right i n xce ,
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riq. 3.11. SO\lt bv• • t.rD blot aDaly. i. ot~-traD.l.hd
BAlJ-2 protein probe d wi t h J C:V 1l'J'-1 XX/III oli qoIlUChot id• •
Lanes : 1 , BAG-2 ; 2 , reticulocyte l ysate I 3, luciferase
protein. These proteins we re resolved on a 1.2 \ 50S-PAGE gel,
t r ans f e r red to nitrocellulose membrane and probed with nick-
translated JCV NF- l II/III olig o nucl e o t i de. The a r r owhead and
arrow ind i cate]O a nd 28 .5 kOa tonns of BAG-2 . Molecular
weight marke r s ar e s hown o n right in kDa .
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ilixQ-translated, as described i n Fig. 3.7, llnd probed with
JCV NF-l II/III oligonucleotide also show ed only two proteins
of 30 and 28 .5 kDa (Fig . 3.11, lane 1) . Th e controls, the
reticulocyte lysate and luci!erase proteins, did not show any
binding (lanes 2 and 3) . Taken together, the results of
immunofluorescance and Southwestern blot assays sU9gest that ,
al BAG-2 (possibly BAG-I , 8ee sectIon 3.3.1) is a nuclear
protein and b) two or more Isoforms of BAG-2 are present in
PIg cells .
3.6 Traucrlptional aotivity ot BAa"'Z
3 .1 .1 BAQ-2 tru.aotivatioD ot 'IT JC!V promoter.
To characterize the transcriptional function of BAG-2.
the eDNA was cloned into the pRc/CMV eUka ryot i c e xpression
vect o r. The s t ud i e s were d one in Bela cella, which ware shown
to be deficient in the brain-specific NF-l that is i mportant
for JCV q11al cell-specific expression (Tada II Al., 1989) .
The JCVE and JCVl pro1ll.otar-enhancer reporter plasmids were
transfected either with or without pCMV/BAG-2 . Trallsfection of
JCVE or JCVl showed only a low level of a c t i v i t y (Fig. 3.12,
lanes JCE, Jel) , further indicatin9 the glial cell-specificity
of JCV. However, cotranafection of~ cDNA resulted in 6-
told transactivation of JCV[ (Fig . 3.12, JC[+pCMV-BAG-2) and
s-eere transactivation of JCVl (Fiq. 3.12, JCl+pCMV-BAG-2).
Cotransfection of the CMV vector alone had no effect (data not
shown). The RII[CAT, containing only one 98 bp repeat in the
Fiq. 3.12. Tran••otivation of JCV proaot.r. by BAQ"'2.
A. Plasmids containing the CAT reporter gene under the
control of the JCV early promoter (JC E) , JCV late promoter
(JC~). on e 98 bp repeat in the early orientation (RIlE) and
human polyomavirus BK early promoter (B~) were transfected
into non-g11al xete cells . These plasmids were transfected
without (lanes JCE• JCLI RIll' B~) or with~ cDNA (+pCMV-
BAG-2) . The arrowhead indicates the acetylated labelled CAT
product . Five ~g each of plasmid. containing CAT, with the
exception at BK with 2 ~g, were trllnstected . The numbers below
show the ",g ot~ eDNA cotranstected with the reporter
plasmids.
B. The bar graph shows the results of averages and
standard deviations of 3 diffluent experiments.
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early orientation, vas a180 transactivated 2.S-told (lane
RIIE+pCKV-BAG-21. As II control , BJl;.CAT containing mUltiple NF-l
sites failed to respond to BAG-a . According to thes8 result.s,
the transactivation by BAG-2 was clearly shown for the JCV
promoters . These results are in aqreement. with earlier studies
(Kumar, 1994) .
3.4.2 BAG-a tranaaCltivatioD requirement. of intaot JCV NJ'-l
Further studies were conductBd to test. whether the
integrity of the NF-l sites is essential for transactivatlon
by BAG-2 . The JCV early CAT constructs containing mutations In
the NF-l motif either at regions II and III (II,o>or I,II and
III (OHIO) were employed. The cells used to study the effect
of BAG-2 on IIIO and OK,o CATs were Pl9 glial cells . Since, JCV
itself expresses poorly in aete ceUs, it is difficult to
demonstrate the effect of BAG-2 on thetse mutants in HeLa cell
system. These mutants show a marginal a,ctivity in P19 gUal
cells and the effect of BAG-2 can be better appreciated in
these cells.
From the results in Fig . 3.13, it is clear that neither
IIIO CAT or DM10 CAT was responsive to BAG-2, indicatinq that
the NF-l motifs are essential for transActivation by BAG-2
(Fig. 3.13, lanes II10+p CMV- BAG- 2 and OM,o+pCKV-BAG-2). As a
negative control, I used pAlO CAT (enhancer less SV40
promoter) that was not responsive to BAG-2. Interestingly,
l'i9' . 1. U . '1'raD..aatlvatlaD af JC!V proaatera by 00-2
require.eDt af llltaat 1lJ'-1 II/III aoUf••
A. The CAT r e porter plulIlids c on taining JCV early
promot"r, b"ar inq mutations i n the HF-l motifs in r egions I I
an d III (I110), HF-l mot1f:J in regions I, II a nd III (OKlO)'
en ha nce r les s-SV40 promoter (pAl O) or Rou s sar coma virus LTR
(pRSV-CAT) wl!r e t ransfQcted int o PIg g lial cel ls. These
p l as mi ds v" r e trans t e cted a l on " (lanes 11 10, DK,O' pAlO and
pRSV- CAT) or co t ranstected vi th bAst=.2. eDNA (+pCKV- BAG-:l). 'No
pg e ach of plas . i ds c ontain ing CAT, wi th the exception o f
pRSV- CAT with 1 119, were translecte<!. The numbe r . below
indicate the Amoun ts a t~ e DNA that wo re transfected. The
arrowhead i nd i cat-e the ac e tylated CAT product.
B. The results tor the averagee and standa rd. deviationll
ot 3 i ndependent experi.ents are shown i n the bar diagralll.
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RSV-LTR contains an NF-l motif , TGGC TGGC that was shown to be
responsive to a brain-specific tran8crlption factor, GF-l,
that is important for JCV glial cell-specific expression (Kerr
and 101801111, 1991) . However, observed such
transactivation with BAC-2 . Thus, my results BU99Gsted the
existence of different proteins that can modulate JCV glIal
cell-specific expression . These results also sugqest that~
i eDNA differs from the GF-l eDNA isolated in lO'Ia1111 ls lab.
3.' .3 BAQ-2 trallsaotivation of JC'I promoters in BAG-2-
4efioient U87 KG Cle1ls
Since Northern blot analysis showed that bA9=.2. mRNA is
not expr8ssed in US7 MG cells, these cells may be a good
system to study the effect of BAG-2 on JCV promoters. To this
end, I cotransfected JCVE reporter plasmid and~ eDNA into
U87 KG cells . cotransfection at 2.5 pq of.l:laJl=.Z. transactivated
the JCVE promoter by 1.25-fold . Furthenore , the
transaetivation appeared to be dose dependent . In other words ,
with an increase in concentration of cotransfected .b..asJ=2. eDNA,
an increase in CATactivity was observed. A transactivation of
3-tald was seen with t he maximum 15 pq of cotransfected the
BAG-2 expression plasmid (Fig. 3 .14) .
3 .1.4 ov.rexpr••a1oD ot BAO-Z .zbibit••quelobinq
Thus far, I have examined the effect af BAG-Z on the JCV
promoter in HeLa and UB7 MG cells. It was intriguing- to study
rio. 3 .14 . '1'ran 8a ot!vaUoD of .:lCVI by BAG-2 in VI7 KG o.lh.
A. The CAT-containing r eporter pla smid. unde r t he control
of JCV early promoter (JC; J were tra nllf e c h d i nt o U87 MG
cells. Th e r ep ort er p l a s mi d was tra nefected a l one or
co t ransfected with BAG-2 ex pre s s i on v ector (+pCMV-BAG- 2J in
the nu)llber of ~9 indicated below. The acetylahd CAT llpot i .
indicted by an arrow head . The experbl.ente were repeated 6
times and the r e s ul t s of 2 expe ri1ll.ents are s hown .
B. The bar d ia9ra. show s the ave r a9.. and a tandard
deviat i ons of all 6 experiment• •
A
riq. 3 .15. '1'ran.aaUvaUoD and .quelobiDq of JCV E by ncJ-2 ill
P19 qlial <lell••
A. The J CVE reporter plas mid was trans f ected i nto P19
glial cells . The r eporter plasmid was transfected alone or
cotra nsfected, with the ~q i ndicated below, of the BAG-2
e xp r ession vector , pCMV-BAG-2. The experiments were repeated
6 times and the results of 2 typical experiments are shown .
ThQ arrowhead i nd i c a tes the acetylated CAT product .
B. The bar diagram shows the averaqe8 and standard
de viations of all the 6 experiments .
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the effect of BAG-2 on JCV! and JCVL expression In PIg gUal
cells. Therefore, PI9 glIal cells were cotransfected with JCVE
reporter plasmid and expression plasmid tor BAG-2. At 2.5 #J9.
BAG-2 transactivated JCV f S-fold, further aU9qBllting the
transcriptional function of BAG-2. Interestingly, an increase
in~ cDNA concentration had a negative ettect above 2.5
",g. A progrellslva decrease in the CAT activity wall observed
with increasing concentration of BAG-2 (Fig. 3 .15). Thellle
results are rel:1iniscent of a phenomenon known as "squelching"
(see Introduction; Berger I.t. Al,., 1990; Kelleher n Al ., 1990;
MartIn n Al., 1990). similar experiments with the pCMV vector
alone showed no squelching (data not shown) . Squelching was
similarly observed with JCVl with an increaso in the
concentration of W=2. eDNA (data not shown). By normalizing
the CAT assays with the p-galactosidase expression. these
results indicate a genuine squelching effect and rule out the
possibility of a non-specific effect because of the
overloading of the cell system or poisoning of the cellular
transcriptional Ilachinery by BAG-2. The squelching effect was
also observed in~ transcription aswaylil . The Inczeaee
in concentration of recombinant BAG-2 resulted 1n the
inhibition of activated, but not the basal level of,
transcription from the JCV l promoter (data not shown) .
3 .1.5 Bacterially prOduced DAa-2 aUIll.UlaU.oD cf~
t:ranaoriptioD £'ro. the JCVl prolDoter in Don-qUal B.La celle
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usIng expreaB!on plasmids , BAG-2 clearly trans8ctlvated
the JCV proaoten . To further test the transcriptional
ac t i v i t y o f BAG-2 ,~ transcription assays were
performed. To this end , 11 Glutathione S-transterase (GST) -
BAG-2 fusion protein was made. This fu s i on protein wa s
a f f i n i t y - pur i f i e d on a GST-Sepharose column and cleaved with
thrombi n to liberate the BAG-2 protein. The bacterially
produced and a f Uni ty- puri tie d GST- BAG- 2 fus ion protein was
shown at the top in Fig'. 3 .16, A.
The DNA template , JC[CAT, Which gives a 160 nt nuclear
run-off transcript (Tr) , was used to test the transcriptional
function of the purified BAG-2 protein . HeLa whole cell
extract alone showed basal level activity (Fig . 3 .16, Blane
2), as was also described e arlier (Ahmed At Al ., 1990a) .
However, the addition of 1 ,..,g of purified BAG-2 protein
r esulted in a substantial 3-fold stimulation of J CVE
transcription (co mpare lane 2 with a , Tr) . This 3-fold
stimulation was reproducible for at least 3 times. As ..
positive cont r o l P19 91ial extract was used a nd show ed a high
amount of activity here (lane 1), as was also de scribed
previously (KUJIlar .!l.t. Al . , 1993). The 1 IJg/mL a-amanitin
control was included to demonstrate that the transcription was
by RNAP II, since thb concentration inhibited RNAPII (Zahler
and Prescott , 1989) . ThlB concentration of a-amaniti n
completely blocked all tranlleriptlonal activities (lane 4) .
The internal control (Ie) 18 the adenovirus major late
Pig. 3 .16. Produotion o t BAO-2 in ba ot . r i .. an d t ransoriptional
function at puritied lJAa-2 tor JCV(.
A. BAG-2 in bacterial lysates. The E.coli BL21 cells
containinq pGEX-4T-l -BAG-2 were qrown at JOll C i n 2 liters o f
2X YTA medium. The culture was qrown to a n ""60 of 2 .1 , then
induced with 0 .1 :mM IPTG for 2 hrs . Approximately 10 IJq of
e ach protein were resolved on a 10' 50s-PAGE qel and subjected
to Cooma ss i ve blue staininq. Lane 1 is molecular weiqht
markers a s indIcated in the left in kDa. Lanes 2 represent the
sonicates of E.co11 BL21/pGEX-4T-l-BAG-2. The 60 kDa fusion
prote in is i ndicated by a n ar r ow. Lanes J r epresent t he E.co11
BL2l/pGEX- 4T- l soni cates . Only the G5T protein (arrowhead) was
detected at 30 kDa .
B. .In.Ji..tl:2 transcript iona.l function of bacterially
pz-cduc ed BAG-2 . One IJCJ of the templates, JCVECAT diqested with
pvuII and AdMLP in pUCl] d i qBs t ad with EcoRI , were used . Both
DNA templates were transcribed i n : PIg qUa l extract (lane 1),
uete extract (lane 2) and HeLa extract supplemented with 1 IJq
bacterially produced BAG-2 ( lane 3) and PIg qUal extract i n
the prssence of 1 IJCJ/mL ot a -amanitin RNAP II inhibitor (lane
4). Run -oft transcription products representing 160 nt JC:VE
transcript (Trl and 400 nt AdKLP i nt e r na l co ntrol (Ic)
transcript were resolved on a 5' po lyacrylamide/1 M uxee gel.
The bands ....ere quanti f ied by laser densitometry with the Imaqe
Quant program from Molecular Dynamics .
18.4-
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promoter (AdMLP) construct, which regulates the 400 nt G-less
cassette, as described (Schorpp tit Al" 1988) . Thus , the
results supported the in........Y.i.Y JCV E expression assays (Fig .
3 .12) . and further indicate the .in.....:ti.tl. expression for the
transcriptional regulatory function of BAG-2.
3 .7 Do.ab.. nf BAG-2 1'8CiUb'.d for DNA.-bindinq and
trans.atlv.tIoD
3.7.1 Dd.UOD analysis ot b..M:::.2. ClDNA
To map the regions of the BAG-2 important for
transactivation and DNA-binding precisely. the eDNA was
truncated at definite points with different restriction
enzymes (FIg. 2 .1). The truncationll were veriUed by
translating and examining th8 sizes of the truncated proteins
by SOS-PAGE. The decrease in size of the proteins correlated
with the size expected from the truncated eDNA••... en a 549
nucleotide fragment was deleted from the eDNA, the resultant
protein wac unstable (Fig. 3 .17) . Since the poly(A) tail and
3'-untranslated regions were suggested to influence the
efficiency of translation (Jackson and Standart, 1990)
therefore, lack of poly(A) tails and 3 l-untranslated regions
in .b..I9..:2. cDNAs may explain the smear-like bands observed for
the lDutant BAG-2 proteins.
3.7.2 'rbe BAlJ-2-.peolfio c-t.n.iDu. 1. • •••DU.l tor
tru..aotivaUoD
Fig. 3.17 . SDS-PAGEanalysis o f .1n....Y.i.!I:2-.ynth••i ..d truncated
BAG-2 proteins .
The b..a.9.=.2. c DNA in pBSIncs· was truncated at distinct
sites with restriction enzymes , as i ndicated in Fig . 2 .1 . The
:s S-labe1ed proteins were synthesized using 1 IJCJ of~ cDNA
as t emplate and a ki t froJa Promeg8 . The expected s izes of the
truncated proteins are: .6244, 27 kDa; .6371, 22 kDa ; 114 7 7 , 18
kDa ; .6511, 17 kDa: .6602 , 14 kDa r 117 1 5 , 9 kDa . The truncated
BAG-2 proteins are i ndic at ed by a r r owhea ds and the wild-type
protein i s indica t ed by an arrow.
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I'iq .. 3.18. Domain. of BAQ-2 required, for t.ran.aot.ivation.
A. The truncated~ cDNAs were described in Fig. 2.1,
cloned into the pCKV vector and cotransfected with 10 1J9 CAT
reportor plasmid regulated by the JCVE (J<;) as indicated
above. The non-glial NeLa cell system was used . The arrow head
indicates the acetylated CAT product.
B . The resul te for the averages and standard deviations
of J experiments are shown.
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The truncated cDNAs were cloned i nto the pRc/CMV vector
(1IO'l'_1 the pR C/CKV vector provides the po l y (Al t ail a n d th e
3 I-untranslated r e g ion, so t he efficiency of translation wil l
not be compromised here) and cotransfected with the JCVE
reporter plas.id . Deletion of the C- t erain us resulted in II.
dramatic deCrea88 in transcriptional activat i on by BAG-2 (F 19.
3.18) . only log-told transactivation was observed. The result
was intriguing. since only the C-terminU8 d istingu i she d
between BAG-l and DAG-2. Th ese reBul ts suggest that BAG-2 is
transcriptionally active. These results indicated that t he
transcription activati on property of BAG-2 is con f e r red by t he
e-termin us . ThUS, these results i nd icated that BAG-2 i s II.
novel , unique trans c ription factor . Oth er del e t i ons , wh i ch
remove the cent ral portion of the eDNA, also had an ef fec t on
t ransactivation . This effect may be due to l a ck of DNA-binding
property sine t his r egion is essential for DNA-bind ing (s ee
below) . Finally, the deleti on o f a larqe proportion of e DNA
abrogated the transactivation property at BAG-2. These results
clearly demonstrated that BAG- 2 is e ssential for JCV
transcription. FurtherJllore, these results rule out any
specific effect o f pCMV on t he JCVE prollloter.
3.7.3 DNA-binding aotivity ot tbe oentral coiled-coil region
of OQ-2
The t r u ncat ed cDNAs were~-translated to test the
DNA-bindi ng activity. Removal o t' the C-torminus had no effect
riq. 3 .11.~ biD41Dq t.o wr-l II/III oUqoD\lOleot14. of
truncated. BlQ-2 prot_ba iD qel aobUitr .bUt .....r.
The t ru nc a tad bu:2 a DNAs (F i g . 2. 1 ) were non -
r adioactively translated~. App rox i . ately 4 pL o f eac h
~-translated p r ot ein a nd nic k-tran s lated NF- l II/III
o ligonuc l e oti de wer e u s ed i n b in ding a s s ays. Lan es: 1 , WT BAG-
2 p r ote i n : 2, .&. 244 BAG~ 2 : J , 617 1 BAG- 2 1 4 , 6 511 BAG- 2; 5,
660 2 BAG- 2; 6 , .&.7 15 BAG-2 : 7 , free o l iqonucleot i de probe wi th
no pr ote i n . Br oad a r row i ndica t e s l ow- Ilo bili t y DNA- protein
comp lex and the arrowhead i ndicat es prot ein-unbound tre e
probe .
1234567
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on the DNA-binding activity (Fig . 3.1.9, lane 2) . However,
removal of the central coiled-coil region had a dramatic
effect on DNA-binding, suggestinq that this region \oIa8
essential for DNA-binding (lanes 4,5 and 6). These results
were reproducible for three times . Taken toqether, the.e
results suggested that the transactivation domain is in c-
tenlnus and the DNA-binding domain is in the central colled-
coil reqion. Computer analysis of these two regions failed to
reveal classical activation or DNA-binding domains. sInce the
activation domains of .ost aUkaryotic transcription factors
are poorly studied (Mitchell and Tjtan, 1989 , Pt.ashne and
cann, 1988), the BAG-2 C-tel'1Dinus may derine II novel
transllctivlltion domain . On the other hand the central region
has several positively charged amino acids. These positive
charges may confer DNA-binding property, since positively
charged amino acids were shown to be essential for DNA~binding
of CTF/NF-I (Mermed .!it Al .• 1989).
3.' BAa-z interaot. wIth 801-z
My studIes revealed that BAG-2 Is a novel transcription
factor. I was interested in examining' whether or not BAG-2
interacts with Bcl-2, because of' the tact that BAG-1 does
(Takayama i.t Al., 1995). For this purpose, the Far-Weatern
blot technique wall employed. Clearly, radiolabellad .in...Y.i..tx2-
translated BAG-2 protein specif'ically interacted with the
immobili.zed 8c1-2 (Fig. J. 20, lane 2, arrowhead), but not with
Fig' . 3.20 .~ !Dteraot!oD !l.t•••n BAQ-2 and Bol-2 .
A Far-Western blot is shown. Lanes: 1, BSA; 2 , .1n-..Y1.t.l:2-
translated Bcl-;Z; 3, reticulocyte lysate only; 4 ,~­
translated luciferase. Proteins vere resolved on o!l 12\ SDS-
PAGE gel and transferred to a nitrocellulose membrane. The
i mmobilized proteins were probed with radiolabelled BAG-2
protein . HolQcular weight lllarkQrlI are shown on the right in
xea. The arrow indicates 30 kOa and arrowhead indicates 26 kOa
fo rms of ser-a .
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the re t iculoc y t e l ysate (la ne J), ~-translated
lucUeraae (l a n e 4) or BSA ( la ne 1 ). The arrowhead indi cat e s
the 26 kDa Bcl -2 protein and the a rrow i ndi cates the 30 kDa
t o rm of Bcl-2 wh ich lDay be arising f r oll t he posttran s lational
mod ification of 1lC1-2 i n the~ trans l ation r eaction.
Th ese r esult s a r e not aurpria inq s i nce the BAG- I ' . ubiqui tin-
like doma i n was spe c u l at ed to be essen tial for intera ction
with Bcl -2 (Ta k ayama i1 Al.. 1995) and BAG- 2 mi gh t have
i n teracted with eer-a vi a t he s am e doma i n. The i n terac tio n
b"tw88n BAG-2 a nd Bc l -2 wa a conSlist'lnt ly ob served 1n thre e
independent experiments . Ho weve r, th i s r esult may hel p t o
ex p lain t h e pu z zling latency of the J CN i n the kidney, and
also i n B calls (see Dis cussion) .
3 . ' Iffeat ot BAQ-a OD aurinl p53 proaoter
3.1 .1 Tranaorlptional repr...loD of aou.. p53 promoter by
o.Q"2
AB d !Bcu9sed i n th e I ntrodu ction. p53 waa s hown t o
neqatively re gu l a te e xpress ion of~ by i nteracting wit h a
ne gative r egUl atory element (NRE) in t he .tl£l:Z. q ene ( Young a nd
Ko r smeyer. 1993 ; Miy a s hita and Reed, 199 4bl . I nt ere s ting l y ,
pS3 was recently sho\lll1 t o transact i vata the promoter of b.il.X,
the ant agonist o f Bcl-2 and i nducer of a popt o sis (Miyash i ta
and Reed, 1995 ) . ThUS , p53 appear. t o induc e apoptos ie by
decreasinq Bcl - 2 and i ncreasinq Ba x l evels. Tnis int ricate
J'l q. 3 . 21. Bff_Clt of IIAQ-2 OIL _urine pU prOllot.r.
A. Two pq CAT r eporte r plasaid regulate d by the mou se p53
p r omoter was tranafected into P19 glial c e lls e i t he r wi t h or
wi t hou t the ind i cated # g ah o wn be loW" of BAG-2 exp r ession
plasmid (+p CMV· BAG-2) or wi th t he pCMVvec t o r. The ace t Ylllted
CAT s po t is indicated by an a r rowhea d . The resul ts of 2 of the
8 experiments are shown .
B. A bar d iagr am gives t he aver ages and s tandard
devia tions o f the 8 di f f e r ent expe r iments .
A\~\
o 5 10 5 10
B 8 0 p53
• p53+pCMV·SAG·2
6 Ill! p53+pCMV
c::
0
.i!!
CI) 4
>
c::
0
U
~ 20
0
p53 5 ~g 10 ~g 5 ~g 1 0~g
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control may be necessary to ensure the careful regulation of
cell proliferation (Hockenbery, 1995) . Since Bcl -2 inhibits
apoptosis , eci-a may inhibit p53 via lion uncharacterized
mechanism. BAC>' ,l is Mown to be an abettor of Bcl-2 in the
inhibition of apoptosis . Since .y studies discovered that BAG-
2 has transcriptional properties , BAC-2 Illay have sOllle
influence on the expression of p53 . The rationale ia that,
since BAG-2 binds to the JCN NF-l II/III motif. BAC-2 lIlay
interact with p53 promoter via the NF-l lIlotif . The NF-l llIotH
is present in the p53 promoter , but has not been functionally
characterized (GInsberg .§:t. ill. • 19901 . The rationale for using
the p53 promoter of mouse encompasses two reasons. First , BAG-
2 was cloned from mouse embryonal carcinoma cells. Second , it
is appropriate to study the relationship between BAG-2 and
mouse p53 promoter in a mou s e cell system.
Therefore, the mouse p53 promoter regulating the CAT
reporter plasmid was transfected into PIg q11al cells either
with or without pCMV-BAG-2. The p 53CAT alone showed a
significant activity. Impressively, cotransfection with 5 and
10 pq~ eDNA resulted in a 3-fold and 4-fold represdon,
respectively (Fig . 3.21) . The sama concentrations of the pCHV
vector had no effect. ThUS, the results indicated that BAG-2
down-regulates the p53 promoter .
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These studies were done with the objective o f
c h a r a c ter i z i ng the eDNA cloned f"roJII a P19 9'11al cel l eDNA
library using J CV NF-l II/III motif a s II. probe ( Kuma r, 1994).
Se qu e nc e a na l ys i s of the eDNA rev e aled a novel protein that
showed 85 ' homol ogy to an i mportant , recently r e ported , 801-2
interacting protein c a lled BAG-l (Tak ay ama II Al. , 1995) .
Howev er, the C-terminu& had no homology to BAG- l (Fig . 3 . 2) .
Hence I named the eDNA~. BAG-2 is important for glial
cell-specifIc expression o f JCV (F ig . 3 .12 a nd 3 . 13 ) .
JCV i s a strict human neurotropic virus , and the tiseue-
tropism was sh own to be conferred by the two 98 bp repeats of
the requlatory region (Kenney n Al. , 1984 : Nakshatri n Al .,
19 90a : Tad a .It Al., 1989) . J CV remains latent in kidneys .. B
cells and peripheral blood. leucocytes after t he initial
infection (HOUff §.t Al., 1988 1 Dorries n Al.., 1994) . ThfJ.
latent infection becomes a c t ivat e d during immunosuppression
brought by my r i a d of cause s (reviewed in Fr isque and White ,
1992) . One r e a s on abl e speCUl ation to e xplain the occurrence of
vi r a l reactivation during illlJllunosuppress ion 18 that the
cytokine-induc1ble NF-IeB and GBPi transcription f actors
activate JCV! gene expression (Ranganathan and Khalili, 1993 I
Raj and Khalili, 1994). ThUll, a change in the cytokine profile
"4
would alter JCV gene expressIon and lead to productive
infection and haematoqenou8 spread of JCV to the brain and
other organs (Ault and s toner , 199 4 ; Atwood Jlt Al.., 1 9 9 5 1.
Although JCV is transported to all the organ. by ha••at og e noulil
spread during reactivated infection, JCV DNA replication and
expressIon occur only in the brain. Many studies have
demonstrated the impo rtance of brain-speciUc tranacriptlon
factors , lIke Hr ·1 , AP-l , YB- l , Pur e , NF-cB and dOlllain 0
interacting protein, i n JCV expression (1Olal111 ~ J.l ., 1988:
Ahmed n Al. , 1990b: Amemiya n Al, ., 1992 : Ranqanathan and
Kh a lIl!, 1993 1 Kerr Jlt AJ.. . , 1994: Ch e n n .A.l., 19 9 5 a and b) .
VI r t u a l l y none of these studies showed conclusively whi ch
interaction is important for glIal ce l l-specific expression of
J CV .in....YiE . More r ecently, the JCV core promoter containing
only the TATA bax and the adjacent poly A region wall shown to
be glia l -specific (Krebs n Al. , 1995) . This argues against
the role of other transcription factors in glial ceU-specific
expression of JCV. The above stud y is a naloqoulil with a
p revious s tudy, i n which TFIID from brain , but not from liver,
was shown to confer the b r a i n - s pec i f i c expression of myelin
bas i c protein (MBP) (Talllura.l..t. ll. , 1990a) . Thia suggests that
d!tferent t h Jsues contain different TFIID c ompl e x e s that can
J.·equlate JCV gene expression differentially. A corollary to
't h i s is that such a brain-specific TFIID qo verns the brain-
spe c i f i c expression of JCV. This also s uqge s ta tha functional
r edundancy by the two TATA bo xes of the 98 bp repeat if. the
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JCV requlatory reqion for g11a1 cell-specit'ic expression.
Studies troll our laboratory using a uniquely detined
systelll-P19 embryonal carcinoma cells-attempted to unravel the
1IIolecular mechanlsa of JCV glIal cell-specific expression . The
PI9 undifferentiated cells can be differentiated with RA into
neuronal cells and with OMSO into mUlIcle c ells (McBurney ,
1993) . ThUS, with one cell system, the tissue-speciric
expression of JCV can be studied. Therefore , Jr:v was shown to
express only in P19 glial but not in UD or PI9 lIIu8cle cells
(Nakshatri .tit. Al., 1990a) . The sam. stUdy abo identified
three NF-l motifs in the JCV regulatory region by DNase I
footprinting with nuclear extracts frolll PI9 glial cells .
Subsequently , sIte-directed mutagenesis was used to show the
importance of the NF-l motifs in the 98 bp repeats for strict
'Jlbl cell-specific expression of JCVE (Kumar n Al • • 1993) .
A cDNA was cloned from P19 glial cell cDNA library using JCV
NF-l II/III oligonucleotide (Kumar . 1994).
In my stUdies , sequence analysis of this cDNA revealed II
large ORr of 687 nucleotides potentially coding' for a 30 kDa
protein. A homology search lead to a surprising' finding . The
protein wa~ perfectly identical (85\ identity) , except for the
C-terminus (a .a 195 to a.a 229) (Fig. 3.2), to a novel and
interesting BcI-2 interactinq protein called BAG-1 (Takayama
.I..t. .1.1., 1995) . My finding was surprising. conside.t!!'lq that the
JCV NF-1 motif int&racted with a Bcl-2-interactinq protein.
Analye!s of the~ eDNA sequence identified 3 ATGs at the
".
51 end ot the eDNA. The firet ATG ia In & atronq favour.bI.
context for translation initiation, since 7 of 12 nucleotides
upstream of the first ATG ..tch the con••naua aequence
observed in the majority of eukaryotic aRMA_ (Ko&ak, 1987)
(Fig . 3 .1) . However. translation froa ••cond and third ATCs
can not be excluded, since leaky scanning- (bypassinCJ by the
405 ribosomal subunits of the first ATG and initiating protein
synthesis at downstream ATGs) vas shown to produce different
isoforms of proteins from a single species of mRNA . Examplss
for such a leaky scanning though the tirst ATC is in
favourable context, are cellular genes such as creatine kinase
in chIcken brain, H-myc in hUlllan tUlIlor cell lines (Hakela .It.
A1,., 1989; Soldati .It Al . , 1990) and viral genes ot' influenza
virus B (Williams and Lalllb, 1989) .
ATG-burdened leader sequences are common among proto-
oncogenes, transcription factors and receptor proteins . Such
A'l'G-burdened leader sequences impair translation efficiency
(Kozak, 1989). Thus, mRNAs encoding crit1c!l1 regUlatory
elements are intended to be translated poorly, thereby
critically regulating the cellular homeostasis. One ot' the
important proto-oncogenes is ~. BcI-2 mRNA wall shown to
have ATG-burdened leader sequences and was shown to be
translated inefficiently (Tsujllloto and Croce, 1986). BAG-I
was shown by gene transfer studi•• to inhibit apoptoaia,
either alone or by interactinq with BcI-2 (Takayama At Al.,
1995). ThUS, Jia9.=.1 .ay represent a new class of proto-
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oncogenes. Therefore , the presence of multiple ATea in 5'
leader sequences is not surprIsing. However , recent results
suggest that eukaryotic translation oc cu r s from the first ATG,
despite the presence of a .econd, nearby ATG. That Is, the
fIrst ATG 18 preferred for translatIon Initiation (Xozak,
1995) . Thus , it appean that the tint ATG in RiUI.:.2. initiate.
trans13tlon. However , the next 2 ATGs are also i n a favourable
context for tranalation initiation. Therefore, a ny of the ATea
. s y be utilized.
In.......ili1:2-translation of the lalsl:..2. e DNA yielded two
proteins of 30 and 28 . 5 kDa (Fig . 3 . 7 ) . The 30 kDa protein
app arently arises from fIrst ATG and the 28.5 kDa protein most
likely a r i s e s from the third ATe, based on the respectiv e
molecular ....eIght predictions from the ORF s equences . Rec ent
studies in Ilukaryotes sugqest that, if two 5 ' end ATGs are
closely located , the fint ATG would be preferred for the
initiation of translation (Kozak, 199 5) _ Consistently, the 30
kDa protein is more abundant than the 28.5 kDa s pec i e s . Other
eXllmples, in which two protein i.oforms were shown to arise
from a s inqle species of 1DRNA were creatine kinase and N-myc
(Soldate Jlt Al. , 1990 : Makela Jlt Al., 19 89). Though these two
protein isoforms were shown to have an identical function , the
biological significance for generating such protein isoforms
io unknown . Viruses also are known to use a similar
translational ploy to generate protein isofoOls. For example,
a second ATG adjacent to the first ATe was shown to allow
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leaky scanninq to produce NBand HA glycoprotein. in intluenza
B virus (WilliaJls and Lamb, 1989).
The poly (A) sIgnal in W=..2. cDNA (AATGAAA) deviates tro.
the consensus poly(A) tail. AATAAA . However, the G at 4th
position was ob served in 15' of mRNAa in vertebrates . Further,
mutatIons i n the poly (A) signal impair c l e avage and
polyadenylation, the aite Is not functionally the rate-
Ibdting step in gene expr••don (Sheets Jl.t. Al ., 1990) .
The eDNA cloned fro. our PIg glIal cell eDNA library v••
discovered to code for til 8c1-2-1nteractinq protein, BAG-Z.
Further, BAG-l was suggested to be ubiquitous , ainc8 it w••
cloned from a lIIouse e1llbryonic eDNA library (Takayama Jlt Al.,
1995). Therefore, it ....as essential to test the tissue-specific
distribution of the homologous BAG-2 to address the glial
cell-specificity of JCV. The Northern blot analysis detected
Jag:1 in UO, P19 muscle and PI g glial cells, but not in U87 KG
or HeLa cells (Fig . 3 .5). U87 KG cells support JCV expressioli
(Fig . 3.14) although, BAG-2 fa absent in then calls . This may
indicate that BAG-2 18 not the only transcription factor
conferring the glial cell-specificity to JCV (se. section
1 .2 .3) . Since BAG-l and BAG-2 dltfer at their c-tenini, the
BAG-2 C-terminulI may so ••how confer tissue-specific function .
The detection of the BAG-2-specific C-terainua in uo , P19
muscle and. PI9 gUal cells, but not in HeLa cells , further
complicated the possible .echanislIl for the glial ce11-
speclticity of JCV.
13.
JCV Is expr••••d in P19 glial cells, but not in UD or PIg
muscle cells (Nakshlltri JLt Al., 19908). My studIes revealed
the importance of the C-ter-inu8 of BAG-2 for transcriptional
activation (FI9. 3.18) and the central coiled-coil region for
DNA-binding (FIg. 3.19) . These results therefore aU9gest that
the C-ter1llinU8 t. important for BAG-2 transllctivation, but the
e-terminus is specific to the PIg cells. possible explanations
for a BAG-2 role In q11a1 cell-specIfic expression of JCV are :
1) SpecifIc nuclear translocation : 2) BAG-2 llIay be degraded
specifically in non-glial ceUs, as supported by the presence
ot ubiquitin-Uke dOlllain (Fig. 3 .3 B): 3) BAG-2 Illay be
specifically translated in glial cells, liS revealed by the
Southwestern blot and lllUllunofluorescence results: 4) The other
interacting transcription factors in glial cells may modulate
the effect of BAG-2 : 5) A negative requlatory element (NRE) is
found immediately adjacent to the NF-l sites 1n the JCV
regUlatory region (Fig . 1.2) . Further, the factors that bind
to NRE were shown to negatively regUlate JCV expression in
non-glial cells (Tada n Al., 1989: Tada II .Al., 1990 1 Sharma
and Kumar, 1991) . In glial cells probably , BAG-2 occupies the
NF-l motifs prevllnting the interaction of negative regulators
with NRE thus, allowing glial cell-specific expression of JCV .
Thus, JCV glial cell-specific exprllililion .ay be controlled by
~-elelllents that act positively in glial cells and negatively
in non-glial cella. Furthenore, the .tnnIi-acting factors frolll
non-g11al cel18 that bind to the JCV regulatory region were
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revealed to be dittennt, by~ gel .ability .hitt
aS8ays (Khal1li n Al., 1988; Xwlar At. Al., 1993) . Non~Ud
cells also were dellOnstrated. not to have the brain-specific
NF-l that is iaportent tor JCV expre.don (Tad. n .11. , 1989 ,
T••ura n .1.1. , 1990b) , and 6) Alternatively, .. ahort l ••der
sequence with not .any ATGe i n the 5 1-leader ••quence aay be
important . The Ia,g,:1 cDNA cantil Ina three Aroe and euch la.der
sequences 1IIay be trend.ted acre efficiently in PIg gUal
cells. The higher levels (,)f protein lilly be due to eore
effIcIent translation in glial cells . In contrast, the 5'
leader sequences with lIIany ATGB eay b. tranillated poorly in
non-<)1181 cells . The possible poor translat ion is BU990sted by
the taint band of BAG-2 observed in Southwestern blot analysis
with HE troll P19 au sc l . cells and. UD celIe. However, the eame
amount ot nu clear extract revealed a stronq band tor PIg qli_l
cells (Fig . 3 .10). Alao in i_unotluore.cence asaay. there 101'011.
clearly l e s s BAO-2 protein in UD than P19 q11al cell. (Fig .
3 .4, 28). The Sou t hwe s t e rn blot quantitatively showed that the
expression was .uch grsater in PI9 q11al cells than in P19
.uscle cells (F ig. 3.10) lind UD cells (data not shown). These
results were completely consistent with the Northern blot
analysIs, in which the same amounts ot IlRNA were detected in
all P19 cells but the protein level varied (Fig . 3 .5) . Thb
indicates that translational control is critical tor the
expression ot BAO-2 in Pig cen•• The other poesibility b
that external .1qn818 such as, RA ...y 1ntluence the
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translation efficiency of BAG-2. For example, translation of
the human HOX-5.l gene appeared to be controlled by the
external sIgnal, RA. The 5' leader sequences of HOX-S.l ha ving
fSlier ATGs were added in response to RA (Clanette ~ li.,
1990). Hovever, having many ATGs in the 5
'-leader sequences
may severely impair the translation efficiency in UD and PIg
)Quscle cells.
Preliminary work with .biw.:..Z. eDNA suggested that it
trans8ctivates both JCV prolloters equally (Kumar, 1994) .
However, whether such transactivation required the integrity
ot the NF-l DotH_ in the JCV regulatory region was unclear.
In my studies, cotransfection experiments showed that BAG-2
transactivated JCV E 6-fold and JCV l S-fold (Fig. 3 .12).
Interestingly. the RUE CAT containing one 98 bp repeat in an
early orientation was also transactivated 2.5-fold (Fig .
3 .12) . Since the Jc:Y regulatory region is bidirectional in
function, these results suqgest that one repeat. ill sufficient
for BAG-2 tranll8ctivation. However, no such transactivation
wall observed with JCV containing llIutations in both NF-l motifs
(Fig. 3.13) . ThUS, these result. suggest that transactivation
by BAG-2 is specifically dependent on the integrity of the NF-
l motifs . Moreover, the transactivation is very specific to
JCV, since another hUJlan polyomavirus, BKV, containing
mUltiple NF-l siteSl in its requlatory region was not
responsive to RAG-2 (Fiq. 3.121 . The neqative control pAI0CAT
was not responsIve to BAG-2. Furthermore, recombinant BAG-2
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protein specifically sti.ulated transcription fro. the JCVE
(Fig. 3 .16) . Taken together , the•• results sugge.t that BAG-2
transactivatell specifically the gene expression of JCV and
this requires the integrity of the NF-l .oUte .
Previous work troll RhaIli1's l ab purified a factor frolR
calf brain that interacts with the J CV NF-l motif and was
s hown to transactivate JCVE (Ahmed !It Al •• 19908) . Later work.
from the s ame lab cloned a eDNA by s creening- a hu man brain
eDNA library with a JCV NF-l probe. This eDNA (GF-l e DNA) was
shown to transactivate J CVL (Kerr and Khalil!. 1991) . Though ,
the same probe was used in both the systellls, the rellults were
contradictory and highly inco nclusive . However, the~ eDNA
characterized here t ransactivated both JCV promoters equally.
Interestingly, GF-l cDNA WlUI shown alao to transactivate RSV-
LTR contain ing NF-l motif (Ke r r and Khalili, 1991). On the
other hand, RSV-LTR was not r esponsive t o BAG-2 (Fig . 3.13) .
ThUs , these results clea rly demon strated the e xistenco ot
different brain-specific factore in different cells that
modulated JCV expression differentially . Further, these
results suggest that the BAG-2 eDNA is entirely different from
the cDNA cloned by JOlallli's lab , based on functional as well
as sequenc e data .
Yet another interesting findi ))g with southwestern blots
was the detection of BAG-2 in NEB frOID P19 glial cells and
much lower levels fro. HeLa and P19 musc le c e l l s (Fig . J .10) •
This indicated that BAG-2 was translocated into the nucteua .
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The llllllunofluorescence data displayed the nuclear localization
of the BAG-2 only in PI9 911al cells, not in UD cells (Fi9 .
J. 4, 28). only scattered nuclear etaining was observed in PIg
muscle and HeLa cells (data not shown) . The combined results
suggest that BAG-2 is translated efficiently and transported
into nucleus only in P19 glial cells. The limIted nuclear
localization in UD, PIg auscle and KeLa cells is consistent
wIth JCV expression levels being much higher in PIg glial
cells than UD and PIg muscle cells (Kumar n Al., 1993). Since
the immunofluorescence analysis used an antibody that cross-
reacts with BAG-l N-terminus , it is possible that both BAG-l
and BAG-2 or BAG-2 alone can be translocated into nucleus .
This can be furthel" tested by generating the BAG-2 specific
antibody. sinc. the BAG-2 specific c-t.rminull is essential for
transactivation (Fig. 3.18), only BAG-2 can transactivate JCV
promoters, but not BAG-l despite its nuclear localization.
Recent result.. suggest that BAG-l exists in the cell as a
multicomplex protein associating with various cellular
proteins such as TFII D. FurthenDore, these results have also
indicated the differential subcellular localization of BAG-l
(Gehring, Pers. CODUll). Thus , BAG-l is not only a 1Il.ulticomplex
protein but also a multifunctional protein (John Reed, Pers .
coma). Hence , it is also possible that BAG-2 may have similar
functions partly because of its differential subcellular
localization.
My results .ay partially explaln the latency of JCV in
'"
kidneys and B cells . Though the BAG-2 was expressed In 00, PIg
gllal and P19 muscle cells, the reason for the protein
remaining in the cytoplasm JRay be the existence of a deficient
nuclear transport system or the association of BAG-2 with BCl-
2 or other factors. Thus, a cytoplasalc BAG-2 protein would
protect the cells fro. apoptosis during viral infection,
facilitating persistence and negatively regulating p53
expression. Both would suppress p53-induced apoptosis. U
lllllllunosuppression occurs, viral reactivation and
transportation to the brain could follow . possibly, in ths
brain, the BAG-2 protein would be released from its
association with 801-2 or other proteins. However. this is
analogous with the transcription factor, NF-xD. Although
ubiquitously expressed, NF-cD L.. active only in B cells upon
its nuclear translocation. In the cytoplasm NF-xD is inactive
because the leD inhibitor interacts with the 110 kDa precunor
ot the p50 subunit ot NY-ltD and masks its NLS (Beg' n Al .,
1992). Cytokin....':O disrupt the NF-xD/IxD complex. ThUS, NF-JtD
becomes translocated into the nucleus (&aeuerle and Baltimare,
1988) . My demonstration of the BAG-2/Bcl-2 interaction (Fig.
3.20) may indicate a similar putative mechanism described
above.
Since alternative splicing did not introduce an NLS tor
BAG-2 (Fig . 3 .3, D) the other mechanisms tor translocation lIlay
be important . In the brain, only lytic infection of the
oligodendrocytes is obeerv_d. Hence , the transport of BAG-2
l'i9. 4 .1. Ilode1 for regulation of expr...ioll of JCV by BAG-2.
A. The putative role of BAG-1/2 in JCV latency i n kidney
and B ce l l s .
B. Th e putative i nvolvement of BAG-2 i n J CV expressi on in
bra in cells .
See the text tor abbreviations and details . This model is
not a n exhaustive compilation of literature . However , the
references cited are:
1, Ariza n Al, ., 1994 ; 2, Au1t and Stoner, 1994; 3, Berke ,
1994 and 1995; 4 , Heusel JLtAl . , 1994; 5 , Hock enbery, 199 5; 6,
Kor smeyer, 1995; 7 , Major n al., 1992; S, Miya shita and Reed,
199 5 ; 9 , Hi yashita .e.t. Al.., 1994a ; 10, Raj a nd 1<halili , 1994 ;
11 , Ranganathan and Khalili, 199 3 ; 12 , Takayama n ill., 1995 ;
Kidney end B cella
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into the nucleus may render these cells susceptible to
apoptos!a. The lytic infection of oliqodendrocytes was shown
to produce demyelination, the characteristic feature of PHL
(Trapp n Al., 1988; Major n A.l. , 1992) . Though my results
mirror thh: model, many aspects remain to be tested before an
overall conclusion can be drawn. The model o~ rig. 4.1 shows
how BAG-2 lllay affect JCV latency and pathogenicity. ::In kidney
and B cells, JCV remains latent . This can be explained by the
presence of cytoplasmic BAG-:':, which inhibits the apoptosis by
negatively regUlating p53 (Fig . 3.21) . The inducer of
apoptosis is p53 , which is s hown to be present at higher
levels in JCV-infected cells (Ariza.it. 41.., 19941 as a result
of DNA damage arising from JCV infection (Dorries and Elsner,
U911 Flaegstad n A..l., 1991). p5J Illay induce lIpoptosis by
increasing the levels of ax (Miyashita and Reed, 1995) or by
decreasing tile levels of ~ (Miyashita ~ Al., 1994a),
cUlminatinq in apoptosis. This apoptosie 1s counteracted by
both BAG-l (Takayama m.ll.., 1995) ancl BAG-2. As a result the
virus-infected cell survives for a prolonged time (for
reviewlI, see Hockenbery, 1995; KOrllllleyer , 1995). Thus, JCV
remains latent in JCV-infected kidney and B cells (Fig. 4.1
A) •
The effects of BAG-2 lire distinct in brain cells .
Reactivation of latent infection is under
hUDunocomprolllisinq conditions, which then leada to
haematoqenous spread of JCV to brai. ;, (for review, see Major .it
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Al ., 1992). Thus , in the event ot ilUluno8upprBBslon, JCV 98ts
expr e s s ed in the brain . Exp ression .ay be due to : a) the
braIn-specific rearrangellents in the JC:V requlatory reqion.
which allow efficient expression in brain cells (Ault and
stoner, ],994) 1 b) cytokine-!nducible GBPI and Nf'-KB
t ranscription factors were shown to e nh a nce JCV expression
(Ranganathan and Khalil! , 1993 ; Raj and Khalili, 1994) a nd c)
the nuclear BAG-2 in brain cells , which would also a c tiva t e
JCV expression (this study) . The activation of expressIon of
JCV may l e ad to productive i nf e c t i on and lysis of the
ol1qodendrocytes (for review, see Major n J.1.. , 1992) . The
other possibility is that the c yt ot o xi c T lymphocytes (CTLs) ,
whIch wer e seen in increased numben i n illUllunoliluppressive
cond i t i ons , like AIDS (for reviews, seet aerke , 1994 a nd 1995)
attack the v i ru s - i n fec t e d cells and cause apoptosia . The CTLs
secret e a protease, Gr a nz yme B/fragmentin, wh i c h induces DNA
fragmentation and l eads to apoptosis (Heusel Jtt. Al ., 1994 ) .
Lysis OCC l,; rs as a c ons e quence vi a this pathway . Loss o f the
oligodendroglial cells, whi c h ar e required for mye l i nat i o n
(f or rev iew, see Brophy n ill . , 1993 ). results in
deillyelinat ion and the consequent pathology cal led PHL (Fig .
4.1 B) .
Another objective of this study wall to examine the
effect of BAG-2 on the r equ l a tlon of the p53 prollloter. As
discussed in the Introduction, BcI-2 waB shown to inhibit the
apop tosis i nduced by p53. How 801-2 accomplishes this was
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unknown, since 801-2 does not have any functional motirs tor
biochemical functions that inhibit p53-!nduced apoptosls. As
p53 is )enown to induce apoptosls by increasing tA.x mRNA levels
and decreasing that of 22.l..=.2. (Miyashita and Reed, 1995, Young
and KorsJD.eyer. 1993) I Bcl-2 protein, Bcl-2-related factors or
ser-a interacting factors may have a role in raqulating p53.
I hypothesized that BAG-2 is II Bcl-2-interactinq protein (Fig .
3.20) and acts as II transcription factor (FIg . 3 .12). These
functions may be important for regulating the level of p53
transcription.~ assays showed that BAG-2 do",n-regulat~d
the expression of p53 promoter by 4-fold (Fig. 3.21) .
Generally. the present stUdy did not completely clarify
hoW BAG-2 negatively regulated the pS3 promoter. One
possibility is the binding of BAG-2 to the NF-1 site of p53
located at the tranacription initiation &ite (Ginllber9ll Al.,
1990) may sterically interfere or functionally repress the
initiation of transcription. These results also rule out the
possibility of a non-specific effect of BAG-2 on p53 promoter
since pRC/CMV vector alone had no effect on p53 promoter .
My studies discovered the squelching of the expression of
JCV (Fig. 3 .15) . Kany eukary')tic and viral transcriptional
activators were shown to activate transcription via novel
factors called adaptors (Berger II .a.l., 1990 and 1992;
Kelleher.lt Al. , 1990 : Martin n J.l., 1990: Martinez tt Al. ,
1991). A second possibility is that BAG-2 lIlay act via a higher
order. indirect interaction with the transcriptional
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machinery . Specifically. adaptors act as a bridge between the
upstream activator system and the basal transcription
machinery. overexpression of acti vators blay titrate adaptors
to function as repressors ot transcription. Recantly. an
adaptor protein factor was purified and shown to interact with
the VP16 activation domain and CTD tail of RNAP II (Kim n
.A.l., 1994). My studies showed squelching i n PI9 g11al cells
but not in U87 MG cells. This also supports the possible
presence of cell-specific adaptora . If the putative adaptor is
important for squelching of JCV expression by BAG-2 , then this
may explain why BAG-2 didn I t exhibit squelching in US7 KG
cells . Th e adaptor may be absent in U87 KG cella or non-
functional, however, U87 KGcella also had no BAG-2 mRNA (Fig .
3.5) . Though BAG-2 is ubiquitous , its lo cation a nd as sociation
with other proteins may modulate its transa ctivation
properties. since ubiquitin-like domains were shown to mediate
protein-protein interactions (Toniolo.i..t. Al . , 1988). it is
possible that BAG-2 lIay i nteract with such putative adaptors
v i a the s ame domain . Si mU ar l y . p53 was shown to repress many
cellular and viral promoters (for review SleQ MorcQr, 1992),
not by binding to promoter eequencee , but by
sequestering/squelching the factors essential tor
transcription (pietenpol and Vegelatein, 1993) .
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rOTa.. DI1Q;CTIOll.
The requlation of gene expression is known to occur at
the transcriptional, p08ttranscripticnal and translational
~evQIB. The regulation of the first level, transcription,
constitutes the most important of the three . Further ,
transcription factors that are specific to each tissue for
gene expression are known to govern the expression of only a
particular subset of genes . Thus, only a select cell·specific
clns of genes are transcriptionally activated . whereas others
are transcriptionally repressed . Gene expression in brain
tissues lilac is requlated aainly at the level of
transcription. However, understanding brain·speciflc gene
expression is difficult , b"cause the brain is complex in
function and in tissue diversity. lIuch attention recently has
been focused on the buaen neurotropic virus. JCV. because JCV
is strictly brain-specific in its expression and serves as a
genetically well defined system.
The JCV requlatory region is contained llIainly in two 98
bp tandel\l. repests. that are bound and requlated by several
Ja:Ani-acting factor. (Fig. 1.2) . stUdies fro. our and other
laboratories indicated the importance of NF-l lIIotifs in the
glial cell-specific expression of JCV (Kumar it .Al., 1993).
SUbeequently. a cDNA encodinq the factor that binds to the NF-
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1 sequence s va a bola ted and. s hown t o act iv at. the expre••ion
ot J e'l in non-qllal ce11. (Kuaar , 199 4 ) . Howe v e E', n o
s t ructur e -funct io n s tudi . . were d one . My stud! • • p r ...nted
her e demo nstrated the !aporta nee o~ the fact or e ncoded by this
e DNA, BAG- 2 , a nd I t a int.e r action with the JCV NF-l II/ XI I
1Do t i te, in JCV e xpr e a Bl on.
BAG-l was ubi qu itously expres sed . but the C-te rainUB
specific to BAC-2 ....a . restri cted to P19 ce l l a (Fi g _ 3 .5) .
Interestingly, the 5' leader sequence. a ppea r e d to b e 0811-
spec ifi c, as r e veal ed by PeR ana l y s is of RNA from different.
cel l t yp es (d a ta not sh own ) . Fu rther , llAG-2 belongs to a
fam ily of pro teIns a rlsinq by alternative s plic i ng o f a aing l e
primary transcrIp t , a 8 r evealed by Sou t hern b l ot (dat a not
s h own) . On e at tractiv e con tin uatio n or my s t udie a , wou ld be to
c l one the 5 ' lIe qu enc • • by 5' RACE-PCR all du c ribed (A pt. and
Sie be rt # 1 993). Study inc;J the r ole o f lIpec1tlc 5 ' oIequence. ma y
11llm i nate th e mechani81l t o r the t ranai lltional c ontrol o t BAG-
2 g ene e xpre.8 i on in d i ffe rent cel l a . R89'l latinq t h e
expr es sio n ot the ettector proteins at the trans lational h lvel
ma y be i mportant fo r an effec tive mecha nism t hat allow. the
rap i d res ponse that i. i mpo rtant i n vari ous brain functions
r esponse.
My studi es s howe d t hat BAG-2 wa s local iz ed in the nucleus
i n P1 9 glial c e lla only. It. prote1n( s ) that i nt e r ac t s with the
HISs of BAG-2 may be rostricted to P19 911al cella . In the
t u t u re , such proteina might be id en tifi ed by crou-linking a nd
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ligand-bindinq assays. as described i n other studies (Adam~
Al. , 1 989 ; Li and Tho.as, 1989). Alternatively, anti-idiotype
antibodies specific to t he NLS ot BAG-2 could be generated to
identifY the proteins that specifically interact with NLS of
BAG-2. as described for t he NLS of SV4 0 T -ant igen (Stochaj ~
U " 1990) . Relevantly , the SV40 T-antiqen NI.S waa sh o wn to
interact with di:fterent proteins froll different cell t ypes
(Stochaj §..1; Al,., 1990). To date , my studies did not clarify
whet h e r or not NUl is important for nuclear localization.
Therefore, the NLS funct ion can next be a ddressed by do main
swapping with va r ious proteins , by dslet i ng , by mut at i n g the
NLS . After this would f ollow t esting for the subcellular
l ocalization of the various recombi nant proteins and t h e
mutated BAG- 2 proteins in the BAG-2-daficient cell line, U8 7
KG.
Th ough my s t u d ie s n arrowed the putative seque nce s for the
DNA-binding and tranllactivation domains to t he central c o iled -
coil and C-tanlinU8, the reeidu88 'Which are important fo r
these activities were not identified f unctionally
cha r a c teriz e d . Therefore , site·directed . ut a genesls ca n
addr e s s these issues i n the fu t u re using the methods
pr ev i o us l y descrived (Kunkel g Al. . , 1987) . Further, the
swapping of dOllain.. with va r i o u s proteins , could be used.
Earlier studies trom our l aboratory. showe d that J CVT-
antigen transactlvated JCVL and the hypothesis that t his
occurred wh e n the T·antigen facilitated t he bindi ng at NF-1
'"
WlI8 fOrJllulated (KlaIar, 1994). Since BAG -2 ,,180 tran.activated
JCV4 in my studie., it i ••ssential to ob••rve the putative
interaction between BAG-2 and T-antiq8n to bet this
hypothesis . Theretore, the next step could be to ausy for
this interaction, using the yeast two-hybrid system, as
described (Fields a nd Song , 1989). Most DNA viruses carry
their own "a n t i -de a t h" gene to protect the infected cells trom
PCD. JCV appeared to be unique-instead of having' an anti-death
gene , JCV may instead exploit the counter-apoptotic properUn
of BAG-2. Though BAG-2 regulates J r:v expression in the brain,
a mechanism for BAG-2 allowing JCV to remain latent in other
organs , such as in kidney and B cells Is unknown . Thia
mechanism could be addressed in future stUdies, by isolating
the proteins that intenct with BAG-2. The methOds of choice
are the yeast two-hYbrid system. or protein-affinity
chromatography. For the latter. complexes with BAG-2 would be
i solated and identified by passing the WeEs from kidney and B
cells through a column containing the i mmobilized GST-BAG-2
fusion protein. as de scribed (Formosa .i..t. A.l.• • 1991).
My studies shown i n Fig . J . 15 indicated that squelching-
occurred when BAG-2 was overexprs8liled i n P19 glial cella .
Therefore. the tranlilcriptlonal
raediator/adaptor/coact!vatorvas indicated . A future direction
is to test , isolate and characterize the putative coactivator
between BAG-2 and the basal transcription machinery . Again,
the putative factor can be tested and purified by protein-
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affinity chromatography with GST-BAG-2 f us i on protein, as
described above. Such studies are important t o evaluate the
possible scenario that such an adaptor ill the Ibiting factor
in the kidney and B cella. Then, the latency of JCV in these
cella could be explained. The specificity of such a f act o r in
glial cells ot the CNS could restrict the JCV expression and
pathology of PML.
The results in Fig . 3.21 shoved that BAG-2 repressed t he
p53 promoter. This repress io n 11\aY be achieved by blndinq to
the p53 NF-l motif. In future studies, t o clarify how BAG-2
might have repre9sed the p53 promoter, the following avenues
could be taken .~ transcription a ssay s with increasing
concentrations of my recombinant BAG-2 protein in the presence
and absence of JCIJ HF-l oligonucleotide could be undertaken
using the methods d88cribed previously (Kelleher .It. .ill. ,
1990). The reSUlts would address whether BAG-2 repressed the
p53 promoter by indirectly sequestering the adaptors or
coactlvators fro. the transcriptional machinery .
Alternatively, the lReChllnislR could be direct interaction with
the p53 NF-l motif resulting in repression. This can be tested
by mutating the p53 NF-1 motif , as described previously
(Kunkel .tt..Il•• 1987) .
My studies pr f:s en t ed here 1D.ay address the br ain-specif ic
expression and resul tinq patholoqy i n the eNS and latency i n
other target tissues. However, .any hypotheses require testing
betore a final conclusion can be presented . It the above
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men t i oned hypothese s were p roven t o be correct. then BAG· :Z has
a potential for PHL therapy .
In addition to the illlplications for the patholoqy of JCV,
my studies have identified a. novel transcription fa c t or , MG-
2. Thia cellular protein clearly introduces many exciting
possibilitiea . The con tinement of the brain requires strict
control o f growth by 1lI.echan t s llIs such as apoptosis . Therefore ,
certain non JCV-related etUdies in the future lIay take the
fol lowing directions ; I } Ex aminat ion of the distribution o f
gene expz-eeafcn in va r i ous organs usinq commerciallY available
systems . Su ch systems could be exploited to uncover the
importance of BAG-2 in specific organs . Immunofluorescence
studies of th e interesting- cell types would be a priority 1n
sUbsequent stUdies ot cell speciticity. 2) "Z o o · blots can be
similarly ex amined to evaluate the role of BAG-2 in d ifferent
species . The organs of interest ing and well - studied species
could be examined. Such studies could ad dress the role ot BAG -
2 a nd homologue. in apoptoais for various species across the
phy logenetic spectrum. J ) Th e brain-specificity . and possible
specific i ty to o t her tissues, of BAG-2 could be used t o s tudy
many qenerll1 features of t h e cel lular and molecular biolOCJY
aspects of the exciting process of apop tosis (for reviaw, sea
Hockenbery , 199 5 ) .
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